WO2007117404A2 - Methods and materials for preparing organic compounds from primary amines - Google Patents
Methods and materials for preparing organic compounds from primary amines Download PDFInfo
- Publication number
- WO2007117404A2 WO2007117404A2 PCT/US2007/008221 US2007008221W WO2007117404A2 WO 2007117404 A2 WO2007117404 A2 WO 2007117404A2 US 2007008221 W US2007008221 W US 2007008221W WO 2007117404 A2 WO2007117404 A2 WO 2007117404A2
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- organic
- agent
- nitrosyl
- organic compound
- activating agent
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims abstract description 194
- 150000002894 organic compounds Chemical class 0.000 title claims abstract description 101
- 150000003141 primary amines Chemical class 0.000 title description 23
- 239000000463 material Substances 0.000 title description 3
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 160
- 238000006243 chemical reaction Methods 0.000 claims abstract description 119
- MWUXSHHQAYIFBG-UHFFFAOYSA-N Nitric oxide Chemical group O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 claims abstract description 91
- 230000003213 activating effect Effects 0.000 claims abstract description 75
- 150000004820 halides Chemical class 0.000 claims abstract description 61
- 150000001875 compounds Chemical class 0.000 claims abstract description 36
- 125000002924 primary amino group Chemical class [H]N([H])* 0.000 claims abstract description 36
- GQPLMRYTRLFLPF-UHFFFAOYSA-N Nitrous Oxide Chemical compound [O-][N+]#N GQPLMRYTRLFLPF-UHFFFAOYSA-N 0.000 claims abstract description 26
- 125000000524 functional group Chemical group 0.000 claims abstract description 15
- 239000001272 nitrous oxide Substances 0.000 claims abstract description 10
- -1 alkyl nitrite Chemical compound 0.000 claims description 99
- LPXPTNMVRIOKMN-UHFFFAOYSA-M sodium nitrite Chemical compound [Na+].[O-]N=O LPXPTNMVRIOKMN-UHFFFAOYSA-M 0.000 claims description 72
- 235000001014 amino acid Nutrition 0.000 claims description 69
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 claims description 63
- 150000001413 amino acids Chemical class 0.000 claims description 61
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 57
- 150000001412 amines Chemical class 0.000 claims description 57
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Chemical compound BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 claims description 56
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 53
- 125000004435 hydrogen atom Chemical class [H]* 0.000 claims description 53
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 51
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 claims description 51
- 125000003710 aryl alkyl group Chemical group 0.000 claims description 43
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 42
- 229910052739 hydrogen Inorganic materials 0.000 claims description 42
- 239000001257 hydrogen Substances 0.000 claims description 42
- 229910052794 bromium Inorganic materials 0.000 claims description 41
- 125000000217 alkyl group Chemical group 0.000 claims description 40
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 39
- 125000004446 heteroarylalkyl group Chemical group 0.000 claims description 37
- OWFXIOWLTKNBAP-UHFFFAOYSA-N isoamyl nitrite Chemical compound CC(C)CCON=O OWFXIOWLTKNBAP-UHFFFAOYSA-N 0.000 claims description 33
- PCLIMKBDDGJMGD-UHFFFAOYSA-N N-bromosuccinimide Chemical group BrN1C(=O)CCC1=O PCLIMKBDDGJMGD-UHFFFAOYSA-N 0.000 claims description 32
- IOVCWXUNBOPUCH-UHFFFAOYSA-N Nitrous acid Chemical compound ON=O IOVCWXUNBOPUCH-UHFFFAOYSA-N 0.000 claims description 32
- 239000002253 acid Substances 0.000 claims description 30
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 30
- 125000004404 heteroalkyl group Chemical group 0.000 claims description 30
- 239000002904 solvent Substances 0.000 claims description 30
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims description 26
- 125000003118 aryl group Chemical group 0.000 claims description 25
- 125000001072 heteroaryl group Chemical group 0.000 claims description 25
- 229910052801 chlorine Inorganic materials 0.000 claims description 23
- 229910052731 fluorine Inorganic materials 0.000 claims description 22
- 125000006239 protecting group Chemical group 0.000 claims description 22
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims description 20
- 230000014759 maintenance of location Effects 0.000 claims description 20
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 19
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims description 18
- 235000008206 alpha-amino acids Nutrition 0.000 claims description 17
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 claims description 16
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims description 16
- 125000002252 acyl group Chemical group 0.000 claims description 16
- 125000004453 alkoxycarbonyl group Chemical group 0.000 claims description 16
- 125000005161 aryl oxy carbonyl group Chemical group 0.000 claims description 16
- 235000010288 sodium nitrite Nutrition 0.000 claims description 16
- 125000000547 substituted alkyl group Chemical group 0.000 claims description 16
- 150000001371 alpha-amino acids Chemical class 0.000 claims description 15
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 claims description 15
- 229910052799 carbon Inorganic materials 0.000 claims description 14
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims description 14
- 125000004432 carbon atom Chemical group C* 0.000 claims description 13
- IOVCWXUNBOPUCH-UHFFFAOYSA-M Nitrite anion Chemical compound [O-]N=O IOVCWXUNBOPUCH-UHFFFAOYSA-M 0.000 claims description 12
- 229940061720 alpha hydroxy acid Drugs 0.000 claims description 12
- 150000001280 alpha hydroxy acids Chemical class 0.000 claims description 12
- 239000003153 chemical reaction reagent Substances 0.000 claims description 12
- 125000000753 cycloalkyl group Chemical group 0.000 claims description 11
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 claims description 10
- 125000004093 cyano group Chemical group *C#N 0.000 claims description 9
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims description 9
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims description 8
- 125000003107 substituted aryl group Chemical group 0.000 claims description 8
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 claims description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 8
- VHYBUUMUUNCHCK-UHFFFAOYSA-N 2,4,6-tribromo-1,3,5-triazine Chemical group BrC1=NC(Br)=NC(Br)=N1 VHYBUUMUUNCHCK-UHFFFAOYSA-N 0.000 claims description 7
- 125000004213 tert-butoxy group Chemical group [H]C([H])([H])C(O*)(C([H])([H])[H])C([H])([H])[H] 0.000 claims description 7
- 150000001408 amides Chemical class 0.000 claims description 6
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 6
- 239000011734 sodium Substances 0.000 claims description 6
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 claims description 5
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims description 5
- ATDGTVJJHBUTRL-UHFFFAOYSA-N cyanogen bromide Chemical compound BrC#N ATDGTVJJHBUTRL-UHFFFAOYSA-N 0.000 claims description 5
- MGNCLNQXLYJVJD-UHFFFAOYSA-N cyanuric chloride Chemical group ClC1=NC(Cl)=NC(Cl)=N1 MGNCLNQXLYJVJD-UHFFFAOYSA-N 0.000 claims description 5
- VMKJWLXVLHBJNK-UHFFFAOYSA-N cyanuric fluoride Chemical group FC1=NC(F)=NC(F)=N1 VMKJWLXVLHBJNK-UHFFFAOYSA-N 0.000 claims description 5
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical group I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 claims description 5
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 claims description 5
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 claims description 4
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 claims description 4
- 150000001576 beta-amino acids Chemical class 0.000 claims description 4
- 150000002148 esters Chemical group 0.000 claims description 4
- 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 claims description 4
- SCYULBFZEHDVBN-UHFFFAOYSA-N 1,1-Dichloroethane Chemical compound CC(Cl)Cl SCYULBFZEHDVBN-UHFFFAOYSA-N 0.000 claims description 3
- KRHYYFGTRYWZRS-UHFFFAOYSA-M Fluoride anion Chemical compound [F-] KRHYYFGTRYWZRS-UHFFFAOYSA-M 0.000 claims description 3
- 150000001370 alpha-amino acid derivatives Chemical class 0.000 claims description 3
- YVKOGZPYYZLUDJ-UHFFFAOYSA-N dibromamine Chemical compound BrNBr YVKOGZPYYZLUDJ-UHFFFAOYSA-N 0.000 claims description 3
- 229960004132 diethyl ether Drugs 0.000 claims description 3
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 claims description 3
- 125000005346 substituted cycloalkyl group Chemical group 0.000 claims description 3
- 125000003143 4-hydroxybenzyl group Chemical group [H]C([*])([H])C1=C([H])C([H])=C(O[H])C([H])=C1[H] 0.000 claims description 2
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 claims description 2
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 claims description 2
- 125000002147 dimethylamino group Chemical group [H]C([H])([H])N(*)C([H])([H])[H] 0.000 claims description 2
- 150000002222 fluorine compounds Chemical group 0.000 claims description 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 2
- 125000001981 tert-butyldimethylsilyl group Chemical group [H]C([H])([H])[Si]([H])(C([H])([H])[H])[*]C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H] 0.000 claims description 2
- 230000000717 retained effect Effects 0.000 claims 3
- TVMXDCGIABBOFY-UHFFFAOYSA-N octane Chemical compound CCCCCCCC TVMXDCGIABBOFY-UHFFFAOYSA-N 0.000 claims 2
- DKGAVHZHDRPRBM-UHFFFAOYSA-N Tert-Butanol Chemical compound CC(C)(C)O DKGAVHZHDRPRBM-UHFFFAOYSA-N 0.000 claims 1
- 125000000118 dimethyl group Chemical group [H]C([H])([H])* 0.000 claims 1
- KPUWHANPEXNPJT-UHFFFAOYSA-N disiloxane Chemical group [SiH3]O[SiH3] KPUWHANPEXNPJT-UHFFFAOYSA-N 0.000 claims 1
- QEWYKACRFQMRMB-UHFFFAOYSA-N fluoroacetic acid Chemical compound OC(=O)CF QEWYKACRFQMRMB-UHFFFAOYSA-N 0.000 claims 1
- 150000001298 alcohols Chemical class 0.000 abstract description 5
- HDOUGSFASVGDCS-UHFFFAOYSA-N pyridin-3-ylmethanamine Chemical compound NCC1=CC=CN=C1 HDOUGSFASVGDCS-UHFFFAOYSA-N 0.000 description 24
- 125000001424 substituent group Chemical group 0.000 description 23
- 239000000047 product Substances 0.000 description 21
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 16
- 238000002330 electrospray ionisation mass spectrometry Methods 0.000 description 15
- 235000019439 ethyl acetate Nutrition 0.000 description 13
- 239000000243 solution Substances 0.000 description 13
- 238000007792 addition Methods 0.000 description 12
- 150000001721 carbon Chemical group 0.000 description 12
- 239000007789 gas Substances 0.000 description 12
- 150000003254 radicals Chemical class 0.000 description 12
- 239000000543 intermediate Substances 0.000 description 11
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 10
- 125000003342 alkenyl group Chemical group 0.000 description 10
- 125000000304 alkynyl group Chemical group 0.000 description 10
- JGJLWPGRMCADHB-UHFFFAOYSA-N hypobromite Chemical group Br[O-] JGJLWPGRMCADHB-UHFFFAOYSA-N 0.000 description 10
- 239000000203 mixture Substances 0.000 description 10
- 239000011541 reaction mixture Substances 0.000 description 10
- 229910004749 OS(O)2 Inorganic materials 0.000 description 9
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 9
- 125000005842 heteroatom Chemical group 0.000 description 9
- 229910052757 nitrogen Inorganic materials 0.000 description 9
- 239000012074 organic phase Substances 0.000 description 9
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 9
- KHCXGFNZZRXOND-UHFFFAOYSA-N 3-(bromomethyl)pyridine Chemical compound BrCC1=CC=CN=C1 KHCXGFNZZRXOND-UHFFFAOYSA-N 0.000 description 8
- 230000008569 process Effects 0.000 description 8
- 230000015572 biosynthetic process Effects 0.000 description 7
- 239000011203 carbon fibre reinforced carbon Substances 0.000 description 7
- 238000004128 high performance liquid chromatography Methods 0.000 description 7
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 7
- 150000003839 salts Chemical class 0.000 description 7
- 238000005160 1H NMR spectroscopy Methods 0.000 description 6
- PAYRUJLWNCNPSJ-UHFFFAOYSA-N Aniline Chemical compound NC1=CC=CC=C1 PAYRUJLWNCNPSJ-UHFFFAOYSA-N 0.000 description 6
- 239000007832 Na2SO4 Substances 0.000 description 6
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 6
- 238000004090 dissolution Methods 0.000 description 6
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 6
- 238000004519 manufacturing process Methods 0.000 description 6
- 125000006413 ring segment Chemical group 0.000 description 6
- 229910052938 sodium sulfate Inorganic materials 0.000 description 6
- MVQVNTPHUGQQHK-UHFFFAOYSA-N 3-pyridinemethanol Chemical compound OCC1=CC=CN=C1 MVQVNTPHUGQQHK-UHFFFAOYSA-N 0.000 description 5
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 5
- SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical compound C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 description 5
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 5
- 238000006193 diazotization reaction Methods 0.000 description 5
- 238000002360 preparation method Methods 0.000 description 5
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 5
- 239000007858 starting material Substances 0.000 description 5
- 239000000758 substrate Substances 0.000 description 5
- ODKSFYDXXFIFQN-BYPYZUCNSA-N L-arginine Chemical compound OC(=O)[C@@H](N)CCCN=C(N)N ODKSFYDXXFIFQN-BYPYZUCNSA-N 0.000 description 4
- 238000005481 NMR spectroscopy Methods 0.000 description 4
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 4
- KYQCOXFCLRTKLS-UHFFFAOYSA-N Pyrazine Chemical compound C1=CN=CC=N1 KYQCOXFCLRTKLS-UHFFFAOYSA-N 0.000 description 4
- KAESVJOAVNADME-UHFFFAOYSA-N Pyrrole Chemical compound C=1C=CNC=1 KAESVJOAVNADME-UHFFFAOYSA-N 0.000 description 4
- SMWDFEZZVXVKRB-UHFFFAOYSA-N Quinoline Chemical compound N1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-N 0.000 description 4
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 4
- YTPLMLYBLZKORZ-UHFFFAOYSA-N Thiophene Chemical compound C=1C=CSC=1 YTPLMLYBLZKORZ-UHFFFAOYSA-N 0.000 description 4
- 230000008901 benefit Effects 0.000 description 4
- 239000012267 brine Substances 0.000 description 4
- 125000004433 nitrogen atom Chemical group N* 0.000 description 4
- 125000000018 nitroso group Chemical group N(=O)* 0.000 description 4
- 229910052760 oxygen Inorganic materials 0.000 description 4
- 229920006395 saturated elastomer Polymers 0.000 description 4
- GEHJYWRUCIMESM-UHFFFAOYSA-L sodium sulfite Chemical compound [Na+].[Na+].[O-]S([O-])=O GEHJYWRUCIMESM-UHFFFAOYSA-L 0.000 description 4
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 4
- 239000007787 solid Substances 0.000 description 4
- 238000006467 substitution reaction Methods 0.000 description 4
- 229910052717 sulfur Inorganic materials 0.000 description 4
- XPQIPUZPSLAZDV-UHFFFAOYSA-N 2-pyridylethylamine Chemical compound NCCC1=CC=CC=N1 XPQIPUZPSLAZDV-UHFFFAOYSA-N 0.000 description 3
- XMIIGOLPHOKFCH-UHFFFAOYSA-N 3-phenylpropionic acid Chemical compound OC(=O)CCC1=CC=CC=C1 XMIIGOLPHOKFCH-UHFFFAOYSA-N 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 3
- OFOBLEOULBTSOW-UHFFFAOYSA-N Malonic acid Chemical compound OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 3
- PCNDJXKNXGMECE-UHFFFAOYSA-N Phenazine Natural products C1=CC=CC2=NC3=CC=CC=C3N=C21 PCNDJXKNXGMECE-UHFFFAOYSA-N 0.000 description 3
- 125000004429 atom Chemical group 0.000 description 3
- XSCHRSMBECNVNS-UHFFFAOYSA-N benzopyrazine Natural products N1=CC=NC2=CC=CC=C21 XSCHRSMBECNVNS-UHFFFAOYSA-N 0.000 description 3
- 150000001649 bromium compounds Chemical class 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 125000000664 diazo group Chemical group [N-]=[N+]=[*] 0.000 description 3
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 3
- GVEPBJHOBDJJJI-UHFFFAOYSA-N fluoranthene Chemical compound C1=CC(C2=CC=CC=C22)=C3C2=CC=CC3=C1 GVEPBJHOBDJJJI-UHFFFAOYSA-N 0.000 description 3
- 125000001475 halogen functional group Chemical group 0.000 description 3
- 238000002329 infrared spectrum Methods 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 3
- 239000000725 suspension Substances 0.000 description 3
- 230000009466 transformation Effects 0.000 description 3
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 description 3
- 125000004953 trihalomethyl group Chemical group 0.000 description 3
- KSDTXRUIZMTBNV-INIZCTEOSA-N (2s)-2-(9h-fluoren-9-ylmethoxycarbonylamino)butanedioic acid Chemical compound C1=CC=C2C(COC(=O)N[C@@H](CC(=O)O)C(O)=O)C3=CC=CC=C3C2=C1 KSDTXRUIZMTBNV-INIZCTEOSA-N 0.000 description 2
- DYWUPCCKOVTCFZ-LBPRGKRZSA-N (2s)-2-amino-3-[1-[(2-methylpropan-2-yl)oxycarbonyl]indol-3-yl]propanoic acid Chemical compound C1=CC=C2N(C(=O)OC(C)(C)C)C=C(C[C@H](N)C(O)=O)C2=C1 DYWUPCCKOVTCFZ-LBPRGKRZSA-N 0.000 description 2
- VVQIIIAZJXTLRE-QMMMGPOBSA-N (2s)-2-amino-6-[(2-methylpropan-2-yl)oxycarbonylamino]hexanoic acid Chemical compound CC(C)(C)OC(=O)NCCCC[C@H](N)C(O)=O VVQIIIAZJXTLRE-QMMMGPOBSA-N 0.000 description 2
- OIODSHQRJGRDLE-REOHCLBHSA-N (2s)-2-bromo-3-hydroxypropanoic acid Chemical compound OC[C@H](Br)C(O)=O OIODSHQRJGRDLE-REOHCLBHSA-N 0.000 description 2
- 125000000008 (C1-C10) alkyl group Chemical group 0.000 description 2
- 125000006736 (C6-C20) aryl group Chemical group 0.000 description 2
- 125000003088 (fluoren-9-ylmethoxy)carbonyl group Chemical group 0.000 description 2
- FCEHBMOGCRZNNI-UHFFFAOYSA-N 1-benzothiophene Chemical compound C1=CC=C2SC=CC2=C1 FCEHBMOGCRZNNI-UHFFFAOYSA-N 0.000 description 2
- YBYIRNPNPLQARY-UHFFFAOYSA-N 1H-indene Chemical compound C1=CC=C2CC=CC2=C1 YBYIRNPNPLQARY-UHFFFAOYSA-N 0.000 description 2
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 2
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 description 2
- NVRVNSHHLPQGCU-UHFFFAOYSA-N 6-bromohexanoic acid Chemical compound OC(=O)CCCCCBr NVRVNSHHLPQGCU-UHFFFAOYSA-N 0.000 description 2
- IWHLYPDWHHPVAA-UHFFFAOYSA-N 6-hydroxyhexanoic acid Chemical compound OCCCCCC(O)=O IWHLYPDWHHPVAA-UHFFFAOYSA-N 0.000 description 2
- KDCGOANMDULRCW-UHFFFAOYSA-N 7H-purine Chemical compound N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 description 2
- 125000001313 C5-C10 heteroaryl group Chemical group 0.000 description 2
- RGSFGYAAUTVSQA-UHFFFAOYSA-N Cyclopentane Chemical compound C1CCCC1 RGSFGYAAUTVSQA-UHFFFAOYSA-N 0.000 description 2
- RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 2
- 238000004566 IR spectroscopy Methods 0.000 description 2
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 2
- YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical compound C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 description 2
- UFWIBTONFRDIAS-UHFFFAOYSA-N Naphthalene Chemical compound C1=CC=CC2=CC=CC=C21 UFWIBTONFRDIAS-UHFFFAOYSA-N 0.000 description 2
- ZCQWOFVYLHDMMC-UHFFFAOYSA-N Oxazole Chemical compound C1=COC=N1 ZCQWOFVYLHDMMC-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- GLUUGHFHXGJENI-UHFFFAOYSA-N Piperazine Chemical compound C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 description 2
- WTKZEGDFNFYCGP-UHFFFAOYSA-N Pyrazole Chemical compound C=1C=NNC=1 WTKZEGDFNFYCGP-UHFFFAOYSA-N 0.000 description 2
- LCTONWCANYUPML-UHFFFAOYSA-N Pyruvic acid Chemical compound CC(=O)C(O)=O LCTONWCANYUPML-UHFFFAOYSA-N 0.000 description 2
- 229910019999 S(O)2O Inorganic materials 0.000 description 2
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 2
- 230000002378 acidificating effect Effects 0.000 description 2
- DZBUGLKDJFMEHC-UHFFFAOYSA-N acridine Chemical compound C1=CC=CC2=CC3=CC=CC=C3N=C21 DZBUGLKDJFMEHC-UHFFFAOYSA-N 0.000 description 2
- 125000002015 acyclic group Chemical group 0.000 description 2
- 150000001335 aliphatic alkanes Chemical class 0.000 description 2
- 150000001336 alkenes Chemical class 0.000 description 2
- 150000001345 alkine derivatives Chemical class 0.000 description 2
- 125000003545 alkoxy group Chemical group 0.000 description 2
- HSFWRNGVRCDJHI-UHFFFAOYSA-N alpha-acetylene Natural products C#C HSFWRNGVRCDJHI-UHFFFAOYSA-N 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- MWPLVEDNUUSJAV-UHFFFAOYSA-N anthracene Chemical compound C1=CC=CC2=CC3=CC=CC=C3C=C21 MWPLVEDNUUSJAV-UHFFFAOYSA-N 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 150000004982 aromatic amines Chemical class 0.000 description 2
- 150000001540 azides Chemical class 0.000 description 2
- CUFNKYGDVFVPHO-UHFFFAOYSA-N azulene Chemical compound C1=CC=CC2=CC=CC2=C1 CUFNKYGDVFVPHO-UHFFFAOYSA-N 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- FNXLCIKXHOPCKH-UHFFFAOYSA-N bromamine Chemical compound BrN FNXLCIKXHOPCKH-UHFFFAOYSA-N 0.000 description 2
- 125000001246 bromo group Chemical group Br* 0.000 description 2
- AOJDZKCUAATBGE-UHFFFAOYSA-N bromomethane Chemical compound Br[CH2] AOJDZKCUAATBGE-UHFFFAOYSA-N 0.000 description 2
- 238000004587 chromatography analysis Methods 0.000 description 2
- WDECIBYCCFPHNR-UHFFFAOYSA-N chrysene Chemical compound C1=CC=CC2=CC=C3C4=CC=CC=C4C=CC3=C21 WDECIBYCCFPHNR-UHFFFAOYSA-N 0.000 description 2
- 238000012790 confirmation Methods 0.000 description 2
- VPUGDVKSAQVFFS-UHFFFAOYSA-N coronene Chemical compound C1=C(C2=C34)C=CC3=CC=C(C=C3)C4=C4C3=CC=C(C=C3)C4=C2C3=C1 VPUGDVKSAQVFFS-UHFFFAOYSA-N 0.000 description 2
- 239000012954 diazonium Substances 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-O diazynium Chemical compound [NH+]#N IJGRMHOSHXDMSA-UHFFFAOYSA-O 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 2
- 230000008034 disappearance Effects 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 229940052303 ethers for general anesthesia Drugs 0.000 description 2
- 125000002534 ethynyl group Chemical group [H]C#C* 0.000 description 2
- 125000002485 formyl group Chemical class [H]C(*)=O 0.000 description 2
- 229910052736 halogen Inorganic materials 0.000 description 2
- 125000005843 halogen group Chemical group 0.000 description 2
- 150000002367 halogens Chemical class 0.000 description 2
- 230000020169 heat generation Effects 0.000 description 2
- PQNFLJBBNBOBRQ-UHFFFAOYSA-N indane Chemical compound C1=CC=C2CCCC2=C1 PQNFLJBBNBOBRQ-UHFFFAOYSA-N 0.000 description 2
- PZOUSPYUWWUPPK-UHFFFAOYSA-N indole Natural products CC1=CC=CC2=C1C=CN2 PZOUSPYUWWUPPK-UHFFFAOYSA-N 0.000 description 2
- RKJUIXBNRJVNHR-UHFFFAOYSA-N indolenine Natural products C1=CC=C2CC=NC2=C1 RKJUIXBNRJVNHR-UHFFFAOYSA-N 0.000 description 2
- SUMDYPCJJOFFON-UHFFFAOYSA-N isethionic acid Chemical compound OCCS(O)(=O)=O SUMDYPCJJOFFON-UHFFFAOYSA-N 0.000 description 2
- AWJUIBRHMBBTKR-UHFFFAOYSA-N isoquinoline Chemical compound C1=NC=CC2=CC=CC=C21 AWJUIBRHMBBTKR-UHFFFAOYSA-N 0.000 description 2
- CTAPFRYPJLPFDF-UHFFFAOYSA-N isoxazole Chemical compound C=1C=NOC=1 CTAPFRYPJLPFDF-UHFFFAOYSA-N 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 238000001819 mass spectrum Methods 0.000 description 2
- 150000007522 mineralic acids Chemical class 0.000 description 2
- TXXHDPDFNKHHGW-UHFFFAOYSA-N muconic acid Chemical compound OC(=O)C=CC=CC(O)=O TXXHDPDFNKHHGW-UHFFFAOYSA-N 0.000 description 2
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 2
- FUZZWVXGSFPDMH-UHFFFAOYSA-N n-hexanoic acid Natural products CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 description 2
- 150000002826 nitrites Chemical class 0.000 description 2
- 125000005245 nitryl group Chemical group [N+](=O)([O-])* 0.000 description 2
- 230000003287 optical effect Effects 0.000 description 2
- 150000007524 organic acids Chemical class 0.000 description 2
- 150000007530 organic bases Chemical class 0.000 description 2
- 230000037361 pathway Effects 0.000 description 2
- YNPNZTXNASCQKK-UHFFFAOYSA-N phenanthrene Chemical compound C1=CC=C2C3=CC=CC=C3C=CC2=C1 YNPNZTXNASCQKK-UHFFFAOYSA-N 0.000 description 2
- RDOWQLZANAYVLL-UHFFFAOYSA-N phenanthridine Chemical compound C1=CC=C2C3=CC=CC=C3C=NC2=C1 RDOWQLZANAYVLL-UHFFFAOYSA-N 0.000 description 2
- GBROPGWFBFCKAG-UHFFFAOYSA-N picene Chemical compound C1=CC2=C3C=CC=CC3=CC=C2C2=C1C1=CC=CC=C1C=C2 GBROPGWFBFCKAG-UHFFFAOYSA-N 0.000 description 2
- IOLCXVTUBQKXJR-UHFFFAOYSA-M potassium bromide Chemical compound [K+].[Br-] IOLCXVTUBQKXJR-UHFFFAOYSA-M 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- BBEAQIROQSPTKN-UHFFFAOYSA-N pyrene Chemical compound C1=CC=C2C=CC3=CC=CC4=CC=C1C2=C43 BBEAQIROQSPTKN-UHFFFAOYSA-N 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 238000013341 scale-up Methods 0.000 description 2
- 239000012363 selectfluor Substances 0.000 description 2
- 229910052710 silicon Inorganic materials 0.000 description 2
- 239000000377 silicon dioxide Substances 0.000 description 2
- 235000010265 sodium sulphite Nutrition 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 229930192474 thiophene Natural products 0.000 description 2
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 2
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- QBYIENPQHBMVBV-HFEGYEGKSA-N (2R)-2-hydroxy-2-phenylacetic acid Chemical compound O[C@@H](C(O)=O)c1ccccc1.O[C@@H](C(O)=O)c1ccccc1 QBYIENPQHBMVBV-HFEGYEGKSA-N 0.000 description 1
- PXBMQFMUHRNKTG-HXUWFJFHSA-N (2r)-2-(9h-fluoren-9-ylmethoxycarbonylamino)-3-thiophen-2-ylpropanoic acid Chemical compound C([C@H](C(=O)O)NC(=O)OCC1C2=CC=CC=C2C2=CC=CC=C21)C1=CC=CS1 PXBMQFMUHRNKTG-HXUWFJFHSA-N 0.000 description 1
- CIHPCIUGLIZADU-HSZRJFAPSA-N (2r)-2-(9h-fluoren-9-ylmethoxycarbonylamino)-4-phenylbutanoic acid Chemical compound C([C@H](C(=O)O)NC(=O)OCC1C2=CC=CC=C2C2=CC=CC=C21)CC1=CC=CC=C1 CIHPCIUGLIZADU-HSZRJFAPSA-N 0.000 description 1
- JOOIZTMAHNLNHE-OAQYLSRUSA-N (2r)-2-(9h-fluoren-9-ylmethoxycarbonylamino)-5-[(2-methylpropan-2-yl)oxycarbonylamino]pentanoic acid Chemical compound C1=CC=C2C(COC(=O)N[C@H](CCCNC(=O)OC(C)(C)C)C(O)=O)C3=CC=CC=C3C2=C1 JOOIZTMAHNLNHE-OAQYLSRUSA-N 0.000 description 1
- VCFCFPNRQDANPN-LJQANCHMSA-N (2r)-2-(9h-fluoren-9-ylmethoxycarbonylamino)hexanoic acid Chemical compound C1=CC=C2C(COC(=O)N[C@H](CCCC)C(O)=O)C3=CC=CC=C3C2=C1 VCFCFPNRQDANPN-LJQANCHMSA-N 0.000 description 1
- JBIJSEUVWWLFGV-GOSISDBHSA-N (2r)-2-(9h-fluoren-9-ylmethoxycarbonylamino)pentanoic acid Chemical compound C1=CC=C2C(COC(=O)N[C@H](CCC)C(O)=O)C3=CC=CC=C3C2=C1 JBIJSEUVWWLFGV-GOSISDBHSA-N 0.000 description 1
- BWQQGHPODCJZDB-OAQYLSRUSA-N (2r)-2-cyclohexyl-2-(9h-fluoren-9-ylmethoxycarbonylamino)acetic acid Chemical compound C1([C@@H](NC(=O)OCC2C3=CC=CC=C3C3=CC=CC=C32)C(=O)O)CCCCC1 BWQQGHPODCJZDB-OAQYLSRUSA-N 0.000 description 1
- QNVHCYWPXIGFGN-JOCHJYFZSA-N (2r)-3-(3,4-dichlorophenyl)-2-(9h-fluoren-9-ylmethoxycarbonylamino)propanoic acid Chemical compound C([C@H](C(=O)O)NC(=O)OCC1C2=CC=CC=C2C2=CC=CC=C21)C1=CC=C(Cl)C(Cl)=C1 QNVHCYWPXIGFGN-JOCHJYFZSA-N 0.000 description 1
- OUXUHWHQQLGDQE-SFHVURJKSA-N (2r)-3-ethylsulfanyl-2-(9h-fluoren-9-ylmethoxycarbonylamino)propanoic acid Chemical compound C1=CC=C2C(COC(=O)N[C@@H](CSCC)C(O)=O)C3=CC=CC=C3C2=C1 OUXUHWHQQLGDQE-SFHVURJKSA-N 0.000 description 1
- NBMSMZSRTIOFOK-GOSISDBHSA-N (2r)-5-(carbamoylamino)-2-(9h-fluoren-9-ylmethoxycarbonylamino)pentanoic acid Chemical compound C1=CC=C2C(COC(=O)N[C@H](CCCNC(=O)N)C(O)=O)C3=CC=CC=C3C2=C1 NBMSMZSRTIOFOK-GOSISDBHSA-N 0.000 description 1
- JRRARHJPRLAGNT-RUZDIDTESA-N (2r)-5-[[amino-[(4-methylphenyl)sulfonylamino]methylidene]amino]-2-(9h-fluoren-9-ylmethoxycarbonylamino)pentanoic acid Chemical compound C1=CC(C)=CC=C1S(=O)(=O)NC(N)=NCCC[C@H](C(O)=O)NC(=O)OCC1C2=CC=CC=C2C2=CC=CC=C21 JRRARHJPRLAGNT-RUZDIDTESA-N 0.000 description 1
- IZKGGDFLLNVXNZ-QGZVFWFLSA-N (2r)-5-amino-2-(9h-fluoren-9-ylmethoxycarbonylamino)-5-oxopentanoic acid Chemical compound C1=CC=C2C(COC(=O)N[C@H](CCC(=O)N)C(O)=O)C3=CC=CC=C3C2=C1 IZKGGDFLLNVXNZ-QGZVFWFLSA-N 0.000 description 1
- OYULCCKKLJPNPU-PIGZYNQJSA-N (2r,3r)-2-(9h-fluoren-9-ylmethoxycarbonylamino)-3-hydroxybutanoic acid Chemical compound C1=CC=C2C(COC(=O)N[C@H]([C@H](O)C)C(O)=O)C3=CC=CC=C3C2=C1 OYULCCKKLJPNPU-PIGZYNQJSA-N 0.000 description 1
- HPTFPWMPQFBSHP-IBGZPJMESA-N (2s)-1-[2-(9h-fluoren-9-ylmethoxycarbonylamino)acetyl]pyrrolidine-2-carboxylic acid Chemical compound OC(=O)[C@@H]1CCCN1C(=O)CNC(=O)OCC1C2=CC=CC=C2C2=CC=CC=C21 HPTFPWMPQFBSHP-IBGZPJMESA-N 0.000 description 1
- SWZCTMTWRHEBIN-QFIPXVFZSA-N (2s)-2-(9h-fluoren-9-ylmethoxycarbonylamino)-3-(4-hydroxyphenyl)propanoic acid Chemical compound C([C@@H](C(=O)O)NC(=O)OCC1C2=CC=CC=C2C2=CC=CC=C21)C1=CC=C(O)C=C1 SWZCTMTWRHEBIN-QFIPXVFZSA-N 0.000 description 1
- JYQODLWFOPCSCS-QHCPKHFHSA-N (2s)-2-(9h-fluoren-9-ylmethoxycarbonylamino)-3-(4-methoxyphenyl)propanoic acid Chemical compound C1=CC(OC)=CC=C1C[C@@H](C(O)=O)NC(=O)OCC1C2=CC=CC=C2C2=CC=CC=C21 JYQODLWFOPCSCS-QHCPKHFHSA-N 0.000 description 1
- REHSJSKPWIOKIJ-LJAQVGFWSA-N (2s)-2-(9h-fluoren-9-ylmethoxycarbonylamino)-3-(4-phenylmethoxyphenyl)propanoic acid Chemical compound C([C@@H](C(=O)O)NC(=O)OCC1C2=CC=CC=C2C2=CC=CC=C21)C(C=C1)=CC=C1OCC1=CC=CC=C1 REHSJSKPWIOKIJ-LJAQVGFWSA-N 0.000 description 1
- REITVGIIZHFVGU-IBGZPJMESA-N (2s)-2-(9h-fluoren-9-ylmethoxycarbonylamino)-3-[(2-methylpropan-2-yl)oxy]propanoic acid Chemical compound C1=CC=C2C(COC(=O)N[C@@H](COC(C)(C)C)C(O)=O)C3=CC=CC=C3C2=C1 REITVGIIZHFVGU-IBGZPJMESA-N 0.000 description 1
- ZRHPMMZWDWMKPD-QFIPXVFZSA-N (2s)-2-(9h-fluoren-9-ylmethoxycarbonylamino)-3-[1-[(2-methylpropan-2-yl)oxycarbonyl]imidazol-4-yl]propanoic acid Chemical compound CC(C)(C)OC(=O)N1C=NC(C[C@H](NC(=O)OCC2C3=CC=CC=C3C3=CC=CC=C32)C(O)=O)=C1 ZRHPMMZWDWMKPD-QFIPXVFZSA-N 0.000 description 1
- JAUKCFULLJFBFN-VWLOTQADSA-N (2s)-2-(9h-fluoren-9-ylmethoxycarbonylamino)-3-[4-[(2-methylpropan-2-yl)oxy]phenyl]propanoic acid Chemical compound C1=CC(OC(C)(C)C)=CC=C1C[C@@H](C(O)=O)NC(=O)OCC1C2=CC=CC=C2C2=CC=CC=C21 JAUKCFULLJFBFN-VWLOTQADSA-N 0.000 description 1
- JYUTZJVERLGMQZ-SANMLTNESA-N (2s)-2-(9h-fluoren-9-ylmethoxycarbonylamino)-3-naphthalen-2-ylpropanoic acid Chemical compound C12=CC=CC=C2C2=CC=CC=C2C1COC(=O)N[C@H](C(=O)O)CC1=CC=C(C=CC=C2)C2=C1 JYUTZJVERLGMQZ-SANMLTNESA-N 0.000 description 1
- DYBDGLCDMLNEMJ-QHCPKHFHSA-N (2s)-2-(9h-fluoren-9-ylmethoxycarbonylamino)-3-phenylmethoxypropanoic acid Chemical compound C([C@@H](C(=O)O)NC(=O)OCC1C2=CC=CC=C2C2=CC=CC=C21)OCC1=CC=CC=C1 DYBDGLCDMLNEMJ-QHCPKHFHSA-N 0.000 description 1
- SJVFAHZPLIXNDH-QFIPXVFZSA-N (2s)-2-(9h-fluoren-9-ylmethoxycarbonylamino)-3-phenylpropanoic acid Chemical compound C([C@@H](C(=O)O)NC(=O)OCC1C2=CC=CC=C2C2=CC=CC=C21)C1=CC=CC=C1 SJVFAHZPLIXNDH-QFIPXVFZSA-N 0.000 description 1
- JQLPMTXRCLXOJO-NRFANRHFSA-N (2s)-2-(9h-fluoren-9-ylmethoxycarbonylamino)-3-pyridin-3-ylpropanoic acid Chemical compound C([C@@H](C(=O)O)NC(=O)OCC1C2=CC=CC=C2C2=CC=CC=C21)C1=CC=CN=C1 JQLPMTXRCLXOJO-NRFANRHFSA-N 0.000 description 1
- PXBMQFMUHRNKTG-FQEVSTJZSA-N (2s)-2-(9h-fluoren-9-ylmethoxycarbonylamino)-3-thiophen-2-ylpropanoic acid Chemical compound C([C@@H](C(=O)O)NC(=O)OCC1C2=CC=CC=C2C2=CC=CC=C21)C1=CC=CS1 PXBMQFMUHRNKTG-FQEVSTJZSA-N 0.000 description 1
- FODJWPHPWBKDON-IBGZPJMESA-N (2s)-2-(9h-fluoren-9-ylmethoxycarbonylamino)-4-[(2-methylpropan-2-yl)oxy]-4-oxobutanoic acid Chemical compound C1=CC=C2C(COC(=O)N[C@@H](CC(=O)OC(C)(C)C)C(O)=O)C3=CC=CC=C3C2=C1 FODJWPHPWBKDON-IBGZPJMESA-N 0.000 description 1
- FBNFRRNBFASDKS-IBGZPJMESA-N (2s)-2-(9h-fluoren-9-ylmethoxycarbonylamino)-4-oxo-4-prop-2-enoxybutanoic acid Chemical compound C1=CC=C2C(COC(=O)N[C@@H](CC(=O)OCC=C)C(=O)O)C3=CC=CC=C3C2=C1 FBNFRRNBFASDKS-IBGZPJMESA-N 0.000 description 1
- ORRRSRMARPWARV-VWLOTQADSA-N (2s)-2-(9h-fluoren-9-ylmethoxycarbonylamino)-5-oxo-5-[(2,4,6-trimethoxyphenyl)methylamino]pentanoic acid Chemical compound COC1=CC(OC)=CC(OC)=C1CNC(=O)CC[C@@H](C(O)=O)NC(=O)OCC1C2=CC=CC=C2C2=CC=CC=C21 ORRRSRMARPWARV-VWLOTQADSA-N 0.000 description 1
- UMRUUWFGLGNQLI-QFIPXVFZSA-N (2s)-2-(9h-fluoren-9-ylmethoxycarbonylamino)-6-[(2-methylpropan-2-yl)oxycarbonylamino]hexanoic acid Chemical compound C1=CC=C2C(COC(=O)N[C@@H](CCCCNC(=O)OC(C)(C)C)C(O)=O)C3=CC=CC=C3C2=C1 UMRUUWFGLGNQLI-QFIPXVFZSA-N 0.000 description 1
- QWXZOFZKSQXPDC-NSHDSACASA-N (2s)-2-(9h-fluoren-9-ylmethoxycarbonylamino)propanoic acid Chemical compound C1=CC=C2C(COC(=O)N[C@@H](C)C(O)=O)C3=CC=CC=C3C2=C1 QWXZOFZKSQXPDC-NSHDSACASA-N 0.000 description 1
- KZPTXQVSHOISSL-KYJUHHDHSA-N (2s)-2-[[(2s)-2-(9h-fluoren-9-ylmethoxycarbonylamino)-3-phenylpropanoyl]amino]-3-phenylpropanoic acid Chemical compound C([C@@H](C(=O)O)NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)OCC1C2=CC=CC=C2C2=CC=CC=C21)C1=CC=CC=C1 KZPTXQVSHOISSL-KYJUHHDHSA-N 0.000 description 1
- UEBARDWJXBGYEJ-BYPYZUCNSA-N (2s)-2-bromo-3-methylbutanoic acid Chemical compound CC(C)[C@H](Br)C(O)=O UEBARDWJXBGYEJ-BYPYZUCNSA-N 0.000 description 1
- NNFDHJQLIFECSR-YFKPBYRVSA-N (2s)-2-bromo-4-methylpentanoic acid Chemical compound CC(C)C[C@H](Br)C(O)=O NNFDHJQLIFECSR-YFKPBYRVSA-N 0.000 description 1
- MONMFXREYOKQTI-REOHCLBHSA-N (2s)-2-bromopropanoic acid Chemical compound C[C@H](Br)C(O)=O MONMFXREYOKQTI-REOHCLBHSA-N 0.000 description 1
- AZBCBZPTQNYCPF-SANMLTNESA-N (2s)-3-(1-benzylimidazol-4-yl)-2-(9h-fluoren-9-ylmethoxycarbonylamino)propanoic acid Chemical compound C([C@@H](C(=O)O)NC(=O)OCC1C2=CC=CC=C2C2=CC=CC=C21)C(N=C1)=CN1CC1=CC=CC=C1 AZBCBZPTQNYCPF-SANMLTNESA-N 0.000 description 1
- IXAYZHCPEYTWHW-LJQANCHMSA-N (2s)-3-tert-butylsulfanyl-2-(9h-fluoren-9-ylmethoxycarbonylamino)propanoic acid Chemical compound C1=CC=C2C(COC(=O)N[C@H](CSC(C)(C)C)C(O)=O)C3=CC=CC=C3C2=C1 IXAYZHCPEYTWHW-LJQANCHMSA-N 0.000 description 1
- MJZDTTZGQUEOBL-FQEVSTJZSA-N (2s)-4-(9h-fluoren-9-ylmethoxycarbonylamino)-2-[(2-methylpropan-2-yl)oxycarbonylamino]butanoic acid Chemical compound C1=CC=C2C(COC(=O)NCC[C@H](NC(=O)OC(C)(C)C)C(O)=O)C3=CC=CC=C3C2=C1 MJZDTTZGQUEOBL-FQEVSTJZSA-N 0.000 description 1
- YUGBZNJSGOBFOV-INIZCTEOSA-N (2s)-4-amino-2-(9h-fluoren-9-ylmethoxycarbonylamino)-4-oxobutanoic acid Chemical compound C1=CC=C2C(COC(=O)N[C@@H](CC(=O)N)C(O)=O)C3=CC=CC=C3C2=C1 YUGBZNJSGOBFOV-INIZCTEOSA-N 0.000 description 1
- YEBWACZYMHWWEK-NRFANRHFSA-N (2s)-5-(9h-fluoren-9-ylmethoxycarbonylamino)-2-[(2-methylpropan-2-yl)oxycarbonylamino]pentanoic acid Chemical compound C1=CC=C2C(COC(=O)NCCC[C@H](NC(=O)OC(C)(C)C)C(O)=O)C3=CC=CC=C3C2=C1 YEBWACZYMHWWEK-NRFANRHFSA-N 0.000 description 1
- DVBUCBXGDWWXNY-SFHVURJKSA-N (2s)-5-(diaminomethylideneamino)-2-(9h-fluoren-9-ylmethoxycarbonylamino)pentanoic acid Chemical compound C1=CC=C2C(COC(=O)N[C@@H](CCCN=C(N)N)C(O)=O)C3=CC=CC=C3C2=C1 DVBUCBXGDWWXNY-SFHVURJKSA-N 0.000 description 1
- JHMUQIZIPLJEHW-SANMLTNESA-N (2s)-5-[[amino-[(2,4,6-trimethylphenyl)sulfonylamino]methylidene]amino]-2-(9h-fluoren-9-ylmethoxycarbonylamino)pentanoic acid Chemical compound CC1=CC(C)=CC(C)=C1S(=O)(=O)NC(N)=NCCC[C@@H](C(O)=O)NC(=O)OCC1C2=CC=CC=C2C2=CC=CC=C21 JHMUQIZIPLJEHW-SANMLTNESA-N 0.000 description 1
- IZKGGDFLLNVXNZ-KRWDZBQOSA-N (2s)-5-amino-2-(9h-fluoren-9-ylmethoxycarbonylamino)-5-oxopentanoic acid Chemical compound C1=CC=C2C(COC(=O)N[C@@H](CCC(=O)N)C(O)=O)C3=CC=CC=C3C2=C1 IZKGGDFLLNVXNZ-KRWDZBQOSA-N 0.000 description 1
- JYEVQYFWINBXJU-QFIPXVFZSA-N (2s)-6-(9h-fluoren-9-ylmethoxycarbonylamino)-2-[(2-methylpropan-2-yl)oxycarbonylamino]hexanoic acid Chemical compound C1=CC=C2C(COC(=O)NCCCC[C@H](NC(=O)OC(C)(C)C)C(O)=O)C3=CC=CC=C3C2=C1 JYEVQYFWINBXJU-QFIPXVFZSA-N 0.000 description 1
- HQLBYVWJOXITAM-NRFANRHFSA-N (2s)-6-acetamido-2-(9h-fluoren-9-ylmethoxycarbonylamino)hexanoic acid Chemical compound C1=CC=C2C(COC(=O)N[C@@H](CCCCNC(=O)C)C(O)=O)C3=CC=CC=C3C2=C1 HQLBYVWJOXITAM-NRFANRHFSA-N 0.000 description 1
- UCDMMWCWPVCHLL-OSPHWJPCSA-N (2s,3r)-2-(9h-fluoren-9-ylmethoxycarbonylamino)-3-phenylmethoxybutanoic acid Chemical compound O([C@H](C)[C@H](NC(=O)OCC1C2=CC=CC=C2C2=CC=CC=C21)C(O)=O)CC1=CC=CC=C1 UCDMMWCWPVCHLL-OSPHWJPCSA-N 0.000 description 1
- LZOLWEQBVPVDPR-XOBRGWDASA-N (2s,3s)-2-(9h-fluoren-9-ylmethoxycarbonylamino)-3-[(2-methylpropan-2-yl)oxy]butanoic acid Chemical compound C1=CC=C2C(COC(=O)N[C@@H]([C@@H](OC(C)(C)C)C)C(O)=O)C3=CC=CC=C3C2=C1 LZOLWEQBVPVDPR-XOBRGWDASA-N 0.000 description 1
- LIRBCUNCXDZOOU-HSZRJFAPSA-N (3r)-2-(9h-fluoren-9-ylmethoxycarbonyl)-3,4-dihydro-1h-isoquinoline-3-carboxylic acid Chemical compound C12=CC=CC=C2C2=CC=CC=C2C1COC(=O)N1CC2=CC=CC=C2C[C@@H]1C(=O)O LIRBCUNCXDZOOU-HSZRJFAPSA-N 0.000 description 1
- 125000003837 (C1-C20) alkyl group Chemical group 0.000 description 1
- 125000006273 (C1-C3) alkyl group Chemical group 0.000 description 1
- 125000006737 (C6-C20) arylalkyl group Chemical group 0.000 description 1
- VOXXWSYKYCBWHO-MRVPVSSYSA-N (R)-3-phenyllactic acid Chemical compound OC(=O)[C@H](O)CC1=CC=CC=C1 VOXXWSYKYCBWHO-MRVPVSSYSA-N 0.000 description 1
- MIOPJNTWMNEORI-GMSGAONNSA-N (S)-camphorsulfonic acid Chemical compound C1C[C@@]2(CS(O)(=O)=O)C(=O)C[C@@H]1C2(C)C MIOPJNTWMNEORI-GMSGAONNSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- WBYWAXJHAXSJNI-VOTSOKGWSA-M .beta-Phenylacrylic acid Natural products [O-]C(=O)\C=C\C1=CC=CC=C1 WBYWAXJHAXSJNI-VOTSOKGWSA-M 0.000 description 1
- FLBAYUMRQUHISI-UHFFFAOYSA-N 1,8-naphthyridine Chemical compound N1=CC=CC2=CC=CN=C21 FLBAYUMRQUHISI-UHFFFAOYSA-N 0.000 description 1
- YXZFFTJAHVMMLF-UHFFFAOYSA-N 1-bromo-3-methylbutane Chemical compound CC(C)CCBr YXZFFTJAHVMMLF-UHFFFAOYSA-N 0.000 description 1
- JVESLFWSVWNBQV-UHFFFAOYSA-N 1-ethylbenzimidazol-5-amine Chemical compound NC1=CC=C2N(CC)C=NC2=C1 JVESLFWSVWNBQV-UHFFFAOYSA-N 0.000 description 1
- AMMPLVWPWSYRDR-UHFFFAOYSA-N 1-methylbicyclo[2.2.2]oct-2-ene-4-carboxylic acid Chemical compound C1CC2(C(O)=O)CCC1(C)C=C2 AMMPLVWPWSYRDR-UHFFFAOYSA-N 0.000 description 1
- IMEVDILDSCXKJW-UHFFFAOYSA-N 11-(9h-fluoren-9-ylmethoxycarbonylamino)undecanoic acid Chemical compound C1=CC=C2C(COC(=O)NCCCCCCCCCCC(=O)O)C3=CC=CC=C3C2=C1 IMEVDILDSCXKJW-UHFFFAOYSA-N 0.000 description 1
- HVGIKYAQSSNFCH-UHFFFAOYSA-N 12-(9h-fluoren-9-ylmethoxycarbonylamino)dodecanoic acid Chemical compound C1=CC=C2C(COC(=O)NCCCCCCCCCCCC(=O)O)C3=CC=CC=C3C2=C1 HVGIKYAQSSNFCH-UHFFFAOYSA-N 0.000 description 1
- HYZJCKYKOHLVJF-UHFFFAOYSA-N 1H-benzimidazole Chemical compound C1=CC=C2NC=NC2=C1 HYZJCKYKOHLVJF-UHFFFAOYSA-N 0.000 description 1
- BAXOFTOLAUCFNW-UHFFFAOYSA-N 1H-indazole Chemical compound C1=CC=C2C=NNC2=C1 BAXOFTOLAUCFNW-UHFFFAOYSA-N 0.000 description 1
- MFJCPDOGFAYSTF-UHFFFAOYSA-N 1H-isochromene Chemical compound C1=CC=C2COC=CC2=C1 MFJCPDOGFAYSTF-UHFFFAOYSA-N 0.000 description 1
- AAQTWLBJPNLKHT-UHFFFAOYSA-N 1H-perimidine Chemical compound N1C=NC2=CC=CC3=CC=CC1=C32 AAQTWLBJPNLKHT-UHFFFAOYSA-N 0.000 description 1
- ODMMNALOCMNQJZ-UHFFFAOYSA-N 1H-pyrrolizine Chemical compound C1=CC=C2CC=CN21 ODMMNALOCMNQJZ-UHFFFAOYSA-N 0.000 description 1
- GQHTUMJGOHRCHB-UHFFFAOYSA-N 2,3,4,6,7,8,9,10-octahydropyrimido[1,2-a]azepine Chemical compound C1CCCCN2CCCN=C21 GQHTUMJGOHRCHB-UHFFFAOYSA-N 0.000 description 1
- VEPOHXYIFQMVHW-XOZOLZJESA-N 2,3-dihydroxybutanedioic acid (2S,3S)-3,4-dimethyl-2-phenylmorpholine Chemical compound OC(C(O)C(O)=O)C(O)=O.C[C@H]1[C@@H](OCCN1C)c1ccccc1 VEPOHXYIFQMVHW-XOZOLZJESA-N 0.000 description 1
- HOZZVEPRYYCBTO-UHFFFAOYSA-N 2-(9h-fluoren-9-ylmethoxycarbonylamino)-2-methylpropanoic acid Chemical compound C1=CC=C2C(COC(=O)NC(C)(C)C(O)=O)C3=CC=CC=C3C2=C1 HOZZVEPRYYCBTO-UHFFFAOYSA-N 0.000 description 1
- JYUTZJVERLGMQZ-UHFFFAOYSA-N 2-(9h-fluoren-9-ylmethoxycarbonylamino)-3-naphthalen-2-ylpropanoic acid Chemical compound C12=CC=CC=C2C2=CC=CC=C2C1COC(=O)NC(C(=O)O)CC1=CC=C(C=CC=C2)C2=C1 JYUTZJVERLGMQZ-UHFFFAOYSA-N 0.000 description 1
- JQLPMTXRCLXOJO-UHFFFAOYSA-N 2-(9h-fluoren-9-ylmethoxycarbonylamino)-3-pyridin-3-ylpropanoic acid Chemical compound C12=CC=CC=C2C2=CC=CC=C2C1COC(=O)NC(C(=O)O)CC1=CC=CN=C1 JQLPMTXRCLXOJO-UHFFFAOYSA-N 0.000 description 1
- NDKDFTQNXLHCGO-UHFFFAOYSA-N 2-(9h-fluoren-9-ylmethoxycarbonylamino)acetic acid Chemical compound C1=CC=C2C(COC(=O)NCC(=O)O)C3=CC=CC=C3C2=C1 NDKDFTQNXLHCGO-UHFFFAOYSA-N 0.000 description 1
- WXUCRCWRWDBIFZ-UHFFFAOYSA-N 2-[(9h-fluoren-9-ylmethoxycarbonylamino)-[(2-methylpropan-2-yl)oxycarbonyl]amino]acetic acid Chemical compound C1=CC=C2C(COC(=O)NN(CC(O)=O)C(=O)OC(C)(C)C)C3=CC=CC=C3C2=C1 WXUCRCWRWDBIFZ-UHFFFAOYSA-N 0.000 description 1
- FBKUOPULLUJMOC-UHFFFAOYSA-N 2-[[2-(9h-fluoren-9-ylmethoxycarbonylamino)acetyl]amino]acetic acid Chemical compound C1=CC=C2C(COC(=O)NCC(=O)NCC(=O)O)C3=CC=CC=C3C2=C1 FBKUOPULLUJMOC-UHFFFAOYSA-N 0.000 description 1
- YUYBSGRVYRPYLB-UHFFFAOYSA-N 2-[[2-[[2-(9h-fluoren-9-ylmethoxycarbonylamino)acetyl]amino]acetyl]amino]acetic acid Chemical compound C1=CC=C2C(COC(=O)NCC(=O)NCC(=O)NCC(=O)O)C3=CC=CC=C3C2=C1 YUYBSGRVYRPYLB-UHFFFAOYSA-N 0.000 description 1
- VHMICKWLTGFITH-UHFFFAOYSA-N 2H-isoindole Chemical compound C1=CC=CC2=CNC=C21 VHMICKWLTGFITH-UHFFFAOYSA-N 0.000 description 1
- MGADZUXDNSDTHW-UHFFFAOYSA-N 2H-pyran Chemical compound C1OC=CC=C1 MGADZUXDNSDTHW-UHFFFAOYSA-N 0.000 description 1
- IYEPGRWHRCNDCI-UHFFFAOYSA-N 3-(3-methylbutoxymethyl)pyridine Chemical compound CC(C)CCOCC1=CC=CN=C1 IYEPGRWHRCNDCI-UHFFFAOYSA-N 0.000 description 1
- XLZYKTYMLBOINK-UHFFFAOYSA-N 3-(4-hydroxybenzoyl)benzoic acid Chemical compound OC(=O)C1=CC=CC(C(=O)C=2C=CC(O)=CC=2)=C1 XLZYKTYMLBOINK-UHFFFAOYSA-N 0.000 description 1
- LINBWYYLPWJQHE-UHFFFAOYSA-N 3-(9h-fluoren-9-ylmethoxycarbonylamino)propanoic acid Chemical compound C1=CC=C2C(COC(=O)NCCC(=O)O)C3=CC=CC=C3C2=C1 LINBWYYLPWJQHE-UHFFFAOYSA-N 0.000 description 1
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 1
- ZRPLANDPDWYOMZ-UHFFFAOYSA-N 3-cyclopentylpropionic acid Chemical compound OC(=O)CCC1CCCC1 ZRPLANDPDWYOMZ-UHFFFAOYSA-N 0.000 description 1
- LYUQWQRTDLVQGA-UHFFFAOYSA-N 3-phenylpropylamine Chemical compound NCCCC1=CC=CC=C1 LYUQWQRTDLVQGA-UHFFFAOYSA-N 0.000 description 1
- STABAPSYCQFWOK-UHFFFAOYSA-N 4-chlorobenzenecarboperoxoic acid Chemical compound OOC(=O)C1=CC=C(Cl)C=C1 STABAPSYCQFWOK-UHFFFAOYSA-N 0.000 description 1
- RJWBTWIBUIGANW-UHFFFAOYSA-N 4-chlorobenzenesulfonic acid Chemical compound OS(=O)(=O)C1=CC=C(Cl)C=C1 RJWBTWIBUIGANW-UHFFFAOYSA-N 0.000 description 1
- GDRVFDDBLLKWRI-UHFFFAOYSA-N 4H-quinolizine Chemical compound C1=CC=CN2CC=CC=C21 GDRVFDDBLLKWRI-UHFFFAOYSA-N 0.000 description 1
- SLXKOJJOQWFEFD-UHFFFAOYSA-N 6-aminohexanoic acid Chemical compound NCCCCCC(O)=O SLXKOJJOQWFEFD-UHFFFAOYSA-N 0.000 description 1
- QZQXRZXYWVQWAY-UHFFFAOYSA-N 8-(9h-fluoren-9-ylmethoxycarbonylamino)octanoic acid Chemical compound C1=CC=C2C(COC(=O)NCCCCCCCC(=O)O)C3=CC=CC=C3C2=C1 QZQXRZXYWVQWAY-UHFFFAOYSA-N 0.000 description 1
- GJCOSYZMQJWQCA-UHFFFAOYSA-N 9H-xanthene Chemical compound C1=CC=C2CC3=CC=CC=C3OC2=C1 GJCOSYZMQJWQCA-UHFFFAOYSA-N 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- WWZKQHOCKIZLMA-UHFFFAOYSA-N Caprylic acid Natural products CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- WBYWAXJHAXSJNI-SREVYHEPSA-N Cinnamic acid Chemical compound OC(=O)\C=C/C1=CC=CC=C1 WBYWAXJHAXSJNI-SREVYHEPSA-N 0.000 description 1
- 241000784713 Cupido Species 0.000 description 1
- XFXPMWWXUTWYJX-UHFFFAOYSA-N Cyanide Chemical group N#[C-] XFXPMWWXUTWYJX-UHFFFAOYSA-N 0.000 description 1
- PMPVIKIVABFJJI-UHFFFAOYSA-N Cyclobutane Chemical compound C1CCC1 PMPVIKIVABFJJI-UHFFFAOYSA-N 0.000 description 1
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 1
- LVZWSLJZHVFIQJ-UHFFFAOYSA-N Cyclopropane Chemical compound C1CC1 LVZWSLJZHVFIQJ-UHFFFAOYSA-N 0.000 description 1
- 150000008574 D-amino acids Chemical class 0.000 description 1
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- CBPJQFCAFFNICX-LJQANCHMSA-N Fmoc-D-Leu-OH Chemical compound C1=CC=C2C(COC(=O)N[C@H](CC(C)C)C(O)=O)C3=CC=CC=C3C2=C1 CBPJQFCAFFNICX-LJQANCHMSA-N 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 229940121710 HMGCoA reductase inhibitor Drugs 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical compound Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 description 1
- WRYCSMQKUKOKBP-UHFFFAOYSA-N Imidazolidine Chemical compound C1CNCN1 WRYCSMQKUKOKBP-UHFFFAOYSA-N 0.000 description 1
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 1
- 150000008575 L-amino acids Chemical class 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- 125000000393 L-methionino group Chemical group [H]OC(=O)[C@@]([H])(N([H])[*])C([H])([H])C(SC([H])([H])[H])([H])[H] 0.000 description 1
- 229910010084 LiAlH4 Inorganic materials 0.000 description 1
- TXXHDPDFNKHHGW-CCAGOZQPSA-N Muconic acid Natural products OC(=O)\C=C/C=C\C(O)=O TXXHDPDFNKHHGW-CCAGOZQPSA-N 0.000 description 1
- MBBZMMPHUWSWHV-BDVNFPICSA-N N-methylglucamine Chemical compound CNC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO MBBZMMPHUWSWHV-BDVNFPICSA-N 0.000 description 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
- IWYDHOAUDWTVEP-UHFFFAOYSA-N R-2-phenyl-2-hydroxyacetic acid Natural products OC(=O)C(O)C1=CC=CC=C1 IWYDHOAUDWTVEP-UHFFFAOYSA-N 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- FZWLAAWBMGSTSO-UHFFFAOYSA-N Thiazole Chemical compound C1=CSC=N1 FZWLAAWBMGSTSO-UHFFFAOYSA-N 0.000 description 1
- SLGBZMMZGDRARJ-UHFFFAOYSA-N Triphenylene Natural products C1=CC=C2C3=CC=CC=C3C3=CC=CC=C3C2=C1 SLGBZMMZGDRARJ-UHFFFAOYSA-N 0.000 description 1
- QVXFGVVYTKZLJN-KHPPLWFESA-N [(z)-hexadec-7-enyl] acetate Chemical compound CCCCCCCC\C=C/CCCCCCOC(C)=O QVXFGVVYTKZLJN-KHPPLWFESA-N 0.000 description 1
- DGEZNRSVGBDHLK-UHFFFAOYSA-N [1,10]phenanthroline Chemical compound C1=CN=C2C3=NC=CC=C3C=CC2=C1 DGEZNRSVGBDHLK-UHFFFAOYSA-N 0.000 description 1
- JDPAVWAQGBGGHD-UHFFFAOYSA-N aceanthrylene Chemical group C1=CC=C2C(C=CC3=CC=C4)=C3C4=CC2=C1 JDPAVWAQGBGGHD-UHFFFAOYSA-N 0.000 description 1
- 125000004054 acenaphthylenyl group Chemical group C1(=CC2=CC=CC3=CC=CC1=C23)* 0.000 description 1
- SQFPKRNUGBRTAR-UHFFFAOYSA-N acephenanthrylene Chemical group C1=CC(C=C2)=C3C2=CC2=CC=CC=C2C3=C1 SQFPKRNUGBRTAR-UHFFFAOYSA-N 0.000 description 1
- HXGDTGSAIMULJN-UHFFFAOYSA-N acetnaphthylene Natural products C1=CC(C=C2)=C3C2=CC=CC3=C1 HXGDTGSAIMULJN-UHFFFAOYSA-N 0.000 description 1
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 229910001413 alkali metal ion Inorganic materials 0.000 description 1
- 150000003973 alkyl amines Chemical class 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 229960002684 aminocaproic acid Drugs 0.000 description 1
- 125000004202 aminomethyl group Chemical group [H]N([H])C([H])([H])* 0.000 description 1
- 229960003116 amyl nitrite Drugs 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 125000002029 aromatic hydrocarbon group Chemical group 0.000 description 1
- 238000007080 aromatic substitution reaction Methods 0.000 description 1
- 125000005018 aryl alkenyl group Chemical group 0.000 description 1
- 125000005015 aryl alkynyl group Chemical group 0.000 description 1
- 125000004104 aryloxy group Chemical group 0.000 description 1
- 150000001542 azirines Chemical class 0.000 description 1
- RFRXIWQYSOIBDI-UHFFFAOYSA-N benzarone Chemical compound CCC=1OC2=CC=CC=C2C=1C(=O)C1=CC=C(O)C=C1 RFRXIWQYSOIBDI-UHFFFAOYSA-N 0.000 description 1
- SRSXLGNVWSONIS-UHFFFAOYSA-N benzenesulfonic acid Chemical compound OS(=O)(=O)C1=CC=CC=C1 SRSXLGNVWSONIS-UHFFFAOYSA-N 0.000 description 1
- 229940092714 benzenesulfonic acid Drugs 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 description 1
- GONOPSZTUGRENK-UHFFFAOYSA-N benzyl(trichloro)silane Chemical compound Cl[Si](Cl)(Cl)CC1=CC=CC=C1 GONOPSZTUGRENK-UHFFFAOYSA-N 0.000 description 1
- 125000005998 bromoethyl group Chemical group 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 125000004369 butenyl group Chemical group C(=CCC)* 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000000480 butynyl group Chemical group [*]C#CC([H])([H])C([H])([H])[H] 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 150000005829 chemical entities Chemical class 0.000 description 1
- 150000001805 chlorine compounds Chemical class 0.000 description 1
- VZWXIQHBIQLMPN-UHFFFAOYSA-N chromane Chemical compound C1=CC=C2CCCOC2=C1 VZWXIQHBIQLMPN-UHFFFAOYSA-N 0.000 description 1
- QZHPTGXQGDFGEN-UHFFFAOYSA-N chromene Chemical compound C1=CC=C2C=C[CH]OC2=C1 QZHPTGXQGDFGEN-UHFFFAOYSA-N 0.000 description 1
- 235000013985 cinnamic acid Nutrition 0.000 description 1
- 229930016911 cinnamic acid Natural products 0.000 description 1
- WCZVZNOTHYJIEI-UHFFFAOYSA-N cinnoline Chemical compound N1=NC=CC2=CC=CC=C21 WCZVZNOTHYJIEI-UHFFFAOYSA-N 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 238000010960 commercial process Methods 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 125000000392 cycloalkenyl group Chemical group 0.000 description 1
- 125000006639 cyclohexyl carbonyl group Chemical group 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 150000008049 diazo compounds Chemical class 0.000 description 1
- ZBCBWPMODOFKDW-UHFFFAOYSA-N diethanolamine Chemical compound OCCNCCO ZBCBWPMODOFKDW-UHFFFAOYSA-N 0.000 description 1
- 230000003467 diminishing effect Effects 0.000 description 1
- 229910001873 dinitrogen Inorganic materials 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000003480 eluent Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 150000002118 epoxides Chemical class 0.000 description 1
- AFAXGSQYZLGZPG-UHFFFAOYSA-N ethanedisulfonic acid Chemical compound OS(=O)(=O)CCS(O)(=O)=O AFAXGSQYZLGZPG-UHFFFAOYSA-N 0.000 description 1
- CCIVGXIOQKPBKL-UHFFFAOYSA-M ethanesulfonate Chemical compound CCS([O-])(=O)=O CCIVGXIOQKPBKL-UHFFFAOYSA-M 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- LRMHFDNWKCSEQU-UHFFFAOYSA-N ethoxyethane;phenol Chemical group CCOCC.OC1=CC=CC=C1 LRMHFDNWKCSEQU-UHFFFAOYSA-N 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- RMBPEFMHABBEKP-UHFFFAOYSA-N fluorene Chemical compound C1=CC=C2C3=C[CH]C=CC3=CC2=C1 RMBPEFMHABBEKP-UHFFFAOYSA-N 0.000 description 1
- JZUZJVFERQWLNC-FQEVSTJZSA-N fmoc-3-nitro-l-tyrosine Chemical compound C([C@@H](C(=O)O)NC(=O)OCC1C2=CC=CC=C2C2=CC=CC=C21)C1=CC=C(O)C([N+]([O-])=O)=C1 JZUZJVFERQWLNC-FQEVSTJZSA-N 0.000 description 1
- 238000013467 fragmentation Methods 0.000 description 1
- 238000006062 fragmentation reaction Methods 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 235000011087 fumaric acid Nutrition 0.000 description 1
- 238000002290 gas chromatography-mass spectrometry Methods 0.000 description 1
- 230000014509 gene expression Effects 0.000 description 1
- 239000000174 gluconic acid Substances 0.000 description 1
- 235000012208 gluconic acid Nutrition 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- DMEGYFMYUHOHGS-UHFFFAOYSA-N heptamethylene Natural products C1CCCCCC1 DMEGYFMYUHOHGS-UHFFFAOYSA-N 0.000 description 1
- 125000005312 heteroarylalkynyl group Chemical group 0.000 description 1
- QSQIGGCOCHABAP-UHFFFAOYSA-N hexacene Chemical compound C1=CC=CC2=CC3=CC4=CC5=CC6=CC=CC=C6C=C5C=C4C=C3C=C21 QSQIGGCOCHABAP-UHFFFAOYSA-N 0.000 description 1
- PKIFBGYEEVFWTJ-UHFFFAOYSA-N hexaphene Chemical compound C1=CC=C2C=C3C4=CC5=CC6=CC=CC=C6C=C5C=C4C=CC3=CC2=C1 PKIFBGYEEVFWTJ-UHFFFAOYSA-N 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- ZLTPDFXIESTBQG-UHFFFAOYSA-N isothiazole Chemical compound C=1C=NSC=1 ZLTPDFXIESTBQG-UHFFFAOYSA-N 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- QDLAGTHXVHQKRE-UHFFFAOYSA-N lichenxanthone Natural products COC1=CC(O)=C2C(=O)C3=C(C)C=C(OC)C=C3OC2=C1 QDLAGTHXVHQKRE-UHFFFAOYSA-N 0.000 description 1
- 239000012280 lithium aluminium hydride Substances 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 229960002510 mandelic acid Drugs 0.000 description 1
- 238000004949 mass spectrometry Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 229910021645 metal ion Inorganic materials 0.000 description 1
- 229940098779 methanesulfonic acid Drugs 0.000 description 1
- WBYWAXJHAXSJNI-UHFFFAOYSA-N methyl p-hydroxycinnamate Natural products OC(=O)C=CC1=CC=CC=C1 WBYWAXJHAXSJNI-UHFFFAOYSA-N 0.000 description 1
- CSDTZUBPSYWZDX-UHFFFAOYSA-N n-pentyl nitrite Chemical compound CCCCCON=O CSDTZUBPSYWZDX-UHFFFAOYSA-N 0.000 description 1
- KVBGVZZKJNLNJU-UHFFFAOYSA-N naphthalene-2-sulfonic acid Chemical compound C1=CC=CC2=CC(S(=O)(=O)O)=CC=C21 KVBGVZZKJNLNJU-UHFFFAOYSA-N 0.000 description 1
- 125000004923 naphthylmethyl group Chemical group C1(=CC=CC2=CC=CC=C12)C* 0.000 description 1
- 229910017604 nitric acid Inorganic materials 0.000 description 1
- 150000002825 nitriles Chemical class 0.000 description 1
- BMNDJWSIKZECMH-UHFFFAOYSA-N nitrosyl bromide Chemical compound BrN=O BMNDJWSIKZECMH-UHFFFAOYSA-N 0.000 description 1
- NIHNNTQXNPWCJQ-UHFFFAOYSA-N o-biphenylenemethane Natural products C1=CC=C2CC3=CC=CC=C3C2=C1 NIHNNTQXNPWCJQ-UHFFFAOYSA-N 0.000 description 1
- PFTXKXWAXWAZBP-UHFFFAOYSA-N octacene Chemical compound C1=CC=CC2=CC3=CC4=CC5=CC6=CC7=CC8=CC=CC=C8C=C7C=C6C=C5C=C4C=C3C=C21 PFTXKXWAXWAZBP-UHFFFAOYSA-N 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- OVPVGJFDFSJUIG-UHFFFAOYSA-N octalene Chemical compound C1=CC=CC=C2C=CC=CC=CC2=C1 OVPVGJFDFSJUIG-UHFFFAOYSA-N 0.000 description 1
- WTFQBTLMPISHTA-UHFFFAOYSA-N octaphene Chemical compound C1=CC=C2C=C(C=C3C4=CC5=CC6=CC7=CC=CC=C7C=C6C=C5C=C4C=CC3=C3)C3=CC2=C1 WTFQBTLMPISHTA-UHFFFAOYSA-N 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 125000002524 organometallic group Chemical group 0.000 description 1
- LSQODMMMSXHVCN-UHFFFAOYSA-N ovalene Chemical compound C1=C(C2=C34)C=CC3=CC=C(C=C3C5=C6C(C=C3)=CC=C3C6=C6C(C=C3)=C3)C4=C5C6=C2C3=C1 LSQODMMMSXHVCN-UHFFFAOYSA-N 0.000 description 1
- WCPAKWJPBJAGKN-UHFFFAOYSA-N oxadiazole Chemical compound C1=CON=N1 WCPAKWJPBJAGKN-UHFFFAOYSA-N 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- PMJHHCWVYXUKFD-UHFFFAOYSA-N penta-1,3-diene Chemical compound CC=CC=C PMJHHCWVYXUKFD-UHFFFAOYSA-N 0.000 description 1
- SLIUAWYAILUBJU-UHFFFAOYSA-N pentacene Chemical compound C1=CC=CC2=CC3=CC4=CC5=CC=CC=C5C=C4C=C3C=C21 SLIUAWYAILUBJU-UHFFFAOYSA-N 0.000 description 1
- GUVXZFRDPCKWEM-UHFFFAOYSA-N pentalene Chemical compound C1=CC2=CC=CC2=C1 GUVXZFRDPCKWEM-UHFFFAOYSA-N 0.000 description 1
- JQQSUOJIMKJQHS-UHFFFAOYSA-N pentaphene Chemical compound C1=CC=C2C=C3C4=CC5=CC=CC=C5C=C4C=CC3=CC2=C1 JQQSUOJIMKJQHS-UHFFFAOYSA-N 0.000 description 1
- 125000002080 perylenyl group Chemical group C1(=CC=C2C=CC=C3C4=CC=CC5=CC=CC(C1=C23)=C45)* 0.000 description 1
- CSHWQDPOILHKBI-UHFFFAOYSA-N peryrene Natural products C1=CC(C2=CC=CC=3C2=C2C=CC=3)=C3C2=CC=CC3=C1 CSHWQDPOILHKBI-UHFFFAOYSA-N 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- NQFOGDIWKQWFMN-UHFFFAOYSA-N phenalene Chemical compound C1=CC([CH]C=C2)=C3C2=CC=CC3=C1 NQFOGDIWKQWFMN-UHFFFAOYSA-N 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- LFSXCDWNBUNEEM-UHFFFAOYSA-N phthalazine Chemical compound C1=NN=CC2=CC=CC=C21 LFSXCDWNBUNEEM-UHFFFAOYSA-N 0.000 description 1
- DIJNSQQKNIVDPV-UHFFFAOYSA-N pleiadene Chemical compound C1=C2[CH]C=CC=C2C=C2C=CC=C3[C]2C1=CC=C3 DIJNSQQKNIVDPV-UHFFFAOYSA-N 0.000 description 1
- WSHYKIAQCMIPTB-UHFFFAOYSA-M potassium;2-oxo-3-(3-oxo-1-phenylbutyl)chromen-4-olate Chemical compound [K+].[O-]C=1C2=CC=CC=C2OC(=O)C=1C(CC(=O)C)C1=CC=CC=C1 WSHYKIAQCMIPTB-UHFFFAOYSA-M 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 125000004368 propenyl group Chemical group C(=CC)* 0.000 description 1
- 235000019260 propionic acid Nutrition 0.000 description 1
- 125000002568 propynyl group Chemical group [*]C#CC([H])([H])[H] 0.000 description 1
- CPNGPNLZQNNVQM-UHFFFAOYSA-N pteridine Chemical compound N1=CN=CC2=NC=CN=C21 CPNGPNLZQNNVQM-UHFFFAOYSA-N 0.000 description 1
- LNKHTYQPVMAJSF-UHFFFAOYSA-N pyranthrene Chemical compound C1=C2C3=CC=CC=C3C=C(C=C3)C2=C2C3=CC3=C(C=CC=C4)C4=CC4=CC=C1C2=C34 LNKHTYQPVMAJSF-UHFFFAOYSA-N 0.000 description 1
- USPWKWBDZOARPV-UHFFFAOYSA-N pyrazolidine Chemical compound C1CNNC1 USPWKWBDZOARPV-UHFFFAOYSA-N 0.000 description 1
- PBMFSQRYOILNGV-UHFFFAOYSA-N pyridazine Chemical compound C1=CC=NN=C1 PBMFSQRYOILNGV-UHFFFAOYSA-N 0.000 description 1
- HNJBEVLQSNELDL-UHFFFAOYSA-N pyrrolidin-2-one Chemical compound O=C1CCCN1 HNJBEVLQSNELDL-UHFFFAOYSA-N 0.000 description 1
- 229940107700 pyruvic acid Drugs 0.000 description 1
- JWVCLYRUEFBMGU-UHFFFAOYSA-N quinazoline Chemical compound N1=CN=CC2=CC=CC=C21 JWVCLYRUEFBMGU-UHFFFAOYSA-N 0.000 description 1
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 1
- SBYHFKPVCBCYGV-UHFFFAOYSA-N quinuclidine Chemical compound C1CC2CCN1CC2 SBYHFKPVCBCYGV-UHFFFAOYSA-N 0.000 description 1
- 239000012048 reactive intermediate Substances 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000004007 reversed phase HPLC Methods 0.000 description 1
- FMKFBRKHHLWKDB-UHFFFAOYSA-N rubicene Chemical compound C12=CC=CC=C2C2=CC=CC3=C2C1=C1C=CC=C2C4=CC=CC=C4C3=C21 FMKFBRKHHLWKDB-UHFFFAOYSA-N 0.000 description 1
- WEMQMWWWCBYPOV-UHFFFAOYSA-N s-indacene Chemical compound C=1C2=CC=CC2=CC2=CC=CC2=1 WEMQMWWWCBYPOV-UHFFFAOYSA-N 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 150000003335 secondary amines Chemical class 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- BCNZYOJHNLTNEZ-UHFFFAOYSA-N tert-butyldimethylsilyl chloride Chemical compound CC(C)(C)[Si](C)(C)Cl BCNZYOJHNLTNEZ-UHFFFAOYSA-N 0.000 description 1
- 150000003536 tetrazoles Chemical class 0.000 description 1
- VLLMWSRANPNYQX-UHFFFAOYSA-N thiadiazole Chemical compound C1=CSN=N1.C1=CSN=N1 VLLMWSRANPNYQX-UHFFFAOYSA-N 0.000 description 1
- 150000003553 thiiranes Chemical class 0.000 description 1
- 238000004448 titration Methods 0.000 description 1
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 1
- 238000000844 transformation Methods 0.000 description 1
- 230000001131 transforming effect Effects 0.000 description 1
- 150000003852 triazoles Chemical class 0.000 description 1
- 125000005580 triphenylene group Chemical group 0.000 description 1
- 239000004474 valine Substances 0.000 description 1
- 238000010626 work up procedure Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C17/00—Preparation of halogenated hydrocarbons
- C07C17/093—Preparation of halogenated hydrocarbons by replacement by halogens
Definitions
- Methods and materials are disclosed for the conversion of primary amines to other functional groups.
- the methods can be used to prepare organic compounds, including chiral organic compounds.
- the methods can be carried out by reacting a primary amine with an activating agent and a nitrosyl agent to produce an organic compound and nitrous oxide.
- the methods can be simple, quick and efficient (e.g., quantitative). . • .
- Methods are disclosed for preparing organic compounds, including organic alcohols and organic halides.
- primary amines can be reacted • with activating agents and nitrosyl agents to produce such organic compounds along with nitrous oxide.
- Methods are also disclosed in which a primary organic N-haloamine or N,N-dihaloamine can be reacted with a nitrosyl agent to produce the organic compound and nitrous oxide.
- Methods are also disclosed for preparing an ⁇ -hydroxy acid or derivative thereof by treating a ⁇ -amino acid or derivative thereof with an activating agent and a nitrosyl agent, with resulting generation of nitrous oxide.
- Novel compounds and compositions prepared by the methods are also disclosed.
- the disclosed compounds, compositions or methods can be used in a number of processes, including large scale and commercial processes, and in a wide variety of useful products including, for- example, bromides, chlorides, chiral bromides derived from chiral amines, ⁇ -halo acids, Z)-amino acids from £-amino acids in two steps and in a general procedure for inversion of chiral centers via an amine intermediate.
- a variety of substituted chemical entities can be prepared from amines using the disclosed methods, for example, azides, cyanides, phenolic ethers and esters. Reagents and reaction mixtures useful for carrying out the conversions of amines to the corresponding products are also disclosed.
- reagents useful for converting amines to the corresponding- halides can include halides and inter-halides, N-halo reagents, nitroso and nitryl reagents and hydroxyl halides.
- Figure 1 provides a mass spectra for the reaction of 1.0 equivalent each of amyl nitrite and Br 2 with aniline (a; upper, panel) and with 3-aminomethylpyrid ⁇ ne (AMP; b; lower panel).
- Figure 2 provides an " infrared spectrum of the N 2 O evolved from the reaction of AMP and 1.1 equivalents of isoamyl nitrite and 5.0 equivalents bromine.
- Figure 3 provides analytical HPLC traces for the two amines, AMP (trace a) and 2-(2-aminoethyl)pyridine (AEP - trace b), before and after addition of 1.1 equivalent isoairiyl nitrite and 5.0 equivalents of Ef ⁇ .
- Figure 4 provides an HPLC trace of a ⁇ -bromo acid converted from the amino acid Tyr(tBu).
- Figure 5 provides HPLC traces of three ⁇ -bromo acids converted from the amino acids Trp(Boc), Asp(OtBu), and His(Trt).
- Figure 6 provides HPLC traces of three ⁇ -bromo acids converted from the amino acids Lys(Fmoc). Phe, and Lys(Boc).
- Figure 7 provides graphs demonstrating the disappearance of AMP and appearance of 3-bromomethylpyridine as a function of equivalents of isoamyl nitrite and Br 2 added.
- Methods are provided for converting primary amines to other organic compounds with the resultant production of nitrous oxide. Methods as disclosed herein can result in the production of new organic compounds having a new functional group in place of the amine in the starting material.
- substitutions can include azide, cyanide, phenol ether and ester substitutions.
- the new functional group can be a hydroxyl group, resulting in an organic alcohol.
- the functional group can be a halide, resulting in an organic halide.
- the activating agent can be any compound that can activate the amine.
- the activating agent can halogenate the amine to generate an N- haloamine or an N,N-dihaloamine.
- the activating agent can include but is not limited to an alkyl nitrite and X 2 , XNO2, HOX, an alkyl hypohalite, cyanogen bromide, NO 2 -BX 4 and X 2 , N-halosuccinimide, l-(chloromethyl)-4-fluoro-l,4- diazoniabicyclo[2.2.2]octane bis(tetrafluoroborate) (e.g. SELECTFLUOR ® ), or cyanuric halide, wherein X is F, Cl, Br, or I.
- the activating agent can be N-bromosuccinide. Alternatively, it can be isoamyl nitrite and bromine; sodium nitrite and bromine; cyanuric bromide; cyanuric chloride; or cyanuric fluoride.
- Any nitrosyl agent that can convert either the primary amine or the activated amine into the desired organic compound can be used.
- the nitrosyl agent can be added with the activating agent to a reaction mixture or it can be added separately from the activating agent.
- the activating agent and nitrosyl agent can be different from one another, or can be the same.
- Useful nitrosyl agents that can cause the production of an organic halide can include, but is not necessarily limited to, XNO, NO-BX4 and X 2 , HONO and X2, NaNO2 and trifluoroacetic acid and X 2 , NaNO2 and acetic acid and X2, Na 2 Fe(CN)S(NO) and X 2 , or a nitrite and an acid and X2, wherein X is Br, Cl or F.
- the nitrosyl agent can be BrNO, HNO2 and bromine, NaNO2 and trifluoroacetic acid and Br 2 , cyanuric chloride and NO- BF4, cyanuric fluoride and NO-BF 4 , or cyanuric bromide and NO-BF 4 .
- Useful nitrosyl agents that can cause the production of the organic alcohol include, but are not limited to, NO 2 -BX 4 and trifluoroacetic acid, HONO, NaNO 2 and trifluoroacetic acid, NaNO 2 and acetic acid, or a nitrite and an acid, wherein X is Br, Cl or F.
- the nitrosyl agent can be generated by the any combination of nitrite salt and acid, e.g. any organic or inorganic nitrite salt and any organic or inorganic acid.
- the organic alcohol can be prepared from the nitrosyl agent HONO or NaNO 2 and trifluoroacetic acid.
- the activating agent and the nitrosyl agent can be in the form of one or more compounds added directly to the reaction mixture, can be generated in situ in the reaction mixture, or can be formed in the reaction mixture as intermediates of the reaction.
- the activating agent and nitrosyl agent can be generated by the combination of alkyl nitrite, X 2 , and primary amine, wherein X is F, Cl, Br, or I.
- the activating agent and nitrosyl agent can be generated by the combination of isoamyl nitrite, Br 2 , and primary amine.
- Tn contrast to the intermediates formed when aniline is reacted, which indicates a diazo reaction pathway
- Figure 1 shows the presence of both the N-bromo and N,N-dibromo intermediates of AMP with very little of the final product 3-(bromomethyl)pyridine present.
- the three compounds indicated as ionized radicals in trace b of Figure 1 at m/z 93, 108, and 186/188, are the results of fragmentation by loss of a bromine atom during the mass spectroscopy process. On addition of either reagent alone only AMP is observed in the spectrum, suggesting that Br 2 is not reacting directly with the amine.
- another method can include the conversion of the primary organic N-haloamine or primary organic N,N-dihaIoamine to the organic compound, wherein the intermediate can be treated with a nitrosyl agent to produce an organic compound and nitrous oxide.
- the nitrosyl agent can be any nitrosyl agent.
- the nitrosyl agent can include any species as set forth above, e.g.
- the nitrosyl agent can include any species as set forth above, e.g. NO 2 -BX4 and trifluoroacetic acid, HONO, NaNO 2 and trifluoroacetic acid, NaNO 2 and acetic acid, or a nitrite and an acid, wherein X is Br, Cl or F.
- the reaction conditions can include any conditions that allow a facile reaction to occur.
- the organic amine can be partially dissolved in a solvent.
- the solvent can be any solvent, including but not limited to tetrahydrofuran, dichloromethane, chloroform, carbon tetrachloride, dimethyl formamide, dimethyl sulfoxide, /-butanol, diethylether, acetic acid, hexane, dichloroethane, ethyl acetate, acetonitrile, methanol, ethanol, bromine, water and the like.
- the reaction can be conducted in tetrahydrofuran or dichloromethane.
- the ratio of amine to activating agent to nitrosyl agent can be about 1.0:0.1 :0.1 to about 1:10:100, preferably 1:1:1 to about 1 :5:10, and more preferably 1 :2:3.
- the reaction can be conducted at a range of temperatures, including between about -78 0 C and about 200 0 C, or -50 °C and about 50 0 C, preferably about 25 0 C.
- One advantage of the disclosed reactions is that they can be carried out at mild temperatures. This is caused by the facile nature of the reaction in terms of heat generation.
- a surprising benefit of the disclosed methods is the ability to conduct the reaction at above about 0 0 C. Consequently, in some embodiments the reaction can be conducted between about 10 0 C and about 40 0 C, preferably between about 20 0 C and about 30 0 C, and more preferably at about room temperature.
- the yield of the preparation of organic alcohol or organic halide can be greater than about 50%, preferably greater than about 75%, and more preferably greater than about 90% and can be nearly quantitative. Furthermore, because the disclosed reactions can be more facile than the diazo reaction, the conversion of the primary amine can be conducted on a multigram or large scale, including greater than 10 grams, • greater than 100 grams, and greater than 1 kilogram. Finally, the stereochemistry of any chiral primary amine is not lost. Therefore, conversion can occur with greater than about 90% retention of stereochemistry, e.g. about 90% or more, about 91% .
- Substrates suitable for use with methods as disclosed herein include any primary amines, particularly aliphatic primary amines.
- One of the differences between methods as disclosed herein and prior methods was that previously known methods were limited to aryl amines and to amino acids in which a neighboring group effect was implicated in the conversion of the amino to a halide or alcohol.
- methods as disclosed herein provide for conversion of simple aliphatic amines, e.g. 2- aminoethylpyridine, 6-amin ⁇ hexanoic acid, under facile conditions.
- any primary amine having a chiral center can be converted to an organic alcohol or organic halide with retention of stereochemistry at the same chiral center.
- Amino acids can include any compound containing an amine and an acid group, or their derivatives, including but not limited to ⁇ -amino acids, ⁇ -amino acids, achiral amino acids, chiral amino acids, racemic amino acids, enantiomerically enriched amino acids, enantiomerically pure amino acids, diastereomerically enriched amino acids, diastereomerically pure amino acids, and derivatives thereof.
- ⁇ amino acids include the 20 naturally occurring amino acids, non-naturally occurring amino acids, .D-amino acids, L- amino acids, and mixtures of D- and Z-amino acids, including derivatives thereof.
- Primary amines can include, but are not limited to ⁇ -amino acids, ⁇ - amino acids, ⁇ -amino amides, ⁇ -amino amides, ⁇ -amino esters, ⁇ -amino esters, ⁇ -amino aldehydes, ⁇ -amino aldehydes, ⁇ -amino ether, a ⁇ -amino alcohol, ⁇ -amino ether, or a ⁇ - amino alcohol.
- derivatives as used herein is meant to include but is not limited to esters, ethers, alcohols, aldehydes, amines, weinreb amides, salts, and compounds that contain one or more protecting groups, particularly two or more orthogonal protecting groups.
- derivatives of possible amino acid starting materials include, but are not limited to, derivatives such as ⁇ -amino amide, ⁇ -amino amide, ⁇ -amino ester, ⁇ -amino ester, ⁇ -amino aldehyde, ⁇ -amino aldehyde, ⁇ -amino ether, a ⁇ -amino alcohol, ⁇ -amino ether, or a ⁇ -amino alcohol, and the corresponding protected versions thereof.
- Exemplary amino acid substrates that can be converted by the disclosed methods include l-Boc-piperidine-4-Fmoc-amino-4-carboxylic acid, Boc-(Fmoc- amino)glycine, Boc-Dpr(Fmoc)-OH, Boc-Lys(Fmoc)-OH, Boc-Orn(Fmoc)-OH, Fmoc- (aminomethyl)benzoic acid, Fmoc-11-Aun-OH, Fmoc-12-Ado-OH, Fmoc-2-Me-Ala- OH, Fmoc-3-(4-biphenyl)aIan ⁇ ne, Fmoc-3-nitrotyrosine, Fmoc-4,5-dehydroleucine, Fmoc-4-aminomethylphenylacetic acid, Fmoc-4-chlorophenylalanine, Fmoc-5- aminovaleric acid, Fmoc-8-amin
- An exemplary set of substrates suitable for conversion to organic compounds such as the product organic alcohols and organic halides by methods disclosed herein can also be described by Formulas T and II.
- R 1 , R 2 , R 3 can be independently hydrogen, alkyl, substituted alkyl, aryl, substituted aryl, arylalkyl, substituted arylalkyl, heteroalkyl, substituted heteroalkyl, heteroaryl, substituted heteroaryl, heteroarylalkyl, substituted heteroarylalkyl, acyl, substituted acyl, alkoxycarbonyl, substituted alkoxycarbonyl, aryloxycarbonyl, substituted aryloxycarbonyl, carbamoyl, substituted carbamoyl, carboxyl, nitro, cyano, or optionally R 1 and R 2 together with the carbon atom to which they are attached form a cycloalkyl, substituted cycloalkyl, cycloheteroalkyl or substituted cycloheteroalkyl ring.
- R 1 is hydrogen and R 2 is acyl, substituted acyl, alkoxycarbonyl, substituted alkoxycarbonyl, aryloxycarbonyl, substituted aryloxycarbonyl, carboxyl, carbamoyl, substituted carbamoyl, carboxyl, nitro or cyano.
- R 1 is hydrogen and R 3 is hydrogen, alkyl, substituted alkyl, aryl, substituted aryl, arylalkyl, substituted arylalkyl, heteroalkyl, substituted heteroalkyl, heteroaryl, substituted heteroaryl, heteroarylalkyl or substituted heteroarylalkyl.
- R 2 is acyl, substituted acyl, carboxyl, alkoxycarbonyl, substituted alkoxycarbonyl, aryloxycarbonyl, substituted aryloxycarbonyl, carbamoyl, substituted carbamoyl, nitro or cyano and R 3 is hydrogen, alkyl, substituted alkyl, aryl, substituted aryl, arylalkyl, substituted arylalkyl, heteroalkyl, substituted heteroalkyl, heteroaryl, substituted heteroaryl, heteroarylalkyl or substituted heteroarylalkyl.
- R 1 is hydrogen and R 2 is acyl, substituted acyl, carboxyl, alkoxycarbonyl, substituted alkoxycarbonyl, aryloxycarbonyl, substituted aryloxycarbonyl, carbamoyl, substituted carbamoyl, nitro or cyano and R 3 is hydrogen, alkyl, substituted alkyl, aryl, substituted aryl, arylalkyl, substituted arylalkyl, heteroalkyl, substituted heteroalkyl, heteroaryl, substituted heteroaryl, heteroarylalkyl or substituted heteroarylalkyl.
- R 1 is hydrogen and R 2 is acyl, carboxyl, carbamoyl, substituted carbamoyl, alkoxycarbonyl, or aryloxycarbonyl.
- R 2 is acyl, carboxyl, alkoxycarbonyl, or aryloxycarbonyl and R 3 is hydrogen, alkyl, substituted alkyl, arylalkyl, substituted arylalkyl, heteroalkyl, substituted heteroalkyl, heteroarylalkyl or substituted heteroarylalkyl.
- R 1 is hydrogen and R 3 is hydrogen, alkyl, substituted alkyl, arylalkyl, substituted arylalkyl, heteroalkyl, substituted heteroalkyl, heteroarylalkyl or substituted heteroarylalkyl.
- R 1 is hydrogen
- R 2 is acyl, carboxyl, carbamoyl, substituted carbamoyl, alkoxycarbonyl, or aryloxycarbonyl
- R 3 is hydrogen, alkyl, substituted alkyl, arylalkyl, substituted arylalkyl, heteroalkyl, substituted heteroalkyl, heteroarylalkyl or substituted heteroarylalkyl.
- R 1 is hydrogen and R 2 is carboxyl, carbamoyl or substituted carbamoyl.
- R 2 is carboxyl, carbamoyl or substituted carbamoyl and R 3 is hydrogen, alkyl, substituted alkyl, arylalkyl, substituted arylalkyl, heteroalkyl, substituted heteroalkyl, heteroarylalkyl or substituted heteroarylalkyl.
- R 1 is a hydrogen
- R 2 is carboxyl
- R 3 is hydrogen, alkyl, substituted alkyl, arylalkyl, substituted arylalkyl, heteroalkyl, substituted heteroalkyl, heteroarylalkyl or substituted heteroarylalkyl.
- R 3 is a hydrogen or alkyl group, more preferably R 3 is a hydrogen, methyl, isopropyl, isobutyl, .sec-butyl, /"-butyl, cyclopentyl or cyclohexyl group.
- R 3 can be a substituted alkyl group. More preferably R 3 can be -CH 2 OH, -CH(OH)CH 3 , -CH 2 CO 2 H, -CH 2 CH 2 CO 2 H, -CH 2 CONH 2 , -CH 2 CH 2 CONH 2 , -CH 2 CH 2 SCH 3 , -CH 2 SH, -CH 2 (CH 2 ) 3 NH 2 or -CH 2 CH 2 CH 2 NHC(NH)NH 2 .
- R 3 can be aryl, arylalkyl, substituted arylalkyl or heteroarylalkyl and even more preferably R 3 can be phenyl, benzyl, 4-hydroxybenzyl, 4-im ⁇ dazolylmethyl or 3-indolylmethyl.
- Preferred classes of substrates described by Formula I and Formula II can contain protecting groups, wherein R 1 , R 2 or R 3 contains one or more functional groups that are independently attached to a protecting groups.
- R 1 , R 2 or R 3 protecting groups can contain one or more -OH groups that are independently protected as -O-t-butyl, OBzI, -OAc, -OTrityl, or protecting groups commonly used for Ser, Thr, Tyr amino acid sidechains.
- R 1 , R 2 or R 3 can contain one or more -NH 2 groups that are independently protected as -NHBoc, -NHBzI, -N(BzI) 2 , -N(Bzl)Boc, -NHAc, -NHCbz, -NH(2-Cl-Cbz), -N(Me) 2 , -NHCOCF 3 , -NHFmoc, -NHDde, NHTrityl. NHMtt, or protecting groups commonly used for Lys or Orn amino acid sidechains.
- R 1 , R 2 or R 3 can contain one or more -NH- groups that are independently protected as -N(Boc)-, — N(Bom)-, — N(tosyl)-, — N(Trityl)-, or protecting groups commonly used for His and Trp amino acid sidechains.
- R 1 , R 2 or R 3 can contain one or more -SH groups that are independently protected as — SBzI, -STrityl, -SMtt, or protecting groups commonly used for Cys amino acid sidechains.
- R 1 , R 2 or R 3 can contain one or more -COOH group(s) that are independently protected as -COO-t-butyl, -COOBzI, -COOAHyI, -COODmab, or protecting groups commonly used for Asp or GIu amino acid sidechains.
- Primary amines in the context of the present disclosure, also encompass salts of the primary amines.
- Alkyl by itself or as part of another substituent, refers to a saturated or unsaturated, branched, straight-chain or cyclic monovalent hydrocarbon radical derived by the removal of one hydrogen atom from a single carbon atom of a parent alkane, alkene or alkyne.
- Typical alkyl groups include, but are not limited to, methyl; ethyls such as ethanyl, ethenyl, ethynyl; propyls such as propan-1-yl, propan-2-yl, cyclo ⁇ ropan-1-yl, prop-1-en-l-yl, prop-l-en-2-yl, prop-2-en-l-yl (allyl), cycloprop-1-en-l-yl; cycloprop-2-en-l-yl, prop-1-yn-l-yl, prop-2-yn-l-yl, etc.; butyls such as butan-1-yl, butan-2-yl, 2-methyl-propan-l-yl, 2-methyl-propan-2-yl, cyclobutan-1-yl, but-1-en-l-yl, but-l-en-2-yl, 2-methyl-prop-l-en-yl, but-2-en-yl-yl
- alkyl is specifically intended to include groups having any degree or level of saturation, e.g., groups having exclusively single carbon-carbon bonds, groups having one or more double carbon-carbon bonds, groups having one or more triple carbon-carbon bonds and groups having mixtures of single, double and triple carbon-carbon bonds. Where a specific level of saturation is intended, the expressions “alkanyl,” “alkenyl,” and “alkynyl” are used.
- an alkyl group comprises from 1 to 20 carbon atoms (C1-C20 alkyl). In other embodiments, an alkyl group comprises from 1 to 10 carbon atoms (C1-C10 alkyl). In still other embodiments, an alkyl group comprises from 1 to 6 carbon atoms (Ci -Ce alkyl).
- Alkanyl by itself or as part of another substituent, refers to a saturated branched, straight-chain or cyclic alkyl radical derived by the removal of one hydrogen atom from a single carbon atom of a parent alkane.
- Typical alkanyl groups include, but are not limited to, methanyl; ethanyl; propanyls such as propan-1-yl, propan-2-yl (isopropyl), cyclopropan-1-yl, etc.; butanyls such as butan-1-yl, butan-2-yl (see-butyl), 2-methyl-propan-l-yl (isobutyl), 2-methyl-propan-2-vl (tf-butyl), cyclobutan-1-yl and the like.
- Alkenyl by itself or as part of another substituent, refers to an unsaturated branched, straight-chain or cyclic alkyl radical having at least one carbon-carbon double bond derived by the removal of one hydrogen atom from a single carbon atom of a parent alkene.
- the group can be in either the cis or trans conformation about the double bond(s).
- Typical alkenyl groups include, but are not limited to, ethenyl; propenyls such as prop-1-en-l-yl, prop-l-en-2-yl, prop-2-eri-l-yl (allyl), prop-2-en-2-yl, cycloprop-1-en-l-yl; cycloprop-2-en-l-yl; butenyls such as but-1-en-l-yl, but-l-en-2-yl, 2-methyl-prop-l-en-l-yl, but-2-en-l-yl , but-2-en-l-yl, but-2-en-2-yl, buta-l,3-dien-l-yl, buta-l,3-dien-2-yl, cyclobut-1-en-l-yl, cyclobut-l-en-3-yl, cyclobuta-l,3-dien-.l-yl and the like.
- Alkynyl by itself or as part of another substituent refers to an unsaturated branched, straight-chain or cyclic alkyl radical having at least one carbon-carbon triple bond derived by the removal of one hydrogen atom from a single carbon atom of a parent alkyne.
- Typical alkynyl groups include, but are not limited to, ethynyl; propynyls such as prop-1-yn-l-yl, prop-2-yn-l-yl, etc.; butynyls such as -but-1-yn-l-yl, but-l-yn-3-yl, but-3-yn-l-yl and the like.
- Alkoxy by itself or as part of another substituent refers to a radical -OR 30 where R 30 is alkyl, substituted alkyl, heteroatkyl or substituted heteroalkyl, as defined herein. Representative examples include, but are not limited to, methoxy, ethoxy, propoxy, butoxy, cyclohexyloxy and the like.
- Alkoxycarbonyl by itself or as part of another substituent, refers to a radical of the formula -C(O)-R 30 , where R 30 is as defined above.
- Acyl by itself or as part of another substituent refers to a radical -C(O)R 31 , where R 31 is hydrogen, alkyl, substituted alkyl, aryl, substituted aryl, arylalkyl, substituted arylalkyl, heteroalkyl, substituted heteroalkyl, heteroarylalkyl or substituted heteroarylalkyl as defined herein.
- Representative examples include, but are not limited to formyl, acetyl, cyclohexylcarbonyl, cyclohexylmethylcarbonyl, benzoyl, benzylcarbonyl and the like.
- Aryl by itself or as part of another substituent, refers to a monovalent aromatic hydrocarbon group derived by the removal of one hydrogen atom from a single carbon atom of a parent aromatic ring system, as defined herein.
- Typical aryl groups include, but are not limited to, groups derived from aceanthrylene, acenaphthylene, acephenanthrylene, anthracene, azulene, benzene, chrysene, coronene, fluoranthene, fluorene, hexacene, hexaphene, hexalene, .w-indacene, s-indacene, indane, indene, naphthalene, octacene, octaphene, octalene, ovalene, penta-2,4-diene, pentacene, pentalene, pentaphene, perylene, phen
- an aryl group comprises from 6 to 20 carbon atoms (C 6 -C 20 aryl). In other embodiments, an aryl group comprises from 6 to 15 carbon atoms (C ⁇ -Cis aryl). In still other embodiments, an aryl group comprises from 6 to 15 carbon atoms (Ce-Ci o aryl).
- Arylalkyl by itself or as part of another substituent, refers to an acyclic alkyl group in which one of the hydrogen atoms bonded to a carbon atom;, typically a terminal or sp 3 carbon atom, is replaced with an aryl group as, as defined herein.
- Typical arylalkyl groups include, but are not limited to, benzyl, 2-phenylethan-l-yl, 2-phenylethen-l-yl, naphthylmethyl, 2-naphthylethan-l-yl, 2-naphthylethen-l-yl, naphthobenzyl, 2-naphthophenylethan-l-yl and the like.
- an arylalkyl group is (C6-C 30 ) arylalkyl, e.g., the alkanyl, alkenyl or alkynyl moiety of the arylalkyl group is (C 1 -C 10 ) alkyl and the aryl moiety is (C6-C20) aryl.
- an arylalkyl group is (C6-C 2 0) arylalkyl, e.g., the alkanyl, alkenyl or alkynyl moiety of the arylalkyl group is (Cj-C ⁇ ) alkyl and the aryl moiety is (Ce-Ci 2) aryl.
- an arylalkyl group is (C ⁇ -Cis) arylalkyl, e.g., the alkanyl, alkenyl or alkynyl. moiety of the arylalkyl group is (C 1 -C 5 ) alkyl and the aryl moiety is (C ⁇ -Cio) aryl.
- Aryloxycarbonyl by itself or as part of another substituent, refers to a radical of the formula -C(O)-O-R 32 , where R 32 is aryl, substituted aryl, arylalkyl, substituted arylalkyl, heteroaryl, substituted heteroaryl, heteroarylalkyl or substituted heteroarylalkyl.
- Aryloxy by itself or as part of another substituent refers to a radical -OR 32 , where R 32 is defined as above.
- Carbamoyl by itself or as part of another substituent, refers to a radical of the formula -C(O)NR 33 R 34 , where R 33 and R 34 are independently selected from the group consisting of hydrogen, alkyl and alkoxy as defined herein, or alternatively, R 33 and R 34 , taken together with the nitrogen atom to which they are attached, form a 4-, 5-, 6- or 7-membered cycloheteroalkyl ring as defined herein, which can optionally include from 1 to 4 of the same or different additional heteroatoms selected from the group consisting of O, S and N.
- Cycloalkyl by itself or as part of another substituent, refers to a saturated or unsaturated cyclic alkyl radical, as defined herein. Where a specific level of saturation is intended, the nomenclature “cycloalkanyl” or “cycloalkenyl” is used.
- Typical cycloalkyl groups include, but are not limited to, groups derived from cyclopropane, cyclobutane, cyclopentane, cyclohexane, and the like.
- the cycloalkyl group comprises from 3 to 10 ring atoms (C 3 -C 10 cycloalkyl).
- the ' cycloalkyl group comprises from 3 to 7 ring atoms (C 3 -C 7 cycloalkyl).
- Cycloheteroalkyl by itself or as part of another substituent, refers to a saturated or unsaturated cyclic alkyl radical in which one or more carbon atoms (and optionally any associated hydrogen atoms) are independently replaced with the same or different heteroatom.
- Typical heteroatoms to replace the carbon atom(s) include, but are not limited to, N, P, O, S, Si, etc. Where a specific level of saturation is intended, the nomenclature “cycloheteroalkanyl” or “cycloheteroalkenyl” is used.
- Typical cycloheteroalkyl groups include, but are not limited to, groups derived from epoxides, azirines, thiiranes, imidazolidine, morpholine, piperazine, piperidine, pyrazolidine, pyrrolidone, quinuclidine, and the like.
- the cycloheteroalkyl group comprises from 3 to. 10 ring atoms (3-10 membered cycloheteroalkyl)
- the cycloalkyl group comprise from 5 to 7 ring atoms (5-7 membered cycloheteroalkyl).
- a cycloheteroalkyl group can be substituted at a heteroatom, for example, a nitrogen atom, with a (Ci-C ⁇ ) alkyl group.
- a heteroatom for example, a nitrogen atom
- a (Ci-C ⁇ ) alkyl group for example, N-methyl-imidazolidinyl, N-methyl-morpholinyl, N-methyl-piperazinyl,
- N-methyl-piperidinyl, N-methyl-pyrazolidinyl and N-methyl-pyrrolidinyl are included within the definition of "cycloheteroalkyl.”
- a cycloheteroalkyl group can be attached to the remainder of the molecule via a ring carbon atom or a ring heteroatom.
- Heteroalkyl refers to alkyl, alkanyl, alkenyl and alkynyl groups, respectively, in which one or more of the carbon atoms (and optionally any associated hydrogen atoms), are each, independently of one another, replaced with the same or different heteroatoms or heteroatomic groups.
- Typical heteroatoms or heteroatomic groups which can replace the carbon atoms include, but are not limited to, O, S, N, Si, -NH-, -S(O)-, -S(O) 2 -, -S(O)NH-, -S(O) 2 NH- and the like and combinations thereof.
- the heteroatoms or heteroatomic groups can be placed at any interior position of the alkyl, alkenyl or alkynyl groups.
- Heteroaryl by itself or as part of another substituent, refers to a monovalent heteroaromat ⁇ c radical derived by the removal of one hydrogen atom from a single atom of a parent heteroaromatic ring systems, as defined herein.
- Typical heteroaryl groups include, but are not limited to, groups derived from acridine, D-carboline, chromane, chromene, cinnoline, fiiran, imidazole, indazole, indole, indoline, indoliz ⁇ ne, isobenzofiiran, isochromene.
- the heteroaryl group comprises from 5 to 20 ring atoms (5-20 membered heteroaryl). In other embodiments, the heteroaryl group comprises from 5 to 10 ring atoms (5-10 membered heteroaryl).
- Exemplary heteroaryl groups include those derived from furan, thiophene, pyrrole, benzothiophene, benzofuran, benzimidazole, indole, pyridine, pyrazole, quinoline, imidazole, oxazole, isoxazole and pyrazine.
- Heteroarylalkyl by itself or as part of another substituent refers to an acyclic alkyl group in which one of the hydrogen atoms bonded to a carbon atom, typically a terminal or sp 3 carbon atom, is replaced with a heteroaryl group. Where specific alkyl moieties are intended, the nomenclature heteroarylalkanyl, heteroarylakenyl and/or heteroarylalkynyl is used.
- the heteroarylalkyl group is a 6-21 membered heteroarylalkyl, e.g., the alkanyl, alkenyl or alkynyl moiety of the heteroarylalkyl is (Ci -Ce) alkyl and the heteroaryl moiety is a 5-15-membered heteroaryl.
- the heteroarylalkyl is a 6-13 membered heteroarylalkyl, e.g., the alkanyl, alkenyl or alkynyl moiety is (C 1 -C 3 ) alkyl and the heteroaryl moiety is a 5- 10 membered heteroaryl.
- Protecting group refers to a grouping of atoms that when attached to a reactive functional group in a molecule masks, reduces or prevents reactivity of the functional group. Examples of protecting groups can be found in Greene et ah, "Protective Groups in Organic Chemistry", (Wiley, 4 th ed. 2006) and Harrison et ah, “Compendium of Synthetic Organic Methods", VoIs. 1-12 (John Wiley and Sons, 1971- 2007). •
- Substituted when used to modify a specified group or radical, means that one or more hydrogen atoms of the specified group or radical are each, independently of one another, replaced with the same or different substituent(s).
- substituent groups useful for substituting unsaturated carbon atoms in the specified group or radical include, but are not. limited to, -R a , halo, -O " , -OR b , -SR b , -S " , -NR 0 R 0 , trihalomethyl, -CF 3 , -CN, -OCN, -SCN, -NO, -NO 2 , -N 3 , -S(O) 2 R b , -S(O) 2 O " , -S(O) 2 OR b , -OS(O) 2 R b , -OS(O) 2 O " , -OS(O) 2 OR b , -P(O)(O " ) 2 , -P(O)(OR 1 O(O-), -P(O)(OR ⁇ (OR 15 ), -C(O)R b , -C(S)R
- Substituent groups useful for substituting nitrogen atoms in heteroalkyl and cycloheteroalkyl groups include, but are not limited to, -R a , -O ' , -OR b , -SR b , -S ' , -NR C R C , trihalomethyl, -CF 3 , -CN, -NO, -NO 2 , -S(O) 2 R b , -S(O) 2 O-, -S(O) 2 OR", -OS(O) 2 R b , -OS(O) 2 O-, -OS(O) 2 OR b , -P(O)(O ) 2 , -P(O)(ORO(O ), -P(O)(OR b )(OR b ), -C(O)R b , -C(S)R b , -C(NR b )R b ,
- the substituents used to substitute a specified group can be further substituted, typically with one or more of the same or different groups selected from the various groups specified above.
- Salt refers to a salt of a compound.
- Such salts include acid addition salts, formed with inorganic acids, including but not limited to hydrochloric acid, hydrobromic acid, sulfuric acid, nitric acid, or phosphoric acid; or formed with organic acids including but not limited to acetic acid, propionic acid, hexanoic acid, cyclopentanepropionic acid, glycolic acid, pyruvic acid, lactic acid, malonic acid, succinic acid, malic acid, maleic acid, fumaric acid, tartaric acid, citric acid, benzoic acid, 3-(4-hydroxybenzoyl) benzoic acid, cinnamic acid, mandelic acid, methanesulfonic acid, ethanesulfonic acid, 1 ,2-ethane-disulfonic acid, 2-hydroxyethanesulfonic acid, benzenesulfonic acid, 4-chlorobenzenesulfonic acid, 2-na
- This example demonstrates methods of preparing an ⁇ -bromo acid from an amino acid precursor.
- This example demonstrates methods using aliphatic amines without aromatic substitution or acid substitution ⁇ to the amine.
- the gas evolved by the reaction was identified by collecting the gas in an IR cell and examining by IR Spectroscopy.
- the IR spectrum in Figure 2 shows the N 2 O gas produced by the reaction.
- Lys(Boc), Leu, Met, Asn, GIn, Ser(tBu), Thr.(tBu), Trp(Boc), Tyr(tBu) A small fraction of the amino acid was added to a solution of isoamyl nitrite (2 equiv.) and bromine (5 equiv.) in CH2CI 2 (1 .mL/mmol of amino acid), after the beginning of gas evolution the rest of the amino acid (1 equiv.) was added gradually. Five minutes after the complete dissolution of the amino acid, the reaction was stopped by removing the solvent under reduced pressure. The residue obtained was suspended in EtOAc (10 mL), and was washed with 5% HCl (3 x 25 ml) and water (3 x 25 ml).
- Figures 4, 5, and 6 provide HPLC traces of ⁇ -bromoamino acids produced as described above.
- Conversion of a primary amine to the corresponding fluoride can be achieved by reacting the amine with the N-fluorinating reagent SELECTFLUOR ® in the presence OfNOBF 4 .
- Table 3 Summary of preparative scale conversions conducted at room temperature for the conversion of ⁇ -amino acids to ⁇ -bromo acids.
- GIu(OtBu), Arg, Asn and Tyr(tBu) were converted by the same procedure to the corresponding ⁇ -hydroxy acids and confirmed by RP-HPLC-ESMS.
- N-bromosuccinimide (2.05 equiv.).
- a 2.8M solution of trifluoroacetic acid (5 equiv.) in CH 2 Cl 2 is added to sodium nitrite (5 equiv.) to generate a solution of nitrous acid.
- the nitrous acid solution is slowly added to the phenylalanine mixture, and stirred at room temperature for 10 minutes.
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Methods are disclosed for the conversion of primary amines to other functional groups. The methods can be used to prepare chiral organic compounds, including organic alcohols and organic halides. The methods can be carried out by treating a primary amine with an activating agent and a nitrosyl agent to produce the transformed compound along with nitrous oxide.
Description
METHODS AND MATERIALS FOR PREPARING ORGANIC COMPOUNDS
FROM PRIMARY AMINES
CROSS REFERENCE TO RELATED APPLICATIONS
[0001] This application claims priority under 35 U.S.C. §119(e) to U.S. Provisional Application Serial No. 60/787,830 filed March 31, 2006, the disclosure of which is incorporated by reference in its entirety herein.
BACKGROUND
[0002] There is a constant need for new and different molecules having unique structures for use in the treatment of diseases and, more generally, for the advancement of science. While recent advances in organometallic chemistry have expanded synthetic strategies to create new carbon carbon bonds, much synthetic organic chemistry still relies on well known functional groups for the creation of new compounds. New synthetic strategies must be economically practical before they will find widespread use in the pharmaceutical or industrial context".
[0003] One well known synthetic strategy is the conversion of an amino group to a leaving group, for example halogen, or to another functional group, for example hydroxyl. In the past this reaction has been considered practical only for aromatic amines. The reaction was known as early as 1849 and has been the subject of much research and analysis in the succeeding years. During this time no simple alternative transformation has been identified, despite the obvious importance to, for example, medicinal chemistry where nitrogen chemistry is central. The archetype of this reaction is a diazonium mediated transformation with resultant liberation of dinitrogen. This reaction has been considered to be of little synthetic utility with simple alkyl amines, a viewpoint that is well documented by general organic chemistry textbooks. Even in synthetic schemes that are amenable to diazonium reactions, challenges exist with regard to scale-up.
[0004] Another consideration with functional group transformations is the creation, incorporation and maintenance of chirality. While a limited number of reactions are known that provide control over chirality, a common method is to utilize chiral building blocks isolated from nature as starting materials. Amino acids are one
significant source of chiral molecules. If a method for transforming the functional groups of the amino acids into other types of functional groups could be found, then amino acids could be used as starting materials for the preparation of a wide variety of chiral compounds.
[0005] A number of amino acid-based compounds having α-hydroxy and α-halo acids have been prepared using a diazotization process. For example, Souers et. al.(Synthesis, No. 4, 583-85 (1999)) purports to have demonstrated the conversion of amino acids to α-bromo acids, via a diazotization process with sodium nitrite, potassium bromide and 0.75 M HBr at -4 to -7 0C. The yields were said to be between 54 and 86 %, with greater than 95% retention of stereochemistry. Reactions were noted as "vigorously exothermic." In addition, Shin et. al.(Journal of Organic Chemistry, Vol. 65, 7667-75 (2000)) purports to have converted 7 naturally-occurring amino acids to α- hydroxy acids via a diazotization process using sodium nitrite and acid, either sulfuric, hydrochloric or acetic, at 00C. In 2004, Deegchongkit et. al. (Organic Letters, Vol. 6(4), 497-500 (2004)) reportedly developed chemistry to produce 18 chiral α-hydroxy acids which were said to be derived from 18 chiral amino acids (glycine being achiral, proline being a secondary amine.) Deegchongkit et. al. also utilized a diazotization process, with sodium nitrite and acid, and noted that only 15 of 18 worked by this process. They also noted that the preparation of some compounds were problematic due to side chain incompatibility with the acidic or oxidizing conditions, or due to intramolecular attack of side chains. Cupido et. al. {Tetrahedron Letters, Vol. 46, 6733- 35, (2005)) noted that intramolecular attack was problematic. in several compounds by Deegchongkit et. al., and provided some improvement in the yields for arginine-like amino acids. Cupϊdo's reaction was also accomplished by a diazotization process.
[0006] New and facile methods are needed for the conversion of the functional group of primary amines to other groups. Ideally, the methods will be useful for the production of chiral compounds. In addition, the methods should be simple to carry out, quick and efficient (e.g., quantitative).
SUMNdARY
[0007] Methods and materials are disclosed for the conversion of primary amines to other functional groups. The methods can be used to prepare organic compounds, including chiral organic compounds. The methods can be carried out by
reacting a primary amine with an activating agent and a nitrosyl agent to produce an organic compound and nitrous oxide. The methods can be simple, quick and efficient (e.g., quantitative). . • .
[0008] Methods are disclosed for preparing organic compounds, including organic alcohols and organic halides. In such methods, primary amines can be reacted • with activating agents and nitrosyl agents to produce such organic compounds along with nitrous oxide. Methods are also disclosed in which a primary organic N-haloamine or N,N-dihaloamine can be reacted with a nitrosyl agent to produce the organic compound and nitrous oxide. Methods are also disclosed for preparing an α-hydroxy acid or derivative thereof by treating a α-amino acid or derivative thereof with an activating agent and a nitrosyl agent, with resulting generation of nitrous oxide. Novel compounds and compositions prepared by the methods are also disclosed.
[0009] The disclosed compounds, compositions or methods can be used in a number of processes, including large scale and commercial processes, and in a wide variety of useful products including, for- example, bromides, chlorides, chiral bromides derived from chiral amines, α-halo acids, Z)-amino acids from £-amino acids in two steps and in a general procedure for inversion of chiral centers via an amine intermediate. A variety of substituted chemical entities can be prepared from amines using the disclosed methods, for example, azides, cyanides, phenolic ethers and esters. Reagents and reaction mixtures useful for carrying out the conversions of amines to the corresponding products are also disclosed. Fqr example, reagents useful for converting amines to the corresponding- halides can include halides and inter-halides, N-halo reagents, nitroso and nitryl reagents and hydroxyl halides.
[0010] Additional features and advantages are described herein, and will be apparent from the following Detailed Description and the Figures.
BRIEF DESCRIPTION OF THE FIGURES
[0011] Figure 1 provides a mass spectra for the reaction of 1.0 equivalent each of amyl nitrite and Br2 with aniline (a; upper, panel) and with 3-aminomethylpyridϊne (AMP; b; lower panel).
[0012] Figure 2 provides an" infrared spectrum of the N2O evolved from the reaction of AMP and 1.1 equivalents of isoamyl nitrite and 5.0 equivalents bromine. .
[0013] Figure 3 provides analytical HPLC traces for the two amines, AMP (trace a) and 2-(2-aminoethyl)pyridine (AEP - trace b), before and after addition of 1.1 equivalent isoairiyl nitrite and 5.0 equivalents of Efø.
[0014] Figure 4 provides an HPLC trace of a α-bromo acid converted from the amino acid Tyr(tBu).
[0015] Figure 5 provides HPLC traces of three α-bromo acids converted from the amino acids Trp(Boc), Asp(OtBu), and His(Trt).
[0016] Figure 6 provides HPLC traces of three α-bromo acids converted from the amino acids Lys(Fmoc). Phe, and Lys(Boc).
[0017] Figure 7 provides graphs demonstrating the disappearance of AMP and appearance of 3-bromomethylpyridine as a function of equivalents of isoamyl nitrite and Br2 added.
DETAILED DESCRIPTION
[0018] Methods are provided for converting primary amines to other organic compounds with the resultant production of nitrous oxide. Methods as disclosed herein can result in the production of new organic compounds having a new functional group in place of the amine in the starting material. A wide variety of substitutions are possible. For example, substitutions can include azide, cyanide, phenol ether and ester substitutions. In some embodiments, the new functional group can be a hydroxyl group, resulting in an organic alcohol. In other embodiments, the functional group can be a halide, resulting in an organic halide.
[0019] Methods are provided that can be carried out with an activating agent and a nitrosyl agent The activating agent can be any compound that can activate the amine. In preferred methods, the activating agent can halogenate the amine to generate an N- haloamine or an N,N-dihaloamine. In other methods, the activating agent can include but is not limited to an alkyl nitrite and X2, XNO2, HOX, an alkyl hypohalite, cyanogen bromide, NO2-BX4 and X2, N-halosuccinimide, l-(chloromethyl)-4-fluoro-l,4- diazoniabicyclo[2.2.2]octane bis(tetrafluoroborate) (e.g. SELECTFLUOR®), or cyanuric halide, wherein X is F, Cl, Br, or I. In some preferred embodiments, the activating agent can be N-bromosuccinide. Alternatively, it can be isoamyl nitrite and bromine; sodium nitrite and bromine; cyanuric bromide; cyanuric chloride; or cyanuric fluoride.
[0020] Any nitrosyl agent that can convert either the primary amine or the activated amine into the desired organic compound can be used. The nitrosyl agent can
be added with the activating agent to a reaction mixture or it can be added separately from the activating agent. The activating agent and nitrosyl agent can be different from one another, or can be the same.
[0021] Useful nitrosyl agents that can cause the production of an organic halide can include, but is not necessarily limited to, XNO, NO-BX4 and X2, HONO and X2, NaNO2 and trifluoroacetic acid and X2, NaNO2 and acetic acid and X2, Na2Fe(CN)S(NO) and X2, or a nitrite and an acid and X2, wherein X is Br, Cl or F. In a preferred embodiment to produce the organic halide, the nitrosyl agent can be BrNO, HNO2 and bromine, NaNO2 and trifluoroacetic acid and Br2, cyanuric chloride and NO- BF4, cyanuric fluoride and NO-BF4, or cyanuric bromide and NO-BF4.
[0022] Useful nitrosyl agents that can cause the production of the organic alcohol include, but are not limited to, NO2-BX4 and trifluoroacetic acid, HONO, NaNO2 and trifluoroacetic acid, NaNO2 and acetic acid, or a nitrite and an acid, wherein X is Br, Cl or F. The nitrosyl agent can be generated by the any combination of nitrite salt and acid, e.g. any organic or inorganic nitrite salt and any organic or inorganic acid. In preferred methods, the organic alcohol can be prepared from the nitrosyl agent HONO or NaNO2 and trifluoroacetic acid.
[0023] The activating agent and the nitrosyl agent can be in the form of one or more compounds added directly to the reaction mixture, can be generated in situ in the reaction mixture, or can be formed in the reaction mixture as intermediates of the reaction. In some embodiments, to produce the organic halide, the activating agent and nitrosyl agent can be generated by the combination of alkyl nitrite, X2, and primary amine, wherein X is F, Cl, Br, or I. In preferred embodiments, the activating agent and nitrosyl agent can be generated by the combination of isoamyl nitrite, Br2, and primary amine.
[0024] As disclosed herein, the conversion of 3-aminomethylpyridine (AMP) to 3-(bromomethyl)pyridine was studied. The reaction of AMP in methylene chloride produces an off-white precipitate during the addition of one equivalent of each of isoamyl nitrite and Br2. The precipitate redissolves on the further addition of Br2. This suggests that the reaction proceeds through an intermediate that is most likely unstable. To identify the intermediates of the reaction directly, both aniline and AMP were reacted with 1 equivalent each of isoamyl nitrite and Br2, and neat acetonitrile used as the solvent for dilution prior to obtaining mass spectra. Tn contrast to the intermediates
formed when aniline is reacted, which indicates a diazo reaction pathway, Figure 1 shows the presence of both the N-bromo and N,N-dibromo intermediates of AMP with very little of the final product 3-(bromomethyl)pyridine present. The three compounds indicated as ionized radicals in trace b of Figure 1 at m/z 93, 108, and 186/188, are the results of fragmentation by loss of a bromine atom during the mass spectroscopy process. On addition of either reagent alone only AMP is observed in the spectrum, suggesting that Br2 is not reacting directly with the amine.
[0025] While not being bound by a theory, a proposed reaction process for conversion of a primary amine to an organic bromide with isoamyl nitrite and bromine is set forth below in Scheme 1. Conversion of the amine to the N-bromoamine and N,N-dibromoamine can occur with the addition of isoamyl nitrite and bromine. This intermediate then can react with a reactive intermediate, nitrylbromide (BrNC>2), which can be itself formed by reaction. Confirmation that the isoamyl bromide can result from reaction of isoamyl nitrite with bromine was obtained by GC/MS and by NMR. To account for the almost complete conversion of AMP to 3-(bromomethyl)pyridine as observed by HPLC, an alternative pathway to the N-bromoamine or N,N-dibromoamine intermediates of AMP is postulated as shown by reactions 6 and 7. In this example, the activating agent is hypobromite (HOBr), which can be formed as per reaction 5. Independent confirmation of this was obtained by reacting AMP with either N- bromosuccinimide or a mixture of 4-chloroperoxybenzoic acid and Br2, and then completing conversion to the 3-(bromomethyl)pyridine by addition of a CH2CI2 solution of nitrous acid and Br2, reaction 8. Under normal reaction conditions it is thought that nitrosyl bromide (BrNO) can be formed as per reaction 5.
[0026] Formation of 3-(hydroxymethyl) pyridine is postulated to proceed as shown in reaction 9. Without wishing to be bound by any particular theory, this suggests an explanation for the finding that best yields of an organic bromide require about 5 equivalents of total Br2, and is the result of mass action driven competition for nitrous acid by a large excess of added Br2, reaction 5. Alternatively, the organic alcohol can be optimized by increasing the amount of nitrous acid in the reaction.
SCHEME l
1 isoamyl-N02 + Br2 → isoamyl-Br + BrNO2
2 R-NH2 + BrNO2 → R-NHBr + HNO2
3 R-NHBr + BrNO2 → R-NBr2 + HNO2 x R-NH2
4 R-NH2 + BrNO2 → y R-NHBr
. z R-NBr2
5 HNO2 + Br2 → HOBr + BrNO
6 R-NH2 + HOBr → R-NHBr + H2O
7 R-NHBr + HOBr → R-NBr2 + H2O
8 R-NBr2 + BrNO → R-Br + N2Ot + Br2
9 R-NBr2 + HNO2 → R-OH + N2Ot + Br2
[0027] Because the methods of converting an primary amine to an organic compound are thought to involve an intermediate N-haloamine or N,N-dihaloamine, another method can include the conversion of the primary organic N-haloamine or primary organic N,N-dihaIoamine to the organic compound, wherein the intermediate can be treated with a nitrosyl agent to produce an organic compound and nitrous oxide. The nitrosyl agent can be any nitrosyl agent. For the organic halide, the nitrosyl agent can include any species as set forth above, e.g. XNO, NO-BX4 and X2, HONO and X2, NaNO2 and trifluoroacetic acid and X2, NaNO2 and acetic acid and X2, Na2Fe(CN)S(NO) and X2, or a nitrite and an acid and X2, wherein X can be Br, Cl or F. For an organic alcohol, the nitrosyl agent can include any species as set forth above, e.g. NO2-BX4 and trifluoroacetic acid, HONO, NaNO2 and trifluoroacetic acid, NaNO2 and acetic acid, or a nitrite and an acid, wherein X is Br, Cl or F.
[0028] The reaction conditions can include any conditions that allow a facile reaction to occur. The organic amine can be partially dissolved in a solvent. The solvent can be any solvent, including but not limited to tetrahydrofuran, dichloromethane, chloroform, carbon tetrachloride, dimethyl formamide, dimethyl sulfoxide, /-butanol, diethylether, acetic acid, hexane, dichloroethane, ethyl acetate,
acetonitrile, methanol, ethanol, bromine, water and the like. Preferably the reaction can be conducted in tetrahydrofuran or dichloromethane.
[0029] The ratio of amine to activating agent to nitrosyl agent can be about 1.0:0.1 :0.1 to about 1:10:100, preferably 1:1:1 to about 1 :5:10, and more preferably 1 :2:3.
[0030] The reaction can be conducted at a range of temperatures, including between about -78 0C and about 200 0C, or -50 °C and about 50 0C, preferably about 25 0C.
[0031] One advantage of the disclosed reactions is that they can be carried out at mild temperatures. This is caused by the facile nature of the reaction in terms of heat generation. The prior art reactions that rely upon the diazo compound to generate nitrogen, while successful with some substrates at small scales, must be conducted at less than 0 °C. Furthermore, that reaction can be hampered in scale-up to multigram scale by the problems with heat generation. A surprising benefit of the disclosed methods is the ability to conduct the reaction at above about 0 0C. Consequently, in some embodiments the reaction can be conducted between about 10 0C and about 40 0C, preferably between about 20 0C and about 30 0C, and more preferably at about room temperature. The yield of the preparation of organic alcohol or organic halide can be greater than about 50%, preferably greater than about 75%, and more preferably greater than about 90% and can be nearly quantitative. Furthermore, because the disclosed reactions can be more facile than the diazo reaction, the conversion of the primary amine can be conducted on a multigram or large scale, including greater than 10 grams, • greater than 100 grams, and greater than 1 kilogram. Finally, the stereochemistry of any chiral primary amine is not lost. Therefore, conversion can occur with greater than about 90% retention of stereochemistry, e.g. about 90% or more, about 91% . or more, about 92% or more, about 93% or more, about 94% or more, about 95% or more, about 96% or more, about 97% or more, about 98% or more, about 99% or more; preferably greater than about 95% retention of stereochemistry, e.g. about 95% or more, about 96% or more, about 97% or more, about 98% or more, about 99% or more; and most preferably with complete retention of stereochemistry. Complete retention for the purposes of this disclosure is as greater than about 99% retention of configuration.
[0032] Substrates suitable for use with methods as disclosed herein include any primary amines, particularly aliphatic primary amines. One of the differences between
methods as disclosed herein and prior methods was that previously known methods were limited to aryl amines and to amino acids in which a neighboring group effect was implicated in the conversion of the amino to a halide or alcohol. In contrast, methods as disclosed herein provide for conversion of simple aliphatic amines, e.g. 2- aminoethylpyridine, 6-aminόhexanoic acid, under facile conditions. Furthermore, the chiral amine i?-(-)-l-methyl-3-phenyIpropylamine, containing no adjacent neighboring group, can be converted to the corresponding bromide with retention of chirality. Consequently, any primary amine can be used in the methods as disclosed herein.
[0033] Furthermore, the disclosed methods can be used to convert any primary amine with retention of stereochemistry. More specifically, any primary amine having a chiral center can be converted to an organic alcohol or organic halide with retention of stereochemistry at the same chiral center.
[0034] Methods for the conversion of amino acids or derivatives thereof, into organic alcohols or organic bromides are also disclosed. Amino acids can include any compound containing an amine and an acid group, or their derivatives, including but not limited to α-amino acids, β-amino acids, achiral amino acids, chiral amino acids, racemic amino acids, enantiomerically enriched amino acids, enantiomerically pure amino acids, diastereomerically enriched amino acids, diastereomerically pure amino acids, and derivatives thereof. In some embodiments, α amino acids include the 20 naturally occurring amino acids, non-naturally occurring amino acids, .D-amino acids, L- amino acids, and mixtures of D- and Z-amino acids, including derivatives thereof.
[0035] Primary amines can include, but are not limited to α-amino acids, β- amino acids, α-amino amides, β-amino amides, α-amino esters, β-amino esters, α-amino aldehydes, β-amino aldehydes, β-amino ether, a β-amino alcohol, γ-amino ether, or a γ- amino alcohol.
[0036] The term "derivatives" as used herein is meant to include but is not limited to esters, ethers, alcohols, aldehydes, amines, weinreb amides, salts, and compounds that contain one or more protecting groups, particularly two or more orthogonal protecting groups. For example derivatives of possible amino acid starting materials include, but are not limited to, derivatives such as α-amino amide, β-amino amide, α-amino ester, β-amino ester, α-amino aldehyde, β-amino aldehyde, β-amino ether, a β-amino alcohol, γ-amino ether, or a γ-amino alcohol, and the corresponding protected versions thereof.
[0037] Exemplary amino acid substrates that can be converted by the disclosed methods include l-Boc-piperidine-4-Fmoc-amino-4-carboxylic acid, Boc-(Fmoc- amino)glycine, Boc-Dpr(Fmoc)-OH, Boc-Lys(Fmoc)-OH, Boc-Orn(Fmoc)-OH, Fmoc- (aminomethyl)benzoic acid, Fmoc-11-Aun-OH, Fmoc-12-Ado-OH, Fmoc-2-Me-Ala- OH, Fmoc-3-(4-biphenyl)aIanϊne, Fmoc-3-nitrotyrosine, Fmoc-4,5-dehydroleucine, Fmoc-4-aminomethylphenylacetic acid, Fmoc-4-chlorophenylalanine, Fmoc-5- aminovaleric acid, Fmoc-8-aminocaprylic acid, Fmoc-Ala-OH, Fmoc-Allo-Thr(tBu)- OH, Fmoc-alpha-methylalanine, Fmoc-Arg(Mts)-OH, Fmoc-Arg(N02)-OH, Fmoc- ATg(PmC)-OH3 Frnoc-Asn(Tmob)-OH, Fmoc-Asn-OH, Fmoc-Asp(O-l-Ada)-OH, Fmoc-Asp(OAllyl)-OH, Fmoc-Asp(Ocyclohexyl)-OH, Fmoc-Asp(OtBu)-OH, Fmoc- benzothienylalanϊne, Fmoc-beta-alanine, Fmoc-beta-cyclopropylalanine, Fmoc-Cha- OH, Fmoc-Cys(Et)-OH, Fmoc-D-2-thienylalanine, Fmoc-D-3-(2-naphthyl)alanine, Fmoc-D-3(3-pyridyl)alanine, Fmoc-D-3,4-dichlorophenylalanine, Fmoc-D-Arg(Tos)- OH, Fmoc-D-Cit-OH, Fmoc-D-cyclohexylglycine, Fmoc-D-Cys(tBu)-OH, Fmoc-delta- amiπobutyric acid, Fmoc-D-Gln-OH, Fmoc-D-homophenylalanine, Fmoc-DL-2- aminotetraline-2-carboxylic acid, Fmoc-D-Leu-OH, Fmoc-DL-p-fluorophenylalanine, Fmoc-D-Lys(nicotinoyl)-OH, Fmoc-D-Met, Fmoc-D-norleucine, Fmoc-D-norvaline, Fmoc-D-Orn(Boc)-OH, Fmoc-D-Ser, Fmoc-D-Thr-OH, Fmoc-D-Tic-OH, Fmoc- Gln(Tmob)-OH, FmOC-GIu(OAlIyI)-OH5 Fmoc-Gly-Gly-Gly-OH, Fmoc-Gly-Gly-OH, Fmoc-Gly-OH, Fmoc-Gly-Phe-OH, Fmoc-Gly-Pro-Hyp-OH, Fmoc-Gly-Pro-OH, Fmoc- His(Boc)-OH, Fmoc-His(Bum)-OH, Fmoc-His(Bzl)-OH, Fmoc-homophenylalanine, Fmoc-Ile-Pro-OH, Fmoc-L-2-thienylalanine, Fmoc-L-3-(2-naphthyl)alanine, Fmoc-L- 3(3-pyridyl)alanine, Fmoc-L-Gln-OH, Fmoc-L-Glu(OtBu)-OH, Fmoc-Lys(Ac)-OH, Fmoc-Lys(Alloc)-ΘH, Fmoc-Lys(Boc)-OH, Fmoc-Lys(Bzl)-OH, Fmoc-methionine sulfoxide, Fmoc-Nal( I)-OH, Fmoc-Nle-Nle-OH, Fmoc-p-benzylphenylalanine, Fmoc- Phe-GIy-OH, Fmoc-phenylglycine, Fmoc-Phe-OH, Fmoc-Phe-Phe-OH, Fmoc-p- nitrophenyl alanine, Fmoc-S-acetomidomethylcysteine, Fmoc-Ser(Bzl)-OH, Fmoc- Ser(tBu)-OH, Fmoc-tert-leucine, Fmoc-Thr(Bzl)-OH, Fmoc-trans-4-
(aminomethyl)cyclohexanecarboxylϊc acid, Fmoc-Tφ(Boc)-OH, Fmoc-Tφ-OH, Fmoc- Trp-Pro-OH, Fmoc-Tyr(Bzl)-OH, Fmoc-Tyr(Me)-OH, Fmoc-Tyr(tBu)-OH, Fmoc-Tyr- AIa-OH, Fmoc-Tyr-OH, Fmoc-Val, N-alpha-Boc-N-gamma-Fmoc-L-diaminobutyric acid, N-alpha-Fmoc-1-aminocyclopropane-l-carboxylic acid, N-alpha-Fmoc-N-gamma- Boc-diaminobutyric acid, N-alpha-Fmoc-pi-benzyloxymethylhistidine, N-Fmoc-Statin
and the like. Of course, the amino protecting group can be removed by methods known in the art prior to the conversion.
[0038] An exemplary set of substrates suitable for conversion to organic compounds such as the product organic alcohols and organic halides by methods disclosed herein can also be described by Formulas T and II.
R2 R3 R2 R3
(0 (π> wherein Y is OH, Br, Cl or F; R1, R2, R3 can be independently hydrogen, alkyl, substituted alkyl, aryl, substituted aryl, arylalkyl, substituted arylalkyl, heteroalkyl, substituted heteroalkyl, heteroaryl, substituted heteroaryl, heteroarylalkyl, substituted heteroarylalkyl, acyl, substituted acyl, alkoxycarbonyl, substituted alkoxycarbonyl, aryloxycarbonyl, substituted aryloxycarbonyl, carbamoyl, substituted carbamoyl, carboxyl, nitro, cyano, or optionally R1 and R2 together with the carbon atom to which they are attached form a cycloalkyl, substituted cycloalkyl, cycloheteroalkyl or substituted cycloheteroalkyl ring.
[0039] In a class of compounds described by Formula I and Formula II, R1 is hydrogen and R2 is acyl, substituted acyl, alkoxycarbonyl, substituted alkoxycarbonyl, aryloxycarbonyl, substituted aryloxycarbonyl, carboxyl, carbamoyl, substituted carbamoyl, carboxyl, nitro or cyano.
[0040] In a class of compounds described by Formula I and Formula II, R1 is hydrogen and R3 is hydrogen, alkyl, substituted alkyl, aryl, substituted aryl, arylalkyl, substituted arylalkyl, heteroalkyl, substituted heteroalkyl, heteroaryl, substituted heteroaryl, heteroarylalkyl or substituted heteroarylalkyl.
[0041] In a class of compounds described by Formula I and Formula II, R2 is acyl, substituted acyl, carboxyl, alkoxycarbonyl, substituted alkoxycarbonyl, aryloxycarbonyl, substituted aryloxycarbonyl, carbamoyl, substituted carbamoyl, nitro or cyano and R3 is hydrogen, alkyl, substituted alkyl, aryl, substituted aryl, arylalkyl, substituted arylalkyl, heteroalkyl, substituted heteroalkyl, heteroaryl, substituted heteroaryl, heteroarylalkyl or substituted heteroarylalkyl.
[0042] In a class of compounds described by Formula I and Formula II, R1 is hydrogen and R2 is acyl, substituted acyl, carboxyl, alkoxycarbonyl, substituted alkoxycarbonyl, aryloxycarbonyl, substituted aryloxycarbonyl, carbamoyl, substituted
carbamoyl, nitro or cyano and R3 is hydrogen, alkyl, substituted alkyl, aryl, substituted aryl, arylalkyl, substituted arylalkyl, heteroalkyl, substituted heteroalkyl, heteroaryl, substituted heteroaryl, heteroarylalkyl or substituted heteroarylalkyl.
[0043] In a class of compounds described by Formula I and Formula II, R1 is hydrogen and R2 is acyl, carboxyl, carbamoyl, substituted carbamoyl, alkoxycarbonyl, or aryloxycarbonyl.
[0044] In a class of compounds described by Formula I and Formula II, R2 is acyl, carboxyl, alkoxycarbonyl, or aryloxycarbonyl and R3 is hydrogen, alkyl, substituted alkyl, arylalkyl, substituted arylalkyl, heteroalkyl, substituted heteroalkyl, heteroarylalkyl or substituted heteroarylalkyl.
[0045] In a class of compounds described by Formula I and Formula II, R1 is hydrogen and R3 is hydrogen, alkyl, substituted alkyl, arylalkyl, substituted arylalkyl, heteroalkyl, substituted heteroalkyl, heteroarylalkyl or substituted heteroarylalkyl.
[0046] In a class of compounds described by Formula I and Formula II, R1 is hydrogen, R2 is acyl, carboxyl, carbamoyl, substituted carbamoyl, alkoxycarbonyl, or aryloxycarbonyl and R3 is hydrogen, alkyl, substituted alkyl, arylalkyl, substituted arylalkyl, heteroalkyl, substituted heteroalkyl, heteroarylalkyl or substituted heteroarylalkyl.
[0047] In a class of compounds described by Formula I and Formula II, R1 is hydrogen and R2 is carboxyl, carbamoyl or substituted carbamoyl.
[0048] In a class of compounds described by Formula I and Formula II, R2 is carboxyl, carbamoyl or substituted carbamoyl and R3 is hydrogen, alkyl, substituted alkyl, arylalkyl, substituted arylalkyl, heteroalkyl, substituted heteroalkyl, heteroarylalkyl or substituted heteroarylalkyl.
[0049] In a class of compounds described by Formula 1 and Formula II, R1 is a hydrogen, R2 is carboxyl, carbamoyl or substituted carbamoyl and R3 is hydrogen, alkyl, substituted alkyl, arylalkyl, substituted arylalkyl, heteroalkyl, substituted heteroalkyl, heteroarylalkyl or substituted heteroarylalkyl.
[0050] In a class of compounds described by Formula I and Formula II, R3 is a hydrogen or alkyl group, more preferably R3 is a hydrogen, methyl, isopropyl, isobutyl, .sec-butyl, /"-butyl, cyclopentyl or cyclohexyl group.
[0051] In a class of compounds described by Formula I and Formula II, R3 can be a substituted alkyl group. More preferably R3 can be -CH2OH, -CH(OH)CH3,
-CH2CO2H, -CH2CH2CO2H, -CH2CONH2, -CH2CH2CONH2, -CH2CH2SCH3, -CH2SH, -CH2(CH2)3NH2 or -CH2CH2CH2NHC(NH)NH2.
[0052] In a class of compounds described by Formula I and Formula II, R3 can be aryl, arylalkyl, substituted arylalkyl or heteroarylalkyl and even more preferably R3 can be phenyl, benzyl, 4-hydroxybenzyl, 4-imϊdazolylmethyl or 3-indolylmethyl.
[0053] Preferred classes of substrates described by Formula I and Formula II can contain protecting groups, wherein R1, R2 or R3 contains one or more functional groups that are independently attached to a protecting groups. R1, R2 or R3 protecting groups can contain one or more -OH groups that are independently protected as -O-t-butyl, OBzI, -OAc, -OTrityl, or protecting groups commonly used for Ser, Thr, Tyr amino acid sidechains.
[0054] Alternatively, R1, R2 or R3 can contain one or more -NH2 groups that are independently protected as -NHBoc, -NHBzI, -N(BzI)2, -N(Bzl)Boc, -NHAc, -NHCbz, -NH(2-Cl-Cbz), -N(Me)2, -NHCOCF3, -NHFmoc, -NHDde, NHTrityl. NHMtt, or protecting groups commonly used for Lys or Orn amino acid sidechains. Alternatively, R1, R2 or R3 can contain one or more -NH- groups that are independently protected as -N(Boc)-, — N(Bom)-, — N(tosyl)-, — N(Trityl)-, or protecting groups commonly used for His and Trp amino acid sidechains.
[0055] Alternatively, R1, R2 or R3 can contain one or more -SH groups that are independently protected as — SBzI, -STrityl, -SMtt, or protecting groups commonly used for Cys amino acid sidechains.
[0056] Alternatively, R1, R2 or R3 can contain one or more -COOH group(s) that are independently protected as -COO-t-butyl, -COOBzI, -COOAHyI, -COODmab, or protecting groups commonly used for Asp or GIu amino acid sidechains.
[0057] Alternatively, R1, R2 or R3 can contain one or more -CONH2 or -NHC(=NH)NH2 groups that are independently protected as protecting groups commonly used for Asn, GIn or Arg amino acid sidechains.
[0058] Primary amines, in the context of the present disclosure, also encompass salts of the primary amines.
[0059] The following definitions are intended to help clarify this disclosure and are not intended to provide any special meanings as the following terms are to be given their normal meaning as the terms would be understood by one of skill in the art.
[0060] "Alkyl," by itself or as part of another substituent, refers to a saturated or unsaturated, branched, straight-chain or cyclic monovalent hydrocarbon radical derived by the removal of one hydrogen atom from a single carbon atom of a parent alkane, alkene or alkyne. Typical alkyl groups include, but are not limited to, methyl; ethyls such as ethanyl, ethenyl, ethynyl; propyls such as propan-1-yl, propan-2-yl, cycloρropan-1-yl, prop-1-en-l-yl, prop-l-en-2-yl, prop-2-en-l-yl (allyl), cycloprop-1-en-l-yl; cycloprop-2-en-l-yl, prop-1-yn-l-yl, prop-2-yn-l-yl, etc.; butyls such as butan-1-yl, butan-2-yl, 2-methyl-propan-l-yl, 2-methyl-propan-2-yl, cyclobutan-1-yl, but-1-en-l-yl, but-l-en-2-yl, 2-methyl-prop-l-en-l-yl, but-2-en-l-yl, but-2-en-2-yl, buta-l,3-dien-l-yl, buta-l,3-dien-2-yl, cyclobut-1-en-l-yl, cyclobut-l-en-3-yl, cyclobuta-l,3-dien-l-yl, but-1-yn-l-yl, but-l-yn-3-yl, but-3-yn-l -yl and the like.
[0061] The term "alkyl" is specifically intended to include groups having any degree or level of saturation, e.g., groups having exclusively single carbon-carbon bonds, groups having one or more double carbon-carbon bonds, groups having one or more triple carbon-carbon bonds and groups having mixtures of single, double and triple carbon-carbon bonds. Where a specific level of saturation is intended, the expressions "alkanyl," "alkenyl," and "alkynyl" are used. In some embodiments, an alkyl group comprises from 1 to 20 carbon atoms (C1-C20 alkyl). In other embodiments, an alkyl group comprises from 1 to 10 carbon atoms (C1-C10 alkyl). In still other embodiments, an alkyl group comprises from 1 to 6 carbon atoms (Ci -Ce alkyl).
[0062] "Alkanyl," by itself or as part of another substituent, refers to a saturated branched, straight-chain or cyclic alkyl radical derived by the removal of one hydrogen atom from a single carbon atom of a parent alkane. Typical alkanyl groups include, but are not limited to, methanyl; ethanyl; propanyls such as propan-1-yl, propan-2-yl (isopropyl), cyclopropan-1-yl, etc.; butanyls such as butan-1-yl, butan-2-yl (see-butyl), 2-methyl-propan-l-yl (isobutyl), 2-methyl-propan-2-vl (tf-butyl), cyclobutan-1-yl and the like.
[0063] "Alkenyl," by itself or as part of another substituent, refers to an unsaturated branched, straight-chain or cyclic alkyl radical having at least one carbon-carbon double bond derived by the removal of one hydrogen atom from a single carbon atom of a parent alkene. The group can be in either the cis or trans conformation about the double bond(s). Typical alkenyl groups include, but are not limited to,
ethenyl; propenyls such as prop-1-en-l-yl, prop-l-en-2-yl, prop-2-eri-l-yl (allyl), prop-2-en-2-yl, cycloprop-1-en-l-yl; cycloprop-2-en-l-yl; butenyls such as but-1-en-l-yl, but-l-en-2-yl, 2-methyl-prop-l-en-l-yl, but-2-en-l-yl , but-2-en-l-yl, but-2-en-2-yl, buta-l,3-dien-l-yl, buta-l,3-dien-2-yl, cyclobut-1-en-l-yl, cyclobut-l-en-3-yl, cyclobuta-l,3-dien-.l-yl and the like.
[0064] "Alkynyl," by itself or as part of another substituent refers to an unsaturated branched, straight-chain or cyclic alkyl radical having at least one carbon-carbon triple bond derived by the removal of one hydrogen atom from a single carbon atom of a parent alkyne. Typical alkynyl groups include, but are not limited to, ethynyl; propynyls such as prop-1-yn-l-yl, prop-2-yn-l-yl, etc.; butynyls such as -but-1-yn-l-yl, but-l-yn-3-yl, but-3-yn-l-yl and the like.
[0065] "Alkoxy" by itself or as part of another substituent refers to a radical -OR30 where R30 is alkyl, substituted alkyl, heteroatkyl or substituted heteroalkyl, as defined herein. Representative examples include, but are not limited to, methoxy, ethoxy, propoxy, butoxy, cyclohexyloxy and the like.
[0066] "Alkoxycarbonyl," by itself or as part of another substituent, refers to a radical of the formula -C(O)-R30, where R30 is as defined above.
[0067] "Acyl" by itself or as part of another substituent refers to a radical -C(O)R31, where R31 is hydrogen, alkyl, substituted alkyl, aryl, substituted aryl, arylalkyl, substituted arylalkyl, heteroalkyl, substituted heteroalkyl, heteroarylalkyl or substituted heteroarylalkyl as defined herein. Representative examples include, but are not limited to formyl, acetyl, cyclohexylcarbonyl, cyclohexylmethylcarbonyl, benzoyl, benzylcarbonyl and the like.
[0068] "Aryl," by itself or as part of another substituent, refers to a monovalent aromatic hydrocarbon group derived by the removal of one hydrogen atom from a single carbon atom of a parent aromatic ring system, as defined herein. Typical aryl groups include, but are not limited to, groups derived from aceanthrylene, acenaphthylene, acephenanthrylene, anthracene, azulene, benzene, chrysene, coronene, fluoranthene, fluorene, hexacene, hexaphene, hexalene, .w-indacene, s-indacene, indane, indene, naphthalene, octacene, octaphene, octalene, ovalene, penta-2,4-diene, pentacene, pentalene, pentaphene, perylene, phenalene, phenanthrene, picene, pleiadene, pyrene, pyranthrene, rubicene, triphenylene, trinaphthalene and the like. In some embodiments, an aryl group comprises from 6 to 20 carbon atoms (C6-C20 aryl). In other
embodiments, an aryl group comprises from 6 to 15 carbon atoms (Cβ-Cis aryl). In still other embodiments, an aryl group comprises from 6 to 15 carbon atoms (Ce-Ci o aryl).
[0069] "Arylalkyl," by itself or as part of another substituent, refers to an acyclic alkyl group in which one of the hydrogen atoms bonded to a carbon atom;, typically a terminal or sp3 carbon atom, is replaced with an aryl group as, as defined herein. Typical arylalkyl groups include, but are not limited to, benzyl, 2-phenylethan-l-yl, 2-phenylethen-l-yl, naphthylmethyl, 2-naphthylethan-l-yl, 2-naphthylethen-l-yl, naphthobenzyl, 2-naphthophenylethan-l-yl and the like. Where specific alkyl moieties are intended, the nomenclature arylalkanyl, arylalkenyl and/or arylalkynyl is used. In some embodiments, an arylalkyl group is (C6-C30) arylalkyl, e.g., the alkanyl, alkenyl or alkynyl moiety of the arylalkyl group is (C1-C10) alkyl and the aryl moiety is (C6-C20) aryl. In other embodiments, an arylalkyl group is (C6-C20) arylalkyl, e.g., the alkanyl, alkenyl or alkynyl moiety of the arylalkyl group is (Cj-Cβ) alkyl and the aryl moiety is (Ce-Ci 2) aryl. In still other embodiments, an arylalkyl group is (Cβ-Cis) arylalkyl, e.g., the alkanyl, alkenyl or alkynyl. moiety of the arylalkyl group is (C1-C5) alkyl and the aryl moiety is (Cβ-Cio) aryl.
[0070] "Aryloxycarbonyl," by itself or as part of another substituent, refers to a radical of the formula -C(O)-O-R32, where R32 is aryl, substituted aryl, arylalkyl, substituted arylalkyl, heteroaryl, substituted heteroaryl, heteroarylalkyl or substituted heteroarylalkyl.
[0071] "Aryloxy" by itself or as part of another substituent refers to a radical -OR32, where R32 is defined as above.
[0072] "Carbamoyl," by itself or as part of another substituent, refers to a radical of the formula -C(O)NR33R34, where R33 and R34 are independently selected from the group consisting of hydrogen, alkyl and alkoxy as defined herein, or alternatively, R33 and R34, taken together with the nitrogen atom to which they are attached, form a 4-, 5-, 6- or 7-membered cycloheteroalkyl ring as defined herein, which can optionally include from 1 to 4 of the same or different additional heteroatoms selected from the group consisting of O, S and N.
[0073] "Cycloalkyl," by itself or as part of another substituent, refers to a saturated or unsaturated cyclic alkyl radical, as defined herein. Where a specific level of saturation is intended, the nomenclature "cycloalkanyl" or "cycloalkenyl" is used. Typical cycloalkyl groups include, but are not limited to, groups derived from
cyclopropane, cyclobutane, cyclopentane, cyclohexane, and the like. In some embodiments, the cycloalkyl group comprises from 3 to 10 ring atoms (C3-C10 cycloalkyl). In other embodiments, the' cycloalkyl group comprises from 3 to 7 ring atoms (C3-C7 cycloalkyl).
[0074] "Cycloheteroalkyl," by itself or as part of another substituent, refers to a saturated or unsaturated cyclic alkyl radical in which one or more carbon atoms (and optionally any associated hydrogen atoms) are independently replaced with the same or different heteroatom. Typical heteroatoms to replace the carbon atom(s) include, but are not limited to, N, P, O, S, Si, etc. Where a specific level of saturation is intended, the nomenclature "cycloheteroalkanyl" or "cycloheteroalkenyl" is used. Typical cycloheteroalkyl groups include, but are not limited to, groups derived from epoxides, azirines, thiiranes, imidazolidine, morpholine, piperazine, piperidine, pyrazolidine, pyrrolidone, quinuclidine, and the like. In some embodiments, the cycloheteroalkyl group comprises from 3 to. 10 ring atoms (3-10 membered cycloheteroalkyl) In other embodiments, the cycloalkyl group comprise from 5 to 7 ring atoms (5-7 membered cycloheteroalkyl).
[0075] A cycloheteroalkyl group can be substituted at a heteroatom, for example, a nitrogen atom, with a (Ci-Cβ) alkyl group. As specific examples, N-methyl-imidazolidinyl, N-methyl-morpholinyl, N-methyl-piperazinyl,
N-methyl-piperidinyl, N-methyl-pyrazolidinyl and N-methyl-pyrrolidinyl are included within the definition of "cycloheteroalkyl." A cycloheteroalkyl group can be attached to the remainder of the molecule via a ring carbon atom or a ring heteroatom.
[0076] "Heteroalkyl," "Heteroalkanyl," "Heteroalkenyl" and "Heteroalkynyl," "by themselves or as part of other substituents, refer to alkyl, alkanyl, alkenyl and alkynyl groups, respectively, in which one or more of the carbon atoms (and optionally any associated hydrogen atoms), are each, independently of one another, replaced with the same or different heteroatoms or heteroatomic groups. Typical heteroatoms or heteroatomic groups which can replace the carbon atoms include, but are not limited to, O, S, N, Si, -NH-, -S(O)-, -S(O)2-, -S(O)NH-, -S(O)2NH- and the like and combinations thereof. The heteroatoms or heteroatomic groups can be placed at any interior position of the alkyl, alkenyl or alkynyl groups. Typical heteroatomic groups which can be included in these groups include, but are not limited to, -O-, -S-, -O-O-, -S-S-, -O-S-, -NR35R36-, =N-N=, -N=N-, -N=N-NR37R38, -PR39-, -P(O)2-, -POR40^5 -0-P(O)2-, -SO-,
-SO2-, -SnR41R42- and the like, where R35, R36, R37, R38, R39, R40, R41 and R42 are independently hydrogen, alkyl, substituted alkyl, aryl, substituted aryl, arylalkyl, substituted arylalkyl, cycloalkyl, substituted cycloalkyl, cycloheteroalkyl, substituted cycloheteroalkyl, heteroalkyl, substituted heteroalkyl, heteroaryl, substituted heteroaryl, heteroarylalkyl or substituted heteroarylalkyl.
[0077] "Heteroaryl," by itself or as part of another substituent, refers to a monovalent heteroaromatϊc radical derived by the removal of one hydrogen atom from a single atom of a parent heteroaromatic ring systems, as defined herein. Typical heteroaryl groups include, but are not limited to, groups derived from acridine, D-carboline, chromane, chromene, cinnoline, fiiran, imidazole, indazole, indole, indoline, indolizϊne, isobenzofiiran, isochromene. isoindole, isoindoliπe, isoquinoline, isothiazole, isoxazole, naphthyridine, oxadiazole, oxazole, perimidine, phenanthridine, phenanthroline, phenazine, phthalazine, pteridine, purine, pyran, pyrazine, pyrazole, pyridazine, pyridine, pyrimϊdine, pyrrole, pyrrolizine, quinazoline, quinoline, quinolizine, quinoxaline, tetrazole, thiadiazole, thiazole, thiophene, triazole, xanthene, and the like. In some embodiments, the heteroaryl group comprises from 5 to 20 ring atoms (5-20 membered heteroaryl). In other embodiments, the heteroaryl group comprises from 5 to 10 ring atoms (5-10 membered heteroaryl). Exemplary heteroaryl groups include those derived from furan, thiophene, pyrrole, benzothiophene, benzofuran, benzimidazole, indole, pyridine, pyrazole, quinoline, imidazole, oxazole, isoxazole and pyrazine.
[0078] "Heteroarylalkyl" by itself or as part of another substituent refers to an acyclic alkyl group in which one of the hydrogen atoms bonded to a carbon atom, typically a terminal or sp3 carbon atom, is replaced with a heteroaryl group. Where specific alkyl moieties are intended, the nomenclature heteroarylalkanyl, heteroarylakenyl and/or heteroarylalkynyl is used. In some embodiments, the heteroarylalkyl group is a 6-21 membered heteroarylalkyl, e.g., the alkanyl, alkenyl or alkynyl moiety of the heteroarylalkyl is (Ci -Ce) alkyl and the heteroaryl moiety is a 5-15-membered heteroaryl. In other embodiments, the heteroarylalkyl is a 6-13 membered heteroarylalkyl, e.g., the alkanyl, alkenyl or alkynyl moiety is (C1-C3) alkyl and the heteroaryl moiety is a 5- 10 membered heteroaryl.
[0079] "Protecting group" refers to a grouping of atoms that when attached to a reactive functional group in a molecule masks, reduces or prevents reactivity of the
functional group. Examples of protecting groups can be found in Greene et ah, "Protective Groups in Organic Chemistry", (Wiley, 4th ed. 2006) and Harrison et ah, "Compendium of Synthetic Organic Methods", VoIs. 1-12 (John Wiley and Sons, 1971- 2007). •
[0080] "Substituted," when used to modify a specified group or radical, means that one or more hydrogen atoms of the specified group or radical are each, independently of one another, replaced with the same or different substituent(s). Substituent groups useful for substituting saturated carbon atoms in the specified group or radical include, but are not limited to -Ra, halo, -O", =O, -ORb, -SRb, -S", =S, -NRCRC, =NRb, =N-ORb, trihalomethyl, -CF3, -CN, -OCN, -SCN, -NO, -NO2, =N2, -N3, -S(O)2Rb, -S(O)2NRb, -S(O)2O", -S(O)2OR15, -OS(O)2R", -OS(O)2O", -OS(O)2ORb, -P(O)(O")2, -P(O)(ORb)(O ), -P(O)(OR^(OR*5), -C(O)Rb, -C(S)Rb, -C(NR1OR13, -C(O)O", -C(O)ORb, -C(S)ORb, -C(O)NRCRC, -C(NR1ONR0R0, -OC(O)Rb, -OC(S)Rb, -OC(O)O', -OC(O)ORb, -OC(S)ORb, -NRbC(O)Rb, -NRbC(S)Rb, -NRbC(O)O', -NRbC(O)ORb, -NRbC(S)ORb, -NRbC(O)NRcRc, -NRbC(NRb)Rb and -NR13C(NR1ONR0R0, where Ra is selected from the group consisting of alkyl, cycloalkyl, heteroalkyl, cycloheteroalkyl, aryl, arylalkyl, heteroaryl and heteroarylalkyl; each Rb is independently hydrogen or Ra; and each R° is independently Rb or alternatively, the two Rcs are taken together with the nitrogen atom to which they are bonded form a 4-, 5-, 6- or 7-membered cycloheteroalkyl which can optionally include from 1 to 4 of the same or different additional heteroatoms selected from the group consisting of O, N and S. As specific examples, -NRCRC is meant to include -NH2, -NH-alkyl, N-pyrrolidinyl and N-morpholinyl.
[0081] Similarly, substituent groups useful for substituting unsaturated carbon atoms in the specified group or radical include, but are not. limited to, -Ra, halo, -O", -ORb, -SRb, -S", -NR0R0, trihalomethyl, -CF3, -CN, -OCN, -SCN, -NO, -NO2, -N3, -S(O)2Rb, -S(O)2O", -S(O)2ORb, -OS(O)2Rb, -OS(O)2O", -OS(O)2ORb, -P(O)(O")2, -P(O)(OR1O(O-), -P(O)(OR^(OR15), -C(O)Rb, -C(S)Rb, -C(NR1OR", -C(O)O", -C(O)ORb, -C(S)ORb, -C(O)NR0R0, -C(NR1^NR0R0, -OC(O)Rb, -OC(S)Rb, -OC(O)O", -0C(0)0Rb, -OC(S)ORb, -NRbC(O)Rb, -NRbC(S)Rb, -NRbC(O)O", -NRbC(6)ORb, -NRbC(S)ORb, -NRbC(O)NR°Rc, -NR5C(NR1OR15 and -NR15C(NR1ONR0R0, where Ra, Rb and Rc are as previously defined.
[0082] Substituent groups useful for substituting nitrogen atoms in heteroalkyl and cycloheteroalkyl groups include, but are not limited to, -Ra, -O', -ORb, -SRb, -S', -NRCRC, trihalomethyl, -CF3, -CN, -NO, -NO2, -S(O)2Rb, -S(O)2O-, -S(O)2OR", -OS(O)2Rb, -OS(O)2O-, -OS(O)2ORb, -P(O)(O )2, -P(O)(ORO(O ), -P(O)(ORb)(ORb), -C(O)Rb, -C(S)Rb, -C(NRb)Rb, -C(O)ORb, -C(S)ORb, -C(O)NRCRC, -C(NR^NR0R0, -OC(O)Rb, -OC(S)R", -OC(O)ORb, -OC(S)OR5, -NRbC(O)Rb, -NRbC(S)Rb, -NRbC(O)ORb, -NRbC(S)ORb, -NRbC(O)NRcRc, -NRbC(NRb)Rb and -NRbC(NRb)NRcRc, where Ra, Rb and Rc are as previously defined.
[0083] Substituent groups from the above lists useful for substituting other specified groups or atoms will be apparent to those of skill in the art.
[0084] The substituents used to substitute a specified group can be further substituted, typically with one or more of the same or different groups selected from the various groups specified above.
[0085] "Salt" refers to a salt of a compound. Such salts include acid addition salts, formed with inorganic acids, including but not limited to hydrochloric acid, hydrobromic acid, sulfuric acid, nitric acid, or phosphoric acid; or formed with organic acids including but not limited to acetic acid, propionic acid, hexanoic acid, cyclopentanepropionic acid, glycolic acid, pyruvic acid, lactic acid, malonic acid, succinic acid, malic acid, maleic acid, fumaric acid, tartaric acid, citric acid, benzoic acid, 3-(4-hydroxybenzoyl) benzoic acid, cinnamic acid, mandelic acid, methanesulfonic acid, ethanesulfonic acid, 1 ,2-ethane-disulfonic acid, 2-hydroxyethanesulfonic acid, benzenesulfonic acid, 4-chlorobenzenesulfonic acid, 2-naphthalenesulfonic acid, 4-toluenesulfonic acid, camphorsulfonic acid, 4-methylbicyclo[2.2.2]-oct-2-ene-l-carboxylic acid, glucoheptonic acid, 3-phenylpropionic acid, trϊmethylacetic acid, tertiary butylacetic acid, Iauryl sulfuric acid, gluconic acid, glutamic acid, hydroxynaphthoϊc acid, salicylic acid, stearic acid, muconic acid, and the like; salts formed when an acidic proton present in the parent compound is replaced by a metal ion, e.g., an alkali metal ion, an alkaline earth ion, or an aluminum ion; an ammonium ion; or an organic base, including but not limited to ethanolamine, diethanolamine, triethanolamine, N-methylglucamine and the like; and zwitterionic salt compounds.
[0086] The following examples further illustrate the methods of the disclosure but, of course, should not be construed as in any way limiting their scope.
EXAMPLE 1
[0087] This example demonstrates methods of preparing an α-bromo acid from an amino acid precursor.
[0088] To a stirred suspension of the amino acid [0.2 mM] in 1 mL of CH2CI2 was added a solution of isoamyl nitrite (1.1 equiv) and bromine (5 equiv) in 1.5 mL of CH2CI2. After complete dissolution of the amino acid, CH2CI2 was removed under reduced pressure. The remaining residue was suspended in EtOAc (10 mL) and washed with 5% aqueous hydrochloric acid (3 x 25 ml), followed by washes with water (3 x 25 ml). The desired product was extracted using aqueous sodium hydroxide (1 M), and then acidified with hydrochloric acid (2 M) until pH 2 and extracted with EtOAc (3 x 20 ml). The organic phase was dried (Na2SO4) and filtered, and the solvent was removed under reduced pressure to give the α-bromo acid.
EXAMPLE 2
[0089] This example demonstrates methods using aliphatic amines without aromatic substitution or acid substitution α to the amine.
[0090] 40 mg of 6-aminohexanoic acid was reacted under conditions set forth in Exmaple 1. The reaction was monitored by MS, and the identity of the product 6- bromohexanoic acid confirmed by NMR.
EXAMPLE 3
[0091] The following example explores reaction conditions and product distributions.
[0092] Under reaction conditions identical to those used with Br2 in Example 1, the reaction using I2 failed to produce the corresponding iodide. Using 10 equivalents of ICl however, as the source of halogen, results in the production of the chloride in good yield without the iodide. In a further experiment, using 10 equivalents of IBr, gives again the bromide with no detectable iodide. As per the postulated mechanism, the highly reactive nitryl, and nitrosyl halides are the active intermediates, neither of which is known for the iodide.
[0093] Conversion of 3-aminomethylpyridine to the bromide in THF was similar to that in CH2Cl2, but decreased in the series CH2Cl2 > CHCl3 > CCl4 with a
corresponding increase in the formation of the hydroxy product. Reaction in DMF or DMSO led to remaining AMP under the conditions used and also favored the formation of the 3-(hydroxymethyl)pyridine over the bromide.
[0094] Using isoamyl nitrite as the nitroso source, and Br2, in water, resulted in an incomplete conversion with very little of the hydroxy product. In all solvents tried using NaNC>2 and acetic acid as the nitroso source, an increased amount of 3- (hydroxymethyl)pyridine was observed with incomplete reaction of the AMP. This latter observation is most likely due to the use of NaNO2 for the nitroso source, as in CH2CI2, increasing additions of acetic acid up to 5 equivalents with respect to AMP, favored the formation of the bromide over the hydroxy product. The stronger acid TFA, however, favored the formation of the hydroxy product over the bromide. Addition of an organic base, TEA, piperidine or DBU was well tolerated up to about 1 equivalent with respect to AMP, with higher amounts leading to less conversion of the amine to the bromide. Reaction to the bromide was concentration dependent with best conversions occurring at > 0.1 molar in AMP (variable only explored in GH2CI2).
[0095] Conversion of 3-aminomethyl pyridine to 3-(bromomethyl)pyridine using 1.1 equiv. of nitrosyl agent and 5 equiv. of bromine was conducted in the solvent shown in Table 1 below. A sample of the reaction mixture was taken and quenched by high dilution into acetontrile for ESMS analysis of the products. 3- (hydroxymethyl)pyridine and 3-(isoamyloxymethyl)pyridine side products were also observed in addition to starting material and 3-(bromomethyl)pyridine product.
Table 1. Product distributions based on variation in reaction conditions.
[0096] The gas evolved by the reaction was identified by collecting the gas in an IR cell and examining by IR Spectroscopy. The IR spectrum in Figure 2 shows the N2O gas produced by the reaction.
[0097] Conversion of 3-aminomethylpyridine (AMP) and 2-(2- aminoethyl)pyrϊdine (AEP) is efficient, as demonstrated by the HPLC traces before and after reaction as shown in Figure 3.
[0098] Titration of the addition of both isoamyl nitrite and Bτ2 to AMP shows that the amine disappears from the reaction mixture on addition of one equivalent each of isoamyl nitrite and Br2. As shown in Figure 7, the formation of the product 3- (bromomethyl)pyridine is out of phase with the disappearance of reacting amine, and in some trials was almost completely absent until greater than one equivalent of isoamyl nitrite and Br2 was added. Best yields were obtained by a total addition of about five equivalents OfBr2.in this example
EXAMPLE 4
[0099] The following example demonstrates the conversion of various amino acids to α-bromo acids.
[00100] Conversion of Ala, Cys(Trt), He, VaI: A small fraction of the amino acid was added to a solution of isoamyl nitrite (2 equiv.) and bromine (5 equiv.) in CH2CI2 (1 mL/mmol of amino acid), after the beginning of gas evolution the remaining amino acid (1 equiv.) is added gradually. Five minutes after complete dissolution of the amino acid, the reaction was stopped by removing the solvent under reduced pressure. The residue obtained was suspended in EtOAc (10 mL), and was washed with 5% HCl (3 x 2 ml) and water (3 x 25 ml). After washing, the desired product was extracted with aqueous IM NaOH, the aqueous solution was then acidified with 2M HCl until pH 2 and extracted with EtOAc (3 x 20 ml).
[00101] Conversion of Arg: A small fraction of the amino acid was added to a solution of isoamyl nitrite (2 equiv.) and bromine (5 equiv.) in CH2CI2 (1 mL/mmol of amino acid), after the beginning of gas evolution the remaining amino acid (1 equiv.) was added gradually. Five minutes after complete dissolution of the amino acid, the desired product was extracted with 1 M HCl (3 x 50 ml). The aqueous phases were combined and concentrated under reduced pressure.
[00102] Conversion of Asp(OtBu), GIu(OtBu), Phe, His(Trt),
Lys(Boc), Leu, Met, Asn, GIn, Ser(tBu), Thr.(tBu), Trp(Boc), Tyr(tBu): A small fraction of the amino acid was added to a solution of isoamyl nitrite (2 equiv.) and bromine (5 equiv.) in CH2CI2 (1 .mL/mmol of amino acid), after the beginning of gas evolution the rest of the amino acid (1 equiv.) was added gradually. Five minutes after the complete dissolution of the amino acid, the reaction was stopped by removing the solvent under reduced pressure. The residue obtained was suspended in EtOAc (10 mL), and was washed with 5% HCl (3 x 25 ml) and water (3 x 25 ml). After washing, the desired product was extracted with IM NaOH, the aqueous solution was then acidified with 2M HCI until pH 2 and extracted with EtOAc (3 x 20 ml). The organic phase was dried (Na2SO4) and filtered, and the solvent was removed under reduced pressure to give the corresponding α-bromo acid. The product was then purified by column chromatography on silica gel using hexane/ethyl acetate (7:3) as eluent.
[00103] Conversion of Phe, Leu, Arg, Ser(tBu), Tyr(tBu): A small fraction of the amino acid was added to a solution of isoamyl nitrite (2 equiv.) and bromine (5 equiv.) in CH2Cb (1 mL/mmol of amino acid), after beginning of gas evolution the remaining amino acid (1 equiv.) is added gradually. Five minutes after complete dissolution of the amino acid the reaction was stopped by adding 50 ml of IM sodium sulfite / 1% HCl. This emulsion was stirred for 5 minutes until colorless. The organic phase was washed 2 more times with the same solution, then with water (30 ml). The organic phase was dried (Na2SO4) and filtered, and the solvent was removed under reduced. pressure to give the corresponding α-bromo acid.
[00104] Figures 4, 5, and 6 provide HPLC traces of α-bromoamino acids produced as described above.
EXAMPLE 5
[00105] The following example demonstrates the retention of stereochemistry.
[00106] Conversion of a chiral amine such as an α-amino acid to the α- bromo acid was achieved without inversion. Several amino acids were reacted under the conditions of 1.1 equivalents of isoamyl nitrite and 5 equivalents OfBr2 in CH2Cl2. The optical rotary power shown in Table 2 below was measured at 589 nm on 20mg of α-bromo acid dissolved in 2 mL of methanol.
Table 2. Product yields and optical rotations of α-bromo acids..
[00107] Conversion of a chiral amine without a neighboring group effect was demonstrated for (i?)-2-bromo-4-phenylbutane. (i?)-(-)-l-Methyl-3~ phenylpropylamine was reacted under the conditions of 1.1 equivalents of isoamyl nitrite and 5. equivalents of Br2 in CH2CI2 to give (i?)-2-bromo-4-phenylbutane, as confirmed by 1H NMR and HPLC-ESMS, and with retention of chirality as confirmed by [α]D = 66.3°
EXAMPLE 6 [00108] The following example demonstrates the preparation of organic fluorides.
[00109] Conversion of a primary amine to the corresponding fluoride can be achieved by reacting the amine with the N-fluorinating reagent SELECTFLUOR® in the presence OfNOBF4.
EXAMPLE 7
[00110] The following example demonstrates the conversion of a series of amino acids to the corresponding α-bromo acids.
[0011 1] A mixture of isoamyl nitrite (2 equiv.) and bromine (5 equiv.) in
CH2CI2 (1 mL/mmol of amino acid) was freshly prepared. To it was added a small portion of the solid amino acid (1 equiv.). After gas evolution begins, the remaining solid is added slowly to keep the reaction under control. After the amino acid has been added and dissolved, the reaction mixture in stirred for a further 5 minutes and then immediately concentrated under reduced pressure. The residue was dissolved in ethyl acetate (1 mL/mmol of amino acid) and was washed with 5% HCl (3 x 25 ml) and brine (3x 25ml). The organic phase was dried over Na2SO4 and the solvent was removed in
vacuo. The residue was purified by silica chromatography eluting with 20% ethyl acetate / hexane.
[00112] As an alternative extraction workup, the residue was dissolved in ethyl acetate (1 mL/mmol of amino acid) and washed with 0.25M sodium sulfite, 1% HCl (3 x 30 ml), and brine (3 x 25ml). The organic phase was dried (Na2SO^ and the solvent was removed in vacuo to give the α-bromo acid.
[00113] (25)-2-bromopropanoic acid. Z-Alanine (0.2 g, 2.24 mmol) was converted to (2S)-2-bromopropanoic acid (0.308g, 2.03 mmol) in 91% yield. ESMS m/z = 151/153 (M-H)" 1HNMR (D6-DMSO): δ 1.69 (d, 3H, 6.8 Hz5 CH3), 4.53 (q, IH, 6.8 Hz, CHBr). [α]20D = -29.8° (1.0 MeOH), literature [α]20 D = -29.8° (1.0 MeOH). -
[00114] (2>S)-2-bromo-3-hydroxypropanoic acid. Z-Serine (0.105 g, 1 mmol) was converted to (2S)-2-bromo-3-hydroxypropionic acid (0.149 g, 0.88 mmol) in 89% yield. ESMS m/z = 167/169 (M-H)". 1H NMR (D6-DMSO): δ 4.03 (t, IH, 6.8 Hz, CHBr), 4.24 (d, 2H, 7.3 Hz, CH2). [α]20 D = -12.9° (1.0 MeOH), literature [α]20 D = -12.8° (1.0 MeOH).
[00115] (^S^-bromo-S-phenylpropanoic acid. Z-Phenylalanine (0.33g,
2mmol) was converted to (2S)-2-bromo-3-hydroxypropionic acid (0.394g, 1.73mmol) in 87% yield. ESMS m/z = 227/229 (M-H)". 1H NMR (D6-DMSO): 8 3.16 (m, IH, CH2Ph), 3.65 (m, IH, CH2Ph), 4.63 (t, IH, 7.7 Hz, CHBr), 7.3 (m, 4H, ArH), 8.44 (s, IH, ArH). [Ct]20D = -10.4° (1.0 MeOH), literature [<x]20 D = -10.2° (1.0 MeOH).
[00116] (2S)-2-bromo-4-methyIpentanoic acid. Z-Leucine (0.261 g,
2mmol) was converted to (2S)-2-bromo-4-methylpentanoic acid (0.338g, 1.74mmol) in 87% yield. ESMS m/z = 193/195 (M-H)" 1H NMR (D6-DMSO): δ 1.14 (d, 6H, 5.6 Hz, Me2), 2.04 (q, IH, 6 Hz, CH2), 2.20 (m, 1 H, CH(Me)2), 4.3 (t, 1Η, 6.1 Hz, -CHBr). [Ot]20D = -39.6° (1.0 MeOH), literature [α]20 D = -39.6° (1.0 MeOH).
[00117] (2_S)-2-bromo-3-methyIbutanoic acid. Z-Valine (0.234 g, 2 mmol) was converted to (2S)-2-bromo-3-methylbutanoic acid (0.34 g, 1.89 mmol) in 95% yield. ESMS m/z = 179/181 (M-H)" 1H NMR (D6-DMSO): δ 1.02 (d, 6H, 6.8 Hz, Me2), 2.83 (m, IH, CHMe2), 4.26 (d, 1Η, 4.9 Hz, CHBr). [α]20 D = -16.1° (1.0 MeOH), literature [α]20 D = -16.1° (1.0 MeOH).
[00118] As an alternate reaction, a mixture of isoamyl nitrite (2 equiv.) and bromine (5 equiv.) in CH2Cl2 (1 mL/mmol of amino acid), freshly prepared, was
treated with a small portion of the solid amino acid Z-arginine (1 equiv.). After gas evolution begins, the remaining solid /,-arginine is added slowly to keep the reaction under control. After the amino acid has been added and dissolved, the reaction mixture in stirred for a further 5 minutes. The product was extracted with IM HCl (3x 50ml), and the aqueous layers concentrated under reduced. pressure to give the corresponding α- bromo acid in 97% yield.
[00119] Yields of several α-bromoacids from amino acids are shown in
Table 3.
Table 3. Summary of preparative scale conversions conducted at room temperature for the conversion of α-amino acids to α-bromo acids.
EXAMPLE 8
[00120] The following example demonstrates the conversion of an amine to the corresponding bromide.
[00121] . A mixture of isoamyl nitrite (1.1 equiv.) and bromine (5 equiv.) in CH2CI2 (1 mL/mmol of amine) was freshly prepared. To it was slowly added the amine (1 equiv.), with the evolution of gas keeping the reaction under control. The
reaction mixture in stirred for- a further 5 minutes and then immediately concentrated under reduced pressure. The residue was dissolved in ethyl acetate and was washed with 5% HCl (3x) and brine (3x). The organic phase was dried over Na2SO4 and the solvent was removed in vacuo. The residue was purified as necessary by silica chromatography.
[00122] 2-(2~bromoethyl)pyridine. ESMS m/z = 186/188 (MH)+. 1H
NMR (D6-DMSO): δ 3.61 (t, 2H5 6.3 Hz, CH2Pyr), 3.95 (t, 2H, 6.4 Hz, CH2Br), 7.98 (t, IH, 6.4 Hz, rø-PyrH), 8.08 (d, IH, 7.08 Hz, /w-PyrH), 8.59 (t, IH, 7.6 Hz, />-PyrH), 8.9 (d, IH, 5.4 Hz, σ-PyrH).
[00123] 3-(bromomethyI)pyridine. ESMS m/z = 172/174 (MH)+. 1H
NMR (D6-DMSO): δ 4.87 (s, 2H, CH2Br), 8.10 (dd, IH, 5.8 Hz, /w-PyrH), 8.69 (dt, IH, 6 Hz,/7-PyrH), 8.89 (d, IH, 5.8 Hz, o-PyrH), 9.07 (d, IH, ø-PyrH).
[00124] 6-bromohexanoic acid. ESMS m/z = 193/195 (M-H)".
EXAMPLE 9
[00125] The following example demonstrates the conversion of a primary amine to an organic alcohol.
[00126] To a suspension of amine (1 equiv.) in CH2Cl2 (0.8ml/mmol), N- bromosuccinimide (2.05 equiv.,) was added followed by a few drops of DMF to ensure complete dissolution. A 2.8M solution of trifluoroacetic acid (5 equiv.) in CH2Cl2 was added to sodium nitrite (5 equiv) to generate a solution of nitrous acid. The nitrous acid solution was slowly added to the amine mixture, and stirred at room temperature for 10 minutes. The reaction was concentrated in vacuo, and the residue redissolved in ethyl acetate (2ml/mmol). The organic phase was washed with 2M HCl (3x), and brine (3x). The organic phase was dried over Na2SO4 and the solvent was removed in vacuo to give the corresponding hydroxy product.
[00127] (2-S)-2-hydroxy-3-phenyIpropanoic acid. Z-Phenylalanine (6 g,
36.4 mmol) was converted to (2S)-2-hydroxy-3-phenylpropionic acid (5.01 g) in 83% yield. RP-HPLC (Ci8 anal.) - ESMS m/z = 165 (M-H)". The gas evolved during the reaction was identified by collecting the gas in an IR cell and examining by IR Spectroscopy. The IR spectrum was identical to that of the N2O collected previously in Figure 2.
[00128] In addition, the amino acids His(Trt), Ser(tBu), LysQBoc),
GIu(OtBu), Arg, Asn and Tyr(tBu) were converted by the same procedure to the corresponding α-hydroxy acids and confirmed by RP-HPLC-ESMS.
[00129] 3-(hydroxymethyl)pyridine. From 3-aminomethylpyridine.
ESMS m/z = 110 (MH)+.
[00130] 2-(2-hydroxyethyI)pyridine. From 2-(2-aminoethyl)pyridine.
ESMS m/z = 124 (MH)+.
[00131] 6-hydroxyhexanoic acid. From 6-hydroxyhexanoic acid. ESMS m/z = 131 (M-H)".
EXAMPLE 10
[00132] The following example demonstrates the preparation of a α- hydroxy acid derivative.
[00133] To a suspension of α-amino Weinreb amide (1 equiv.) in CH2CI2
(0.8ml/mmol) is added N-bromosuccinimide (2.05 equiv.). A 2.8M solution of trifluoroacetic acid (5 equiv.) in CH2Cl2 is added to sodium nitrite (5 equiv.) to generate a solution of nitrous acid. The nitrous acid solution is slowly added to the phenylalanine mixture, and stirred at room temperature for 10 minutes.
[00134] The isolated α-hydroxy Weinreb amide is protected with
TBDMSCl, and then reduced with LiAlH4 to give the TBDMS protected α-hydroxy aldehyde.
[00135] It should be understood that various changes and modifications to the presently preferred embodiments described herein will be apparent to those skilled in the art. Such changes and modifications can be made without departing from the spirit and scope of the present subject matter and without diminishing its intended advantages. It is therefore intended that such changes and modifications be covered by the appended claims.
Claims
WHAT IS CLAIMED IS:
1. A method for preparing an organic compound, comprising reacting a primary amine with an activating agent and a nitrosyl agent to produce an organic compound and nitrous oxide.
2. The method of Claim 1, wherein the organic compound is an organic alcohol or organic halide.
3. The method of Claim I3 wherein the organic compound is an organic alcohol.
4. The method of Claim 1, wherein the organic compound is an organic halide.
5. The method of Claim 1, where the organic compound is an organic bromide, organic chloride or organic fluoride.
6. The method of Claim 1, wherein the organic compound is an organic bromide.
7. The method of Claim 1, wherein the organic compound is an organic halide and the activating agent is an alkyl nitrite and X2, XNO2, HOX, an alkyl hypohalite, cyanogen bromide, NO2-BX4 and X2, N-halosuccinimide, 1- (chloromethyl)-4-fluoro-l,4-diazoniabicyclo[2.2.2]octane bis(tetrafluoroborate), or cyanuric halide, wherein X is F, Cl, Br, or I.
8. The method of Claim 1, wherein the organic compound is an organic halide and the activating agent is N-bromosuccinimide.
9. The method of Claim 1, wherein the organic compound is an organic halide and the activating agent is BrNO2 or isoamyl nitrite and Br2.
10. The method of Claim 1, wherein the organic compound is an organic halide and the nitrosyl agent is XNO, NO-BX4 and X2, HONO and X2, NaNO2 and trifluoroacetic acid and X2, NaNO2 and acetic acid and X2, Na2Fe(CN)5(NO) and X2, cyanuric halide and NO-BX4, or a nitrite and an acid and X2, wherein X is Br, Cl or F.
11. The method of Claim 1, wherein the organic compound is an organic halide and the nitrosyl agent is BrNO.
12. The method of Claim 1, wherein the organic compound is an organic halide and the nitrosyl agent is sodium nitrite and trifluoroacetic acid and Br2.
13. The method of Claim 1, wherein the organic compound is an organic halide and the activating agent is N-bromosuccinimide and the nitrosyl agent is BrNO.
14. The method of Claim 1, wherein the organic compound is an organic halide and the activating agent is N-bromosuccinimide and the nitrosyl agent is HONO and Br2.
15. The method of Claim 1, wherein the organic compound is an organic halide and the activating agent is N-bromosuccinimide and the nitrosyl agent is NaNθ2 and trifluoroacetic acid and Br2.
16. The method of Claim 1, wherein the organic compound is an organic halide and the activating agent is isoamyl nitrite and Br2 and the nitrosyl agent is BrNO.
17. The method of Claim 1, wherein the organic compound is an organic halide and the activating agent and nitrosyl agent are generated by the combination of alkyl nitrite, X2, and primary amine, wherein X is F, Cl, Br, or I.
18. The method of Claim 1, wherein the organic compound is an organic halide and the activating agent is isoamyl nitrite and Br2 and the nitrosyl agent is HONO and Br2.
19. The method of Claim 1, wherein the organic compound is an organic halide and the activating agent is isoamyl nitrite. and Br2 and the nitrosyl agent is NaNO2 and trifluoroacetic acid and Br2.
20. The method of Claim 1, wherein the organic compound is an organic halide and the activating agent is cyanuric chloride and the nitrosyl agent is NO- BF4 and cyanuric chloride.
21. The method of Claim 1, wherein the organic compound is an organic halide and the activating agent is cyanuric chloride and the nitrosyl agent is ClNO.
22. The method of Claim 1, wherein the organic compound is an organic halide and the activating agent is cyanuric fluoride and the nitrosyl agent is "NO-BF4 and cyanuric fluoride.
23. . The method of Claim 1, wherein the organic compound is an organic halide and the activating agent is cyanuric fluoride and the nitrosyl agent is FNO.
24. The method of Claim 1, wherein the organic compound is an organic halide and the activating agent is cyanuric bromide and the nitrosyl agent is NO- BF4 and cyanuric bromide.
25. The method of Claim 1, wherein the organic compound is an organic halide and the activating agent is cyanuric bromide and the nitrosyl agent is BrNO.
26. The method of Claim 1, wherein the organic compound is an organic halide and the primary amine is contacted with the activating agent and nitrosyl agent at between about -78 0C and about 200 0C.
27. The method of Claim 1, wherein the organic compound is an organic halide and the primary amine is contacted with the activating agent and nitrosyl agent at between about -50 0C and about 50 0C.
28. The method of Claim 1, wherein the organic compound is an organic halide and the primary amine is contacted with the activating agent and nitrosyl agent at between about 15 0C and about 30 0C.
29. The method of Claim 1, wherein the organic compound is an organic halide and the ratio of primary amine, activating agent and nitrosyl reagent is about 1:0.1:0.1 to about 1:10:100.
30. The method of Claim 1, wherein the organic compound is an organic halide and the ratio of primary amine, activating agent and nitrosyl reagent is about 1 :1 :1 to about 1:5:10.
31. The method of Claim 1, wherein the organic compound is an organic halide and the ratio of primary amine, activating agent and nitrosyl reagent is about 1:2:3.
32. The method of Claim 1, wherein the organic compound is an organic halide and the primary amine is at least partially dissolved in a solvent.
33. The method of Claim 1, wherein the organic compound is an organic halide and the primary amine is at least partially dissolved in a solvent selected from the group of solvents consisting of tetrahydrofuran, dichloromethane, chloroform, carbon tetrachloride, dimethyl formamϊde, dimethyl sulfoxide, t- butanol, diethylether, acetic acid, hexane, dichloroethane, ethyl acetate, acetonitrile, methanol, ethanol, bromine and water.
34. The method of Claim 1, wherein the organic compound is an organic halide and the primary amine is at least partially dissolved in tetrahydrofuran or dichloromethane.
35. The method of Claim 1, wherein the organic compound is an organic halide and the primary amine is at least partially dissolved in a solvent and the amine is an α-amino acid, β-amino acid, α-amino amide, β-amino amide, α- amino ester, β-amino ester, α-amino aldehyde, β-amino aldehyde, β-amino ether, a β-amino alcohol, γ-amino ether, or a γ-amino alcohol.
36. The method of Claim 1, wherein the organic compound is an organic halide, the primary amine is at least partially dissolved in a solvent and the amine is an α-L-amino acid.
37. The method of Claim 1, wherein the organic compound is an organic halide, the primary amine is at least partially dissolved in a solvent and the amine is an α-D-amino acid.
38. The method of Claim 1, wherein the organic compound is an organic halide, the primary amine is an α-amino acid at least partially dissolved in methylene chloride or tetrahydrofuran, the activating agent is isoamyl nitrite and Br2 and the nitrosyl agent is BrNO and the amine is contacted with the' activating agent and nitrosyl agent at about 25 0C.
39. The method of Claim 1, wherein the organic compound is an organic halide, the primary amine is at least partially dissolved in a solvent and the amine is an α-amino acid, the solvent is methylene chloride or tetrahydrofuran, the activating agent is isoamyl nitrite and Br2 and the nitrosyl agent is isoamyl nitrite and Br2 and the amine is contacted with the activating agent and nitrosyl agent at about 25 0C.
40. The method of Claim 1, wherein the organic compound is an organic halide, the primary amine is at least partially dissolved in a solvent and the amine is an α-amino acid, the solvent is methylene chloride or tetrahydrofuran, the activating agent is N-bromosuccinimide and the nitrosyl agent is BrNO and the amine is contacted with the activating agent and nitrosyl agent at about 25 0C.
41. The method of Claim 1, wherein the organic compound is an organic halide, the primary amine is at least partially dissolved in a solvent and the amine is an α-amino acid, the solvent is methylene chloride or tetrahydrofuran, the activating agent is N-bromosuccinimide and the nitrosyl agent is NaNθ2 and trifluoroacetic acid and Efø, and the amine is contacted with the activating agent and nitrosyl agent at about 25 0C.
42. The method of Claim 1, wherein the organic compound is an organic alcohol and the activating agent is an alkyl nitrite and X2, XNO2, HOX5 an alkyl hypohalite, cyanogen bromide, NO2-BX4 and X2, N-halosuccinimide, 1- (chloromethyl)-4-fluoro-l,4-diazoniabicyclo[2.2.2]octane bis(tetrafluoroborate) or cyanuric halide, wherein X is fluoride, chloride, bromide or iodide.
43. The method of Claim 1, wherein the organic compound is an organic alcohol and the activating agent is N-bromosuccinimide.
44. The method of Claim 1, wherein the organic compound is an organic alcohol and the activating agent is BrNO2 or isoamyl nitrite and Br2.
45. The method of Claim 1, wherein the organic compound is an organic alcohol ■ and the nitrosyl agent is NO2-BX4 and trifluoroacetic acid, HONO, NaNO2 and trifluoroacetic acid, NaNO2 and acetic acid, or a nitrite and an acid, wherein X is Br, Cl or F.
46. The method of Claim 1, wherein the organic compound is an organic alcohol and the nitrosyl agent is HONO.
47. The method of Claim 1, wherein the organic compound is an organic alcohol and the nitrosyl agent is sodium nitrite and trifluoroacetic acid.
48. The method of Claim 1, wherein the organic compound is an organic alcohol and the activating agent is N-bromosuccinimide and the nitrosyl agent is HONO.
49. The method of Claim I5 wherein the organic compound is an organic alcohol and the activating agent is N-bromosuccinimide and the nitrosyl agent is sodium nitrite and trifluoroacetic acid.
50. The method of Claim 1, wherein the organic compound is an organic alcohol and the activating agent is cyanuric bromide and the nitrosyl agent is HONO.
51. The method of Claim 1, wherein the organic compound is an organic alcohol and the activating agent is cyanuric bromide and the nitrosyl agent is sodium nitrite and trifluoroacetic acid.
52. The method of Claim 1, wherein the organic compound is an organic alcohol • and the amine is contacted with the activating agent and nitrosyl agent at between about -78 °C and about 200 0C.
53. The method of Claim 1, wherein the organic compound is an organic alcohol and the amine is contacted with the activating agent and nitrosyl agent at between about -50 0C and about 50 0C.
54. The method of Claim 1, wherein the organic compound is an organic alcohol and the amine is contacted with the activating agent and nitrosyl agent at about 25 0C.
55. The method of Claim 1, wherein the organic compound is an organic alcohol and the ratio of amine, activating agent and nitrosyl reagent is about 1:0.1 :0.1 to about 1:10:100.
56. The method of Claim 1, wherein the organic compound is an organic alcohol and the ratio of amine, activating agent and nitrosyl reagent is about 1:1:1 to about 1:5:10.
57. The method of Claim 1, wherein the organic compound is an organic alcohol and the ratio of amine, activating agent and nitrosyl reagent is about 1 :2:3.
58. The method of Claim 1, wherein the organic compound is an organic alcohol and the primary amine is at least partially dissolved in a solvent.
59. The method of Claim 1, wherein the organic compound is an organic alcohol and the primary amine is at least partially dissolved in a solvent and the solvent is tetrahydrofuran, dichloromethane, chloroform, carbon tetrachloride, dimethyl formamide, dimethyl sulfoxide, /-butanol, diethylether, acetic acid, hexane, dichloroethane. ethyl acetate, acetonitrile, methanol, ethanol, bromine or water.
60. The method of Claim 1, wherein the organic compound is an organic alcohol and the primary amine is at least partially dissolved in tetrahydrofuran or dichloromethane.
61. The method of Claim 1, wherein the organic compound is an organic alcohol and the carbon atom to which the amine is attached is chiral and the chirality is substantially retained in the organic alcohol.
62. The method of Claim 1, wherein the organic compound is an organic alcohol and the primary amine is an α-amino acid, β-amino acid, α-amino amide, β- amino amide, α-amino ester, β-amino ester, α-amino aldehyde, β-amino aldehyde, β-amino ether, a β-amino alcohol, γ-amino ether, or a γ -amino alcohol.
63. The method of Claim 1, wherein the organic compound is an organic alcohol and the amine is an α-amino acid.
64. The method of Claim 1, wherein the organic compound is an organic alcohol and the amine is an α-L-amino acid.
65. The method of Claim 1, wherein the organic compound is an organic alcohol and the amine is an α-D-amino acid.
66. The method of Claim 1, wherein the organic compound is an organic alcohol and the primary amine is at least partially dissolved in methylene chloride or tetrahydrofuran, the activating agent is N-bromosuccinimide and the nitrosyl agent is HONO and the amine is contacted with the activating agent and nitrosyl agent at about 25 0C. •
67. The method of Claim 1, wherein the organic compound is an organic alcohol and wherein the primary amine is an α-amino acid and is at least partially dissolved in acetonitrile, the activating agent is N-bromosuccinimide and the
nitrosyl agent is HONO and the amine is contacted with the activating agent and nitrosyl agent at about 25 0C.
68. The method of Claim 1, wherein the organic compound is an organic alcohol and wherein the primary amine is an α-amino acid and is at least partially dissolved in methylene chloride or tetrahydrofuran, the activating agent is N- bromosuccinimide and the nitrosyl agent is sodium nitrite and trifluoroacetic acid and the amine is contacted with the activating agent and nitrosyl agent at about 25 0C.
69. The method of Claim 1, wherein the organic compound is an organic alcohol and wherein the primary amine is an α-amiπo acid and is at least partially dissolved in acetonitrile, the activating agent is N-bromosuccinimide and the nitrosyl agent is NaNO2 and trifluoroacetic acid, and the amine is contacted with the activating agent and nitrosyl agent at about 25 0C.
70. The method according to Claim 1, wherein the primary amine is described by Formula (I) and the organic compound is described by Formula (IT),
0) (Q) wherein:
Y is OH, Br, Cl or F;
R1, R2, R3 are independently hydrogen, alkyl, substituted alkyl, aryl, substituted aryl, arylalkyl, substituted arylalkyl, heteroalkyl, substituted heteroalkyl, heteroaryl, substituted heteroaryl, heteroarylalkyl, substituted heteroarylalkyl, acyl, substituted acyl, alkoxycarbonyl, substituted alkoxycarbonyl, aryloxycarbonyl, substituted aryloxycarbonyl, carbamoyl, substituted carbamoyl, carboxyl, nitro, cyano, or optionally R1 and R2 together with the carbon atom to which they are attached form a cycloalkyl, substituted cycloalkyl, cycloheteroalkyl or substituted cycloheteroalkyl ring.
71. The method of Claim 70, wherein R1 is hydrogen and R2 is acyl, substituted acyl, alkoxycarbonyl, substituted alkoxycarbonyl, aryloxycarbonyl, substituted aryloxycarbonyl, carboxyl, carbamoyl, substituted carbamoyl, carboxyl, nitro or cyano.
72. The method of Claim 70, wherein R1 is hydrogen, R2 is carboxyl, carbamoyl or substituted carbamoyl and R3 is hydrogen, alkyl, substituted alkyl, arylalkyl, substituted arylalkyl, heteroalkyl, substituted heteroalkyl, heteroarylalkyl or substituted heteroarylalkyl.
73. The method of Claim 70, wherein R1 is hydrogen, R2 is carboxyl, carbamoyl or substituted carbamoyl and wherein R3 is independently hydrogen or alkyl.
74. The method of Claim 70, wherein R1 is hydrogen, R2 is carboxyl, carbamoyl or substituted carbamoyl and wherein R3 is independently hydrogen, methyl, isopropyl, isobutyl, sec-butyl, /-butyl, cyclopentyl or cyclohexyl.
75. The method of Claim 70, wherein R1 is hydrogen, R2 is carboxyl, carbamoyl or substituted carbamoyl and wherein R3 is substituted alkyl.
76. The method of Claim 70, wherein R1 is hydrogen, R2 is carboxyl, carbamoyl or substituted carbamoyl and wherein R3 is -CH2OH, -CH(OH)CH3, -CH2CO2H, -CH2CH2CO2H, -CH2CONH2, -CH2CH2CONH2, -CH2CH2SCH3, -CH2SH, -CH2(CH2J3NH2 or -CH2CH2CH2NHC(NH)NH2.
77. The method of Claim 70, wherein R1 is hydrogen, R2 is carboxyl, carbamoyl or substituted carbamoyl and wherein R3 is aryl, arylalkyl, substituted arylalkyl or heteroarylalkyl.
78. The method of Claim 70, wherein R1 is hydrogen, R2 is carboxyl, carbamoyl or substituted carbamoyl and wherein R3 is phenyl, benzyl, 4-hydroxybenzyl, 4-imidazolylmethyl or 3-indolylmethyl
79. The method of Claim 70, wherein R1 is hydrogen, R2 is carboxyl, carbamoyl or substituted carbamoyl and R3 contains one or more functional groups that are independently attached to protecting groups.
80. The method of Claim 70, wherein R1 is hydrogen, R2 is carboxyl, carbamoyl or substituted carbamoyl and R3 contains one or more -OH groups that are independently protected as -O-t-butyl, OBzI, -OAc, -OTrityl, or protecting groups commonly used for Ser, Thr, Tyr amino acid sidechains.
81. The method of Claim 70, wherein R1 is hydrogen, R2 is carboxyl, carbamoyl or substituted carbamoyl and R3 contains one or more -NH2 groups that are independently protected as -NHBoc, -NHBzI, -N(BzI)2, -N(BzI)BoC, -
NHAc, -NHCbz, -NH(2-CI-Cbz), -N(Me)2, -NHCOCF3, -NHFmoc, - . NHDde, NHTrityl, NHMtt, or protecting groups commonly used for Lys or Orn amino acid sidechains.
82. The method of Claim 70, wherein R1Ms hydrogen, R2 is carboxyl, carbamoyl or substituted carbamoyl and R3 contains one or more -NH- groups that are independently protected as -N(Boc)-, -N(Bom)-, -N(Tosyl)-, -N(Trityl)-, or protecting groups commonly used for His and Trp amino acid sidechains.
83. The method of Claim 70, wherein R1 is hydrogen, R2 is carboxyl, carbamoyl or substituted carbamoyl and R3 contains one or more -SH groups that are independently protected as — SBzI, STrityl, -SMtt. or protecting groups commonly used for Cys amino acid sidechains.
84. The method of Claim 70, wherein R1 is hydrogen, R2 is carboxyl, carbamoyl or substituted carbamoyl and R3 contains one or more -COOH group that are independently protected as -COO-t-butyl, -COOBzI, -COOAllyl, COODmab, or protecting groups commonly used for Asp or GIu amino acid sidechains.
85. The method of Claim 70, wherein R1 is hydrogen, R2 is carboxyl, carbamoyl or substituted carbamoyl and R3 contains one or more — CONH2, - NHC(=NH)NH2 group that are independently protected as protecting groups commonly used for Asn, GIn or Arg amino acid sidechains.
86. The method of Claim 70, wherein the compound of Formula (I) is the L stereoisomer.
87. The method of Claim 70, wherein the stereochemistry of the compound of Formula (I) is retained in the compound of Formula (II).
88. The method of Claim 70, wherein the compound of Formula (I) is the D stereoisomer.
89. The method of Claim 70, wherein the stereochemistry of the compound of Formula (I) is retained in the compound of Formula (II).
90. The method of Claim 70, wherein the activating agent is an alkyl nitrite and X2, XNO2, HOX, an alkyl hypohalite, cyanogen bromide, NO2-BX4 and X2,
N-halosuccϊnimide, l-(chloromethyl)-4-fluoro-l,4-
diazoniabicyclo[2.2.2]octane bis(tetrafluoroborate), or cyanuric halide, wherein X is F5 Cl, Br, or I.
91. The method of Claim 70, wherein, when Y=Br, Cl or F, the nitrosyl agent is XNO, NO-BX4 and X2, HONO and X2, NaNO2 and trifluoroacetic acid and X2, NaNO2 and acetic acid and X2, Na2Fe(CN)5(NO) and X2, cyanuric halide and NO-BX4, or a nitrite and an acid and X2, wherein X is Br, Cl or F.
92. The method of Claim 70, wherein when Y=Cl, Br or F, the activating agent and nitrosyl agent are generated by the combination of alkyl nitrite, X2, and primary amine, wherein X is F, Cl, Br, or I.
93. The method of Claim 70, wherein when Y is Cl, Br or F, the activating agent and nitrosyl agent are generated by the combination of isoamyl nitrite, Br2, and primary amine.
94. The method of Claim 70, wherein, when Y=OH, the nitrosyl agent is NO2- BX4 and trifluoroacetic acid, HONO, NaNθ2 and trifluoroacetic acid, NaNO2 and acetic acid, or a nitrite and an acid, wherein X is Br, Cl or F.
95. The method of Claim 70, wherein the conversion occurs between about 10 0C and about 400C.
96. The method of Claim 70, wherein the conversion is conducted at room temperature.
97. The method of Claim 70, wherein the conversion occurs with greater than 90% retention of stereochemistry.
98. The method of Claim 70, wherein the conversion occurs with greater than 95% retention of stereochemistry.
99. The method of Claim 70, wherein the conversion occurs with complete retention of stereochemistry.
100. A method for preparing an α-hydroxy acid or derivative thereof, comprising treating a α-amino acid or derivative thereof with a activating agent and a nitrosyl agent, with resulting generation of nitrous oxide.
101. The method of Claim 100, wherein the α-hydroxy acid derivative is an α- • hydroxy ester, α-hydroxy aldehyde or α-hydroxy alcohol, and orthogonally protected α-hydroxy esters, α-hydroxy aldehydes or α-hydroxy alcohols.
102. The method according to Claim 100, wherein the α-hydroxy acid derivative is a hydroxyl-protected α-hydroxy aldehyde.
103. The method of Claim 100, wherein the α-hydroxy acid derivative is a hydroxyl-protected α-hydroxy aldehyde and the hydroxyl-protecting group is an ester or an ether.
104. The method of Claim 100, wherein the α-hydroxy acid derivative is a hydroxyl-protected α-hydroxy aldehyde and the hydroxyl-protecting group is a silyl ether protecting group.
105. The method of Claim 100, wherein the α-hydroxy acid derivative is a hydroxyl-protected α-hydroxy aldehyde and the hydroxyl-protecting group is a tert-butyldimethylsilyl group.
106. The method of Claim 100, comprising treating an α-amino acid with a activating agent and a nitrosyl agent to produce the α-hydroxy acid or its derivative, and subsequently reducing the acid or its derivative to an α- hydroxy aldehyde.
107. The method of Claim 100, wherein the α-amino acid derivative is an α-amino Weinreb amide, and the α-amino Weinreb amide is converted to the α- hydroxy Weinreb amide, and subsequently reduced to the aldehye.
108. The method of Claim 100, wherein the conversion occurs with greater than 90% retention of stereochemistry.
109. The method of Claim 100, wherein the conversion occurs with greater than 95% retention of stereochemistry.
110. The method of Claim 100, wherein the conversion occurs with complete retention of stereochemistry.
111. The method of Claim 100, wherein the activating agent is an alkyl nitrite and X2, XNO2, HOX, an alkyl hypohalite, cyanogen bromide, NO2-BX4 and X2, N-halosύccinimide, l-(chloromethyl)-4-fluoro-l,4r
diazoniabicyclo[2.2.2]octane bis(tetrafluoroborate), or cyanuric halide, wherein X is F, Cl, Br5 or I.
112. The method of Claim 100, wherein the nitrosyl agent is NO2-BX4 and trifluoroacetic acid, HONO, NaNθ2 and trifluoroacetϊc acid, NaNθ2 and acetic acid, or a nitrite and an acid, wherein X is Br, Cl or F.
113. - The method according to Claim 1 , wherein the reaction is conducted between about 10 0C and about 400C.
114. The method of Claim 1, wherein the reaction is conducted at about room temperature.
115. The method of Claim 1, wherein the reaction is conducted between about 10 0C and about 40 0C and the yield of the organic alcohol or organic halide is greater than 50%.
116. The method of Claim 1, wherein the reaction is conducted between about 10 0C and about 40 0C and the yield of the organic alcohol or organic halide is greater than 75%.
117. The method of Claim 1, wherein the reaction is conducted between about 10 0C and about 40 0C and the yield of the organic alcohol or organic halide is greater than 90%.
118. The method of Claim 1, wherein the reaction is conducted between about 10 0C and about 40 0C with greater than 90% retention of stereochemistry.
119. The method of Claim 1, wherein the reaction is conducted between about 10 0C and about 40 0C with greater than 95% retention of stereochemistry.
120. The method of Claim 1, wherein the reaction is conducted between about 10 0C and about 40 0C and the conversion occurs with complete retention of stereochemistry.
121. The method of Claim 1, wherein the reaction is conducted between about 10 0C and about 400C and the conversion is conducted on multigram scale.
122. The method of Claim 1, wherein the reaction is conducted between about 10 0C and about 40 0C with greater than about 10 grams of the primary amine.
123. The method of Claim 1, wherein the reaction is conducted between about 10 0C and about 40 0C with greater than about 100 grams of the primary amine.
124. The method of Claim 1, wherein the reaction is conducted between about 10 °C and about 400C with greater than about 1 kilogram of the primary amine.
125. The method of any of claims 122-124, wherein the conversion is conducted at room temperature.
127. A method for preparing an organic compound, comprising treating a primary organic N-haloamine or N,N-dihaloamine with a nitrosyl agent to produce the organic compound and nitrous oxide.
128. The method of Claim 127, wherein the primary organic N,N-dihaloamine is an N, N-dibromoamine.
129. The method of Claim 127, wherein the organic compound is an organic alcohol or organic haiide.
130. The method of Claim 127, wherein the organic compound is an organic alcohol. r
131. The method of Claim 127, wherein the organic compound is an organic haiide.
132. The method of Claim 127, wherein the organic compound is an organic bromide, organic chloride or organic fluoride.
133. The method of Claim 127, wherein the organic compound is an organic bromide.
134. The method of Claim 127, wherein the organic compound is an organic haiide and the nitrosyl agent is XNO5 NO-BX4 and X2, HONO and X2, NaNO2 and trifluoroacetic acid and X2, NaNO2 and acetic acid and X2, Na2Fe(CN)S(NO) and X2, cyanuric haiide and NO-BX4, or a nitrite and an acid and X2, wherein X is Br, Cl or F.
135. The method of Claim 127, wherein the organic compound is an organic haiide and the nitrosyl agent is BrNO.
136. The method of Claim 127, wherein the organic compound is an organic haiide and the nitrosyl agent is isoamyl nitrite and Br2.
137. The method of Claim 127, wherein the organic compound is an organic halide and the nitrosyl agent is sodium nitrite and trifluoroacetic acid and Br2
138. The method of Claim 127, wherein the organic compound is an organic alcohol and the nitrosyl agent is NO2-BX4 and trifluoroacetic acid, HONO, NaNO2 and trifluoroacetic acid, NaNθ2 and acetic acid, or a nitrite and an acid, wherein X is Br, Cl or F.
139. The method of Claim 127, wherein the organic compound is an organic alcohol and the nitrosyl agent is HONO.
140. The method of Claim 127, wherein the organic compound is an organic alcohol and the nitrosyl agent is sodium nitrite and trifluoroacetic acid.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US78783006P | 2006-03-31 | 2006-03-31 | |
US60/787,830 | 2006-03-31 |
Publications (3)
Publication Number | Publication Date |
---|---|
WO2007117404A2 true WO2007117404A2 (en) | 2007-10-18 |
WO2007117404A9 WO2007117404A9 (en) | 2007-11-29 |
WO2007117404A3 WO2007117404A3 (en) | 2008-11-06 |
Family
ID=38581558
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2007/008221 WO2007117404A2 (en) | 2006-03-31 | 2007-03-30 | Methods and materials for preparing organic compounds from primary amines |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2007117404A2 (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2013063296A1 (en) * | 2011-10-25 | 2013-05-02 | The Scripps Research Institute | Synthesis of libraries of peptide tertiary amides |
CN116023283A (en) * | 2023-02-28 | 2023-04-28 | 上海创拓生物科技有限公司 | Preparation method of m-nitro aromatic ring compound |
-
2007
- 2007-03-30 WO PCT/US2007/008221 patent/WO2007117404A2/en active Application Filing
Non-Patent Citations (1)
Title |
---|
LOVEJOY D.J. J. CHEM. SOC. 1968, pages 2325 - 2328 * |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2013063296A1 (en) * | 2011-10-25 | 2013-05-02 | The Scripps Research Institute | Synthesis of libraries of peptide tertiary amides |
US10370409B2 (en) | 2011-10-25 | 2019-08-06 | The Scripps Research Institute | Synthesis of libraries of peptide tertiary amides |
CN116023283A (en) * | 2023-02-28 | 2023-04-28 | 上海创拓生物科技有限公司 | Preparation method of m-nitro aromatic ring compound |
Also Published As
Publication number | Publication date |
---|---|
WO2007117404A3 (en) | 2008-11-06 |
WO2007117404A9 (en) | 2007-11-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP7500102B2 (en) | Intermediate for synthesizing camptothecin derivatives, production method thereof and use thereof | |
EP1554237A1 (en) | Methods for synthesis of acyloxyalkyl derivatives of gaba analogs | |
KR100205769B1 (en) | Stereoselective preparation method of transazetidinone | |
Quadrelli et al. | The mild oxidation of nitrile oxides affords a convenient entry to nitrosocarbonyl intermediates, versatile tools in organic syntheses | |
JP2024009896A (en) | Method for producing prostaglandin analogs that donate nitric oxide | |
WO2007117404A2 (en) | Methods and materials for preparing organic compounds from primary amines | |
KR870000310B1 (en) | Process for preparing penicillanic acid 1,1-dioxide and derivatives | |
CN113278021B (en) | Preparation method of 1, 7-diazaspiro [3.5] nonane-7-tert-butyl formate and oxalate thereof | |
CN111170933B (en) | Preparation method of 2-chloro-5-nitropyridine | |
Wiberg et al. | 2-Substituted bicyclo [1.1. 1] pentanes | |
EP0108547A2 (en) | Process for the preparation of the 1'-ethoxycarbonyloxyethyl ester of benzylpenicillin | |
JP2022544284A (en) | Process for preparing 1,4-dihydro-4-oxoquinoline-2-carboxylate and 4-aminoquinoline compounds therefrom | |
JP3536480B2 (en) | 4,5-Dihalogeno-6-dihalogenomethylpyrimidine and process for producing the same | |
JPH06298683A (en) | Production of 4-(2-substituted)-phenylbenzyl bromide by photo-reaction | |
JPS5826733B2 (en) | Ensocaldehydono Seizouhouhou | |
CN111233857B (en) | Synthetic method for continuously producing pexidininib | |
KR102758184B1 (en) | New synthetic process of aminolevlunic acid derivatives | |
CN115417803B (en) | Synthesis method of Wu Pa tenib intermediate (3R, 4S) -1-benzyloxycarbonyl-4-ethylpyrrolidine-3-carboxylic acid | |
US3417095A (en) | Method of producing pyridoxine by reducing a precursor gamma lactone with a complex borohydride | |
KR100856133B1 (en) | Improved process for preparing atorvastatin | |
CN118598743A (en) | A kind of synthesis method of 2,2-dimethylcyclobutanecarboxylic acid | |
JP2517836B2 (en) | Process for producing 4-chloroimidazole-5-carbaldehyde derivative | |
CN119285508A (en) | Method and application of synthesizing N-sulfonyl amidine compounds using copper-catalyzed calcium carbide as acetylene source | |
JP3257371B2 (en) | Method for producing 5-phthalimido-4-oxopentenoic acid or its pyridine salt | |
CH616424A5 (en) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 07754705 Country of ref document: EP Kind code of ref document: A2 |
|
NENP | Non-entry into the national phase in: |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 07754705 Country of ref document: EP Kind code of ref document: A2 |